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Sex differences are widespread in both mouse and human liver, and are 
associated with sex differences in drug metabolism and liver pathophysiology. 
The secretory patterns of growth hormone (GH) is one of the major drivers of 
liver sex specificity, where intermittent and continuous secretion in male and 
female respectively lead to sex bias in the expression of more than 1000 genes 
in mouse liver, via a complex interplay of GH-responsive transcription factors and 
epigenetic mechanisms. This thesis explores three themes of molecular control 
in the regulation of liver sex differences: microRNAs, DNA methylation, and 
translational control.  Studies herein identified two microRNAs, miR-1948-5p and 
miR-802-5p, whose expression is sex biased and regulated by GH and the 
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transcription factor STAT5b.  Small RNA sequencing confirmed the sex 
specificity of these two microRNAs and identified an additional 18 sex-biased 
microRNAs.  Computational and experimental characterization of miR-1948-5p 
and miR-802-5p confirmed their authenticity. In vivo inhibition of these 
microRNAs by locked nucleic acids indicated that miR-1948-5p and miR-802-5p 
played a functional role in repressing female-biased genes and male-biased 
genes, respectively. This thesis also investigated the impact of GH and STAT5b 
on liver DNA methylation profiles. Reduced representation bisulfite sequencing 
was performed on liver tissues from four mouse models that perturbed the GH 
and STAT5b axis.  In the wildtype liver, sex biased demethylation was positively 
associated with sex biased chromatin opening and gene expression. Global 
hypermethylation was observed in livers of mice with lit/lit mutation resulting in 
GH deficiency or with hepatocyte-specific deletion of the STAT5ab locus. 
Strikingly, these hypermethylated loci were enriched for enhancer elements and 
STAT5b binding sites found in wild-type mouse liver.  Hypophysectomy followed 
by GH replacement mouse models identified differentially methylated regions that 
were sex-biased and rapidly methylated and demethylated in response to GH 
stimulation. Finally, we used ribosome profiling to validate sex-biased protein 
translation and identify mechanisms of translational control. In sum, this body of 
work provides novel insights and broadens our understanding of the diverse 
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Liver is  recognized as a sexually dimorphic organ in many species including 
humans.  Clinically, sex dependent differences are observed in liver metabolism 
and diseases, most strikingly evidenced in the disproportionately higher 
incidences of hepatocellular carcinoma among men than women.  Sex 
differences in the expression levels of P450 enzymes also lead to sex biased 
drug response, as evidenced in the higher clearance rate of many drugs in 
women due to the elevated levels of CYP3A4.  In mouse model, sex differential 
expression characterizes more than 1000 hepatic genes as the result of sex 
biased secretion frequencies of growth hormone (GH), which is a polypeptide 
hormone secreted by the anterior pituitary with wide ranging physiological effects 
on metabolism and somatic growth.  GH secretory pattern is sex differential upon 
puberty in many species including humans; generally characterized by more GH-
free intervals in the male sex.  In male mice, high levels of GH is secreted in 
sharp pulses every 3 to 4 hours, with little to undetectable level of GH between 
pulses.  In contrast, GH is secreted in high frequency in female mice, eliminating 
the interpulse intervals.  This sex specific GH secretory profiles impart temporally 
differential stimulation to various GH responsive transcription factors in the liver 
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notably STAT5b, among a complex network involving CUX2, BCL6 and multiple 
hepatocyte-enriched nuclear factors (HNFs).  These mechanisms effectively 
tailor the hepatocyte chromatin structure, histone landmarks and transcription 
profiles to the metabolic needs of each sex. 
 
This thesis explores three aspects of regulation that may be involved in shaping 
liver specificity: microRNAs, DNA methylation and translational control.  In 
Chapter 2, I present my findings on two sex specific microRNAs, miR-802 and 
miR-1948, which show female and male bias respectively, that are regulated by 
growth hormone and STAT5.  Efforts to elucidate the in vivo targets of these two 
microRNAs are also shown.  In Chapter 3, I present RRBS data delineating the 
DNA methylation changes taking place in three mouse models where GH 
secretion is perturbed, including lit/lit mice, hypophysectomy and GH 
replacement and continuous GH infusion.  Chapter 4 describes the RNA-seq and 
RRBS on mouse liver with hepatocyte-specific deletion of STAT5, elucidating the 
impact of STAT5 on gene expression and DNA methylation in liver.  In Chapter 5, 
I discuss the ribosome profiling data, its technical bias and utility for identifying 






1B.  Sex specific secretion of growth hormone and its impact of liver sex 
bias 
 
Growth hormone (GH) is a protein hormone of 191 amino acids secreted by the 
anterior pituitary that exerts systemic effects on metabolism and cell 
differentiation (Waters and Brooks, 2012).  The liver is acutely sensitive to the 
pattern and strength of GH stimulation (Baik et al., 2011).  Activation of the GH 
receptors in the liver induces complex signaling cascade that leads to 
widespread changes in gene expression, directly stimulating genes such as the 
growth promoting IGF-I (Rotwein, 2012).  GH, like other anterior pituitary 
hormones, is secreted episodically by orchestration of growth hormone releasing 
hormones and somatostatin (Frohman et al., 1992).  Mice and rats exhibit 
prominent sex dependent differences in the temporal pattern of GH secretion.  In 
male rats and mice, high levels of GH is secreted in sharp pulses every 3 to 4 
hours, with little to undetectable level of GH between pulses.  In contrast, GH is 
secreted more continuously in female mice (Jansson et al., 1985b).  This striking 
regularity and sex differentiation of GH secretion in rats and mice make them 
ideal animal models for studying the sex dependent effects of GH on the liver.  
This sex specific GH secretion is observed in many species , and to a subtle 
degree, in humans as well (Pincus et al., 1996).  Early studies have found that 
circulating GH profile regulates sex dependent transcription of key drug 
metabolizing enzymes and P450 enzymes (Zanger and Schwab, 2013), 
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potentially contributing to the clinically significant sex differences in liver 
physiology, metabolism and disease susceptibility (Waxman and Holloway, 
2009b; Wiwi et al., 2004).  In mouse liver, over 1000 genes exhibit sex biased 
expression (Clodfelter et al., 2006).  Near global loss (94%) of sexual dimorphism 
is achieved by adult hypophysectomy (Wauthier et al., 2010b), but not by 
castration or ovariectomy , demonstrating that an intact pituitary is necessary for 
liver sex specificity (Colby et al., 1973; Denef, 1974).   
 
1C. The role of GH-free periods between GH pulses 
 
The defining feature of male GH secretion pattern is the prolonged GH free 
periods between the high amplitude pulses (Jansson et al., 1985a).  In males, 
exposure to neonatal androgens imprints the pulsatile adult GH secretion pattern 
beginning at puberty, and accounts for the masculinization of liver metabolic 
profiles and somatic growth (Cadario et al., 1992; Lofgren et al., 2009).  The GH-
free inter-pulse period allows the hepatocytes to reset the GH-activated 
intracellular signaling pathways, and is required for the expression of many male 
specific liver enzymes, such as cyp2c11 (Waxman et al., 1991).  When a 
subcutaneous osmotic pump that releases continuous GH is implanted to 
override the endogenous GH pulses, the male pattern of liver gene expression is 
abolished and many female specific genes are induced (Holloway et al., 2006a; 
Lau-Corona et al., 2017).  Feminization of the male liver is similarly achieved by 
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knockout of the somatostatin peptide (Low et al., 2001).  Somatostatin is a GH-
release-inhibiting factor secreted by the hypothalamus responsible for the low 
plasma GH between the pulses in males.  Absence of somatostatin eliminates 
the GH-free troughs, resulting in continuous GH profile that promotes a female-
like expression pattern (Banerjee et al., 2013).  Both the continuous GH 
treatment and the somatostatin KO demonstrate that GH-free intervals are 
obligatory to express the masculinizing effects of pulsatile GH.   
 
1D.  Classification of sex specific genes based on hypophysectomy 
 
Hepatic genes that are expressed in a sexually differentiated manner can be 
classified as either male or female specific, the former being more highly 
expressed in the males than in females and the latter vice versa. Male and 
female specific genes can be further divided based on their responses to 
hypophysectomy (hypox) into two sub-categories: class I and class II, to reflect 
the disparate, albeit not fully understood, mechanisms underlying the relative sex 
biased expression patterns.  Male specific genes can arise from two divergent 
mechanisms: active induction by male pituitary hormone profile (male class I 
genes) or active repression by the female pituitary hormone profile (male class II 
genes). Therefore, male class I genes require the male pituitary hormone profile 
for full expression and are consequently repressed in hypophysectomized male; 
whereas the male class II gene, being repressed by the female pituitary hormone 
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profile, become de-repressed upon hypophysectomized in females. The same 
logic applies to female specific class I and class II genes. Of the genes affected 
by hypox, the vast majority (88%) of male specific genes are class I, whereas 
64% of female specific genes are class II. Interestingly, hypophysectomy has 
greater impact on sex specific genes in male than in female mouse liver.  
Hypophysectomy followed by GH replacement also offers another mean to use 
GH responsiveness to characterize direct versus indirect regulation: genes 
responding rapidly to GH (within 90min) may represent direct targets 
GH/STAT5b; while slow responding genes (several days) suggest involvement of 
cooperation with multiple transcription factors or epigenetic mechanisms 
(Wauthier et al., 2010b).   
 
1E.  STAT5b signaling pathway 
 
Transcription factors from the family of Signal Transducers and Activators of 
Transcription (STAT) are activated by cytokines and growth factors and a variety 
of tissues (Paukku and Silvennoinen, 2004).  In liver, STAT5 mediates the 
majority of GH signaling (Baik et al., 2011).  STAT5 includes two closely related 
members: STAT5A and STAT5B.  While STAT5A is more prevalent in mammary 
tissues where it regulates aveolar development (Liu et al., 1997), STAT5B is 
more abundant in liver and muscle, absence of which leads to stunted growth 
(Herrington et al., 2000).  The binding of GH to the growth hormone receptor 
7 
 
(GHR) activates the membrane bound tyrosine kinase JAK2.  JAK2 
phosphorylates the cytoplasmic domain of GHR, generating docking sites for Src 
homology 2 (SH2) domain containing STAT5B, which is transformed from latent 
monomer to activated dimer.  The activated STAT5B dimer then translocates to 
the nucleus where it stimulates gene transcription, thereby propagating multiple 
intracellular signaling pathways with far-reaching effects in the cell (Ram and 
Waxman, 1997).   
 
STAT5B show preferential responsiveness to the male plasma GH pattern (Choi 
and Waxman, 2000).  STAT5B in male rat liver is rapidly activated in response to 
each pulse of male GH, and then quickly deactivated by tyrosine phosphorylases 
and returned to the cytoplasm in the inactive form.  In contrast, STAT5B in 
female rat liver is maintained at a low but persistent activity level by the 
continuous presence of GH in the plasma (Choi and Waxman, 1999; Waxman et 
al., 1995b).   
 
1F.  The roles of STAT5B in regulating liver sex biased genes 
 
STAT5B have been found to be the primary mediator of the sex-dependent 
effects of GH in the liver (Gebert et al., 1997).  Whole body deletion of the 
STAT5B gene revealed that STAT5B is required to maintain the expression of 
~90% of male biased genes and for repression of a subset (~60%) of female-
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biased genes in male mouse liver.  The effect of STAT5B deficiency on gene 
expression is much more modest in females (Clodfelter et al., 2006; Udy et al., 
1997b).  Knockout of STAT5A, an neighboring isoform with 90% sequence 
similarity to STAT5b but expressed at a much lower level, has little effect on the 
sex specific gene expression in the liver(Clodfelter et al., 2007).  To further 
confirm the direct roles of STAT5B in the liver, STAT5B KO mice were 
hypophysectomized and given exogenous pulses of GH.  Whereas exogenous 
GH pulses restored male pattern of gene expression in hypophysectomized 
wildetype mice, hypophysectomized STAT5 KO mice failed to respond to GH 
replacement treatment (Davey et al., 1999).  This confirmed that STAT5 is 
essential for mediating the sex-dependent effects of GH in the liver.  STAT5 can 
regulate transcription by direct binding or indirect regulation involving 
intermediate signaling molecules and transcription factors.  STAT5 chip-seq 
experiments revealed that only 35 to 40% of the sex biased genes have proximal 
STAT5b binding in male mouse liver, suggesting that STAT5 responsive genes 
are regulated by both direct and indirect mechanisms (Zhang et al., 2012).  
Although STAT5 is clearly required for sexually dimorphic expression of liver 
genes, STAT5 activation by itself is not sufficient to impart male pattern of liver 
gene expression.  Activation of STAT5 by exogenous GH in pre-pubertal rat liver, 
which contains adult levels of STAT5 proteins, is unable to induce the male-like 
expression profile as did for hypophysectomized adult rats (Choi and Waxman, 
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2000).  This suggest that additional regulatory factors are required to act in 
concert with STAT5b to regulate sex specific target genes. 
1G.  Other transcription factors involved in liver sex bias 
 
Other factors implicated in GH-dependent, sex-differential liver gene expression 
include several hepatocyte-enriched nuclear factors (HNFs) (Wiwi and Waxman, 
2004b), the homeobox CDP family member CUX2 (Gingras et al., 2005)  and 
BCL6 (Chang et al., 1996).  Hepatocyte nuclear factor (HNF) 4α is a liver specific 
orphan receptor that is critical for liver development and regulation of CYP genes, 
many of which show sex specific expression (Li et al., 2000; Tirona et al., 2003).  
HNF4α participates in complex crosstalk with other HNFs.  Liver-specific HNF4α 
disruption increases hepatic HNF3β and HNF6 RNA levels in males, but has no 
effect in females, indicating that HNF4α confer negative regulation to these 
factors in a male-specific manner (Park and Waxman, 2001; Wiwi and Waxman, 
2004b).  Consequently, the effect of  HNF4α knockout is substantially greater in 
male liver than female liver, where down-regulation of male specific genes and 
up-regulation of female specific genes leads to the loss of sex specificity for 90% 
of sex-specific genes in the male liver, the majority of which also show 
dependence on STAT5b (Holloway et al., 2006b; Holloway et al., 2008; Wiwi et 
al., 2004).  Liver sex-biased genes are mediated by both transcriptional 
activators as well as repressors.  BCL6 is a male specific repressor in both 
mouse and rat liver that is rapidly activated by male GH pulses and repressed by 
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female continuous GH (Meyer et al., 2009).  A substantial fraction of BCL6 
binding sites in male liver overlap with STAT5b binding sites, with enrichment for 
female specific genes, indicating that BCL6 competition with STAT5b is a 
mechanism for the repressing female specific genes in male liver (Zhang et al., 
2012).  Similarly, Cux2, a highly female specific repressor with HNF6/CDP motif, 
is found to repress male specific genes and activate female specific genes in the 
female liver (Laz et al., 2007).  Overexpression of CUX2 via adenovirus delivery 
strikingly induced 36% of female-biased genes and repressed 35% of male-
biased genes in male liver (Conforto et al., 2012).  CUX2 binding sites in the 
female liver are also enriched for HNF6 binding and male-biased STAT5b 
binding associated with male specific genes, suggesting that the inhibitory 
function of CUX2 involves binding site competition (Conforto et al., 2015).  Thus, 
multiple factors in addition to STAT5b are required to coordinate sex-biased gene 
expression in liver. 
 
1H.  Epigenetic regulation involved in liver sex bias 
 
There is increasing evidence demonstrating the importance of epigenetic control 
in the regulation of liver sexual dimorphism. Direct support for the role of 
epigenetic factors comes from the discovery of robust sex differences in 
chromatin structures characterizing more than 1000 DNase hypersensitivity sites 
in the liver, whose open chromatin structure correspond to enhancer elements 
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and transcription factor binding.  The vast majority of male biased DHS sites are 
suppressed by continuous GH treatment in the male liver, while a subset of 
female biased DHS are induced (Ling et al., 2010a).  In another study, global 
chromatin states in male and female liver was established by chip-seq data on a 
panel of six histone marks: K36me3, K9me3, K27me3, K4me1 marks, as well as 
the DHS dataset.  Sex differences in chromatin states are observed near sex 
specific DHS sites, but not at sex specific genes, indicating epigenetic regulation 
occur distally to genes.  H3K27me3 – a histone mark associated with the inactive 
heterochromatin state, is found to be enriched in the male liver at a subset of 
female biased gene (Sugathan and Waxman, 2013b). This observation suggests 
that H3K27me3 is a unique mechanism of gene suppression regulating sexual 
dimorphism in the male liver. 
 
1I.  DNA methylation in vertebrates 
 
Covalent methylation at position 5 of cytosine (5mC) is a highly conserved 
epigenetic mark found in most plant and animal models.  Cytosine methylation 
can occur in three sequence contexts: CG (CpG), CHG, or CHH, where H 
correspond to A, T or C.   In vertebrates, DNA methylation occur primarily in CpG 
dinucleotides, the vast majority of which are methylated with the exception of 
CpG islands (CGI) typically associated with promoters of actively transcribed 
genes (Schubeler, 2015).  Non-CpG methylation is observed in the brain and in 
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embryonic stem cells (Hon et al., 2013).  DNA methylation occur throughout the 
entire genome in vertebrates, as opposed to a mosaic pattern as seen in plants 
and invertebrates, and it is generally associated with stable gene repression 
seen in X chromosome dosage compensation, heterochromatin formation at 
pericentromeric regions, and control of imprinted genes in a parent of origin 
manner (Jones, 2012).  Mechanistically, DNA methylation can interfere with 
transcription factor binding, or recruit methyl-CpG binding domain (MBD) proteins 
to alter chromatin environment (Ambrosi et al., 2017).  However, DNA 
methylation is not always essential to eukaryotic gene regulation as it is absent in 
many organisms, such as yeast and Drosophila melanogaster (Lee et al., 2010). 
 
The CG content of vertebrate genome is less than expected by chance: about 
41% in the human genome.  The depletion of CG over evolutionary time occur 
through inefficient base excision repair.  Spontaneous deamination of 
unmethylated cytosines results in uracil, which is efficiently removed by uracil 
DNA glycosylase followed by base excision repair.  On the other hand, 
spontaneous deamination of methylated cytosine results in thymine, which is a 
proper base and not efficiently removed (Wu et al., 2012).  The result is a bias for 
C to T mutation at CpG dinucleotides, which is a leading source of disease-
causing point mutation (Iengar, 2012).  CPIs retain their expected CG content, as 
they are constitutively unmethylated, regardless of the state of expression 
(Illingworth and Bird, 2009).  Inactive CGIs can remain unmethylated at the DNA 
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level but acquire methylation at H3K27me3, demonstrating that DNA methylation 
is not required for gene repression in most cases (Taberlay et al., 2011).  At 
minority of CPIs where CpG methylation do occur, the result is long-term gene 
repression (Jaenisch and Bird, 2003). In other genomic regions, DNA methylation 
is elevated in gene bodies with transitions at splice junctions, suggesting a role 
for DNA methylation in regulating splicing and suppressing spurious start sites 
(Jjingo et al., 2012; Schwartz et al., 2009).  Enhancers are usually CpG poor, and 
exhibit variable levels of DNA methylation.  Since an individual CpG can only 
exist in a binary state: 0% or 100% methylated, "variable methylation" detected at 
a given CpG site is the averaging of the binary states in the cell, which could 
reflect the competing methylation and demethylation events at the given moment 
(Heyn et al., 2016; Jones, 2012).   
 
1J.  DNA methylation in development 
 
The genome undergo waves of global demethylation and remethylation during 
embryonic development (Cedar and Bergman, 2012; Smith and Meissner, 2013).  
In the blastocyst stage, almost all methylation is erased except for imprinting 
centers .  It is thought that this 'clearing of slate' is the key mechanism for 
resetting the genome after gametogenesis , establishment of CpG islands and 
activation of key pluripotenecy genes (Okae et al., 2014).  After the blastocyst 
stage during  implantation, an upregulation of de novo methylases, Dnmt3a and 
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Dnmt3b (Okano et al., 1999), together with Dnmt1 a maintenance methylases, 
bring about global methylation that silence most of the genome, including 
pluripotent genes such as Oct-3/4 (Feldman et al., 2006).  CpG islands are 
protected from the global methylation by combination of cis-regulatory elements, 
histone mark H3K4me3, specific motifs, and transcription factor binding 
(Straussman et al., 2009).  The resulting basal methylation pattern established at 
the time of implantation is stably maintained during all subsequent cell divisions 
though the entire life time of the organism, with CGI ensuring stable expression 
of many housekeeping genes.  The perpetuation of DNA methylation pattern 
through cell divisions is accomplished by Dnmt1, which lacks de novo 
methylation ability but is highly specific for hemimethylated CpGs generated 
during DNA synthesis (Svedruzic, 2011).  Further adjustments of DNA 
methylation can occur in response to disease states and environmental stimuli in 
a tissue specific manner (Robertson, 2005). 
 
1K.  Relationship between DNA and histone methylation 
 
Since DNA methyltransferase has no inherent sequence specificity beyond 
recognizing CpG dinucleotides, targeting of DNA methylation to specific genomic 
loci is  achieved by concerted interactions involving transcription factors and 
histone methylation chromatin states (Du et al., 2015; Rose and Klose, 2014).  
While the link between DNA and histone methylation is complex and difficult to 
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generalize, several salient relationships emerges.  Firstly, targeting of DNA 
methylation to heterochromatin  is primarily dependent on preexisting H3K9 
methylation (Lehnertz et al., 2003).  This is supported by biochemical studies 
demonstrating physical interactions between H3K9 methyltransferase G9a/GLP 
and Dnmt3a/b (Chang et al., 2011).  In contrast, a mutually exclusive relationship 
exist between CpG methylation and nucleosome bearing H3K4me2 or H3K4me3 
marks, which is the mechanism precluding DNA methylation at CGI promoters 
(Ooi et al., 2007).  K27me3 and DNA methylation have been found to overlap 
indicating that the two marks are compatible, although the mechanisms of 
interactions are not clear (Hagarman et al., 2013).  Finally, it is important to keep 
in mind that de novo methylation requires the presence of nucleosome as 
substrate, therefore constitutively open chromatin cannot acquire DNA 
methylation (Ooi et al., 2007). Integrated analyses of chromatin and DNA 
modifications thus represent a powerful approach to understand underlying 
regulatory activities in the genome. 
 
1L:  DNA methylation changes after implantation: targeted methylation and 
demethylation 
 
While methylation pattern in somatic cells reflects the state at implantation, 
additional changes may occur as a result of environmental influences or as a 
consequence of aging and disease.  Studies have shown that de novo 
methylation and demethylation after implantation is almost always mediated by 
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transcription factors and histone methylases .  A well studied process is the 
inactivation of pluripotency genes Oct3/4 and nanog in embryonic stem cells.  
Inactivation of these genes take place in sequential steps: 1.  transcription is 
halted by repressive factor; 2.  activating histone marks are removed; 3. 
deposition of H3K9 methylation by G9a; 4.  Dnmt3 de novo DNA methylation 
ensures the stable and irreversible repression of these genes (Athanasiadou et 
al., 2010; Feldman et al., 2006).  This example illustrates that DNA methylation 
itself does not initiate repression; rather it suggests that DNA methylation serves 
to solidify the repressed cell state. 
 
DNA demethylation events create low methylation regions in the genome, often 
in a context specific manner.  It is achieved by either by passive loss via lack of 
maintenance, or targeted demethylation by TET enzymes.  Passive 
demethylation is achieved through successive cycles of replication in the 
absence of sufficient Dnmt1 maintenance activity (Kagiwada et al., 2012).  
Targeted demethylation occurs rapidly at many tissue specific genes.  The major 
mechanism for active demethylation in mammals is facilitated by the Tet family of 
DNA dioxygenases, which consists of mammalian members Tet1, Tet2, and Tet3.  
Tet enzymes  mediate step-wise oxidation cascade of 5-methylcytosine (5mC) to 
5-hycroxymethylcytosine (5hmC) and further oxidized to 5-formylcytosine (5fC) 
an d5-carboxycitosine (5caC).  Final demethylation of these oxidized cytosines is 
achieved via replication dependent dilution (as Dnmt1 does not recognized 
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oxidized C), chemical reversal by putative decarboxylases, or TDG mediated 
base excision repair (Kohil and Zhang, 2013).  Demethylation of genes is 
associated with but not required for gene activation.  It is proposed that 
demethylation is driven in part by trans-acting transcription factors and histone 
modifiers(Bestor et al., 2015).   
 
1M.  Perspective on the impact of DNA methylation  
 
The majority of mechanistic studies suggest that DNA methylation is the 
consequence rather than the cause of transcription factor activity, that presence 
or absence of DNA methylation by itself does not repress or activate genes 
respectively (Bestor et al., 2015).  The most straightforward example is that the 
CGI in the promoters of NANOG and OCT4 genes remain unmethylated even in 
differentiated non-expressing tissues (Li et al., 2007), indicating that DNA 
methylation is unlikely to be the mechanism by which the gene is repressed . In 
examples where loss of DNA methylation is correlated with gene activation, 
evidences supports a transcription-induced rather than a transcription-causing 
mechanism.  For example, DNA methylation is reduced around methylated lac 
operator upon binding of the lac repressor in mammalian cells (Han et al., 2001).  
A line of studies demonstrating that loss of DNA methylation does not cause 
aberrant gene expression comes from the creation of Dnmt1 mutant mouse 
embryos, where de-repression of gene was not observed despite severe global 
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demethylation (Walsh and Bestor, 1999).  The Dnmt1-null cells retain normal 
phenotype but undergo apoptosis when differentiated via unknown 
mechanisms(Li et al., 1992).  Similarly, mice lacking the TET1 and TET2 proteins 
are largely viable and fertile, arguing against the central role of demethylation in 
gene regulation (Dawlaty et al., 2013).  Enhancers distal to genes generally 
contain low CpG content and methylation .  To determine how these low-
methylated enhancers are formed, Stadler et al introduced a CTCF motif into an 
otherwise methylated reporter construct and found that CTCF binding is 
necessary and sufficient to create a low methylated region (Stadler et al., 2011).  
It is clear that the essential role of DNA methylation lies in irreversible gene 
silencing involved in imprinted genes and repeat regions (Bestor, 2003).  In 
controlling post-natal dynamic gene expression, transcription factors is the 
dominant force (Jin et al., 2011).   
 
1N.  Liver sex specific DNA methylation 
 
Several early studies have investigated the involvement of DNA methylation in 
regulating liver sex specific genes.   Negishi group found that male preferential 
demethylation occur at the promoter of cyp2d9 and slp genes, both are highly 
male specific genes (Yokomori et al., 1995a; Yokomori et al., 1995b).  
Conversely, female preferential demethylation occurs at female specific gene 
Cyp2a4 (Li et al., 2009b).  In vitro binding experiments suggested that 
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transcription factors bind to these promoter elements only when demethylated, 
suggesting that DNA methylation may regulate liver sex biased genes by 
directing methylation sensitive transcription factors (Yokomori et al., 1995a).  The 
advent of next generation sequencing increased the throughput of DNA 
methylation studies from loci specific analysis to genome-wide precision 
measurements.  The most comprehensive study of DNA methylation in liver sex 
bias comes from the study by Reizel et al, where reduced representation bisulfite 
sequencing (RRBS) was used to analyze male and female mouse livers at 1, 3, 8 
and 20 weeks of age (Reizel et al., 2015).  While male and female livers showed 
equivalent methylation profiles at young age, the male liver undergo progressive 
demethylation beginning at 8wks of age that become more pronounced at 20 
week of age.  This male specific pattern of demethylation is abolished by 
castration at 20 days of age and reversed by testosterone replacement, 
demonstrating that this sex biased DNA methylation pattern is testosterone   
dependent, potentially involving crosstalk with the pituitary GH secretion. These 
demethylated regions correspond to enhancer elements shown by the 
enrichment of H3K4me1and H3K27ac histone marks and male preferential 
binding of several key TFs: STAT5, BCL6 and RXR.  However, castration during 
adult did not reverse the hypomethylated state in the male liver, supporting a 
model where DNA methylation confer epigenetic memory that maintains the 
established DNA methylation states even in the absence of the original induction 




1O.  Technologies to detect DNA methylation 
 
Genome-wide wide measurements of cytosine methylation is made feasible by 
bisulfite treatment followed by high-throughput sequencing, which provides far 
higher resolution and accuracy than enrichment methods using antibodies, such 
as meDIP (Sun et al., 2015; Yong et al., 2016).  Bisulfite treatment of DNA 
converts cytosine nucleotides to uracil, but leaves 5-methylcytosine residues 
unaffected.  During PCR, the converted uracils are amplified as thymine. 
Therefore, the ratio of cytosines and thymine reflects the percent methylation at 
the given CpG site.  Sequencing of bisulfite treated DNA can be performed on a 
genome-wide scale: whole genome bisulfite sequencing (WGBS)(Adusumalli et 
al., 2014), or on a selection of the genome, such as reduced representation 
bisulfite sequencing (RRBS) (Gu et al., 2011).  Currently, WGBS is cost 
prohibitive for most laboratories, making RRBS the method of choice to 
interrogate the DNA methylation for large number of biological samples.  The 
most common RRBS protocol uses methylation-insensitive, CpG specific 
restriction endonuclease MspI to digest genomic DNA to select for ~1% of 
genome enriched for CpGs.  RRBS provides an informative sampling of the 
genome, capturing the majority of CGI and promoters.  The drawback of RRBS is 
that it provides lower coverage at low CpG density regions such as enhancer 




1P.  microRNA biogenesis 
 
The biogenesis of miRNAs is now relatively well characterized.  First, miRNAs 
are first transcribed by RNA polymerase II as long primary transcripts in which 
the miRNA hairpin is embedded.  Primary sequences are capped and poly-
adenylated structures that largely originate from intergenic regions, suggesting 
that most miRNAs arise from autonomous transcriptional units.  A minority of 
primary sequences are found in the introns of known genes, and these are co-
transcribed with the gene.  The primary transcripts then undergo a series of 
cleavages to generate the mature miRNAs.  First, the primary transcript is 
cleaved by the conserved nuclear RNase III Drosha to release the ~80nt  
precursor of miRNA (pre-miRNAs), which are exported to the cytoplasm by 
exportin-5.  Once in the cytoplasm, the pre-miRNAs is cleaved by another RNase 
III enzyme: Dicer to generate the final ~22 not mature miRNA (Ha and Kim, 
2014).  Usually, the least thermodynamically stable strand of the ~22nt duplex is 
degraded (star/passenger strand), while the other strand (guide strand) is 
incorporated into miRNA-containing RNA-induced silencing complex (Desvignes 
et al., 2015).  Through sequence complementarily between the "seed" region of 
the mature miRNA (nt 2-8) and target site on the 3'UTR of target genes, RISC 
can inhibit the expression of target genes through two main mechanisms: 1)  de-
adenylation followed by mRNA degradation, 2) blockade of translation at the 
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initiation step or elongation step (Carthew and Sontheimer, 2009; Guo et al., 
2010; Ha and Kim, 2014). 
 
1Q.  Functions and impact of microRNAs in gene regulation 
 
MicroRNAs (miRNAs) are ~22nt regulatory RNAs conserved across all 
eukaryotes (Bartel, 2009).  Studies have shown that miRNAs exert widespread 
post-transcriptional effect on genes, where each miRNA has the potential to 
target a large number of genes.  In humans, more than 60% of protein coding 
genes are computationally predicted as miRNA targets (Friedman et al., 2009b) 
based on conserved base-pairing between the 3'UTR of genes and the 5' region 
of miRNA known as the "seed" (Lewis et al., 2005).  However, the majority of 
miRNA target interaction results in subtle repression in target proteins, usually 
less than 2 fold (Baek et al., 2008), and many miRNAs can be deleted without 
any obvious phenotype change (Ebert and Sharp, 2012).  In worms, most 
individual miRNA knockout models produce no gross phenotypes (Miska et al., 
2007), and the same can be said for several mouse models devoid of specific 
miRNAs (lacking miR-21, miR-210, etc) (Park et al., 2010).  The most prominent 
reason for lack of phenotype is that each mRNAs is co-regulated by multiple 
miRNAs.  On average, there are four conserved miRNA binding sites per UTR, 
and many more considering other non-conserved sites(Friedman et al., 2009b).  
As such, deletion of the single miRNA is unlikely to generate obvious phenotypes 
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due the build-in redundancy in the miRNA regulatory network.  It is commonly 
observed that the phenotypes related to miRNA deletion is observed only when 
stress or perturbation is applied to the system (Ebert and Sharp, 2012).  For 
example, deletion of heart muscle specific miR-208 in mouse heart produce no 
phenotype under normal circumstances, but results in failure to induce cardiac 
remodeling upon stress (van Rooij et al., 2007).  Similarly, loss miR-7 in 
Drosophila eye has little phenotype under normal condition, but showed eye 
defect when heat shocks are applied (Li et al., 2009a).   These observations lead 
to the consensus that miRNAs generally evolved to ensure the robustness of 
biological systems.  Robustness here refers to the canalization, or the ability of 
the system to maintain its function in spite of internal or external perturbations 
(Hornstein and Shomron, 2006).  As post-transcriptional regulators, miRNAs can 
counteract gene expression variations from upstream processes, such as 
transient bursts and ebbs of transcription factor activity(Blake et al., 2006), 
effectively dampening fluctuations in the output of target protein .  This model 
explains why deletion of key miRNAs results in a biological system less able to 
maintain homeostasis upon stress.   
 
1R.  Regulation at the translational level 
 
Traditionally, measurement of mRNA levels have been used as a proxy for 
measurement of protein abundance due to its throughput and technical ease 
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relative methods for protein detection such as mass spectrophotometry and 
quantitative protein gels.  However, mRNA levels and protein levels are not 
always perfectly correlated, due to the regulation of the translation.  Cellular 
protein level is determined by a multistep step process of transcription, 
translation, and turn-over of mRNA and proteins (Schwanhausser et al., 2011).  
Proteins are about 2800 times more abundant than corresponding transcripts, 
and exhibit a wide range of dynamics.  Measurements of global mRNA and 
protein abundances in mouse fibroblasts by RNA-seq and mass spectrometry 
respectively revealed that proteins levels are best explained by translation rates 
(~60%), followed by transcription rates (~38%). While mRNAs and protein levels 
are correlated (R2=0.41), translation efficiency plays a significant role in 
determining the final protein level in the cell.  Protein stability (measured by half-
life) contribute minimally to protein levels.  Similarly, mRNA levels is 
predominantly determined by the rate of transcription, rather than mRNA 
degradation. 
 
1S.  The ribosome profiling technique 
 
Ribosome profiling involves first treating the cell with cycloheximide or similar 
ribosome-halting drugs, and use RNase treatment to isolate the characteristically 
30nt RNA fragments that are protected from RNase digestion by the bound 
translating ribosomes, which are then sequenced.  As these fragments directly 
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correspond to ribosome "footprints", the technique enable the quantification of 
translational efficiency for all transcripts in the cell and hence provide a more 
accurate measure of protein levels than mRNA-seq alone (Ingolia, 2014b; Ingolia 
et al., 2011).    
 
1T.  Utilities of ribosome profiling  
 
Ribosome profiling has been instrumental in discovering a variety of biological 
processes.  For example, ribosome profiling was used to tease apart the 
contribution of translation and transcriptional repression by miRNAs, forming the 
conclusion that mammalian miRNAs predominantly act to decrease target mRNA 
levels (Guo et al., 2010).  Ribosome profiling also identifies translation outside of 
annotated protein coding genes; specifically, many lincRNAs have been found to 
contain novel open reading frames with  3-nt periodicity read densities indicating 
translation (Ingolia et al., 2014).  Ribosome footprints found in the 5'UTR region 
may represent upstream open reading frame (uORF), which is associated with 
inhibition of downstream translation of the primary ORF (Janich et al., 2015; 




Chapter 2: Sex-specific growth hormone-dependent expression of 





Sex bias characterizes many aspects of liver diseases, physiology and 
metabolism in men and women.  Growth hormone (GH) is the major determinant 
in of liver sex differentiation, where sex differences in the temporal pattern of GH 
secretion and activation of the GH-responsive  transcription factor STAT5b 
dictate sex-biased expression of more than 1000 genes in the liver, including 
many drug metabolizing enzymes.  Here, we characterize two liver-expressed 
microRNAs (miRNAs): miR-1948 and miR-802, which are within genomic regions 
that show sex differences in chromatin accessibility in adult mouse liver.  
Quantification of mature miR-1948 and miR-802 levels in postnatal mouse liver 
and in mouse models with dysregulation of pituitary hormone secretion and GH 
signaling revealed that these miRNAs are respectively expressed in a male-
biased (miR-1948) and female-biased (miR-802) manner, acquire sex specificity 
around puberty, and are dependent on the GH-activated transcription factor 
STAT5b for sex-specific expression. Global analysis of adult liver miRNA 
identified 20 sex-biased miRNAs, including miR-1948-5p and miR-802-5p, which 
are expressed at relatively high abundance. Computational analysis and 
experimental characterization established that miR-1948 is a bona-fide miRNA 
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with strong strand bias for the 5p arm, contains the correct genomic features for 
Drosha/Dicer processing, and is bound by argonaute in liver tissue.  In vivo 
studies using inhibitory locked nucleic acids sequences revealed that miR-1948-
5p preferentially represses female-biased genes and activates male-biased 
genes in male liver, and conversely, miR-802-5p represses male-biased genes 
and promotes expression of female-biased genes in female liver.  We conclude 
that miR-1948-5p and miR-802-5p are components of GH directed regulatory 





Growth hormone (GH) regulates a wide range of physiological effects, including 
longitudinal bone growth, hepatic drug and steroid metabolism, and induction of 
growth factor such as insulin-like growth factor-1 (Rotwein, 2012; Waters and 
Brooks, 2012).  In humans and other species, GH is secreted in a rhythmic 
manner by the anterior pituitary somatotrophs via complex interplay between two 
hypothalamic peptides: the stimulatory GH-releasing hormone (GHRH) and the 
inhibitory somatostatin (Bertherat et al., 1995).  The pattern of GH release is 
sexually dimorphic and is a major regulator of sex differences in liver function, 
metabolism and diseases observed in humans (Waxman and Holloway, 2009a; 
Zhang et al.). In mice, where the sex difference in GH secretion is highly 
pronounced, male GH secretion is characterized by discrete high-amplitude 
pulses every ~3.5 hr with GH-free intervals in between pulses.  In female mice, 
GH is secreted at a higher frequency but at a lower amplitude, resulting in the 
near continuous presence of GH in circulation (Jansson et al., 1985a).  The liver 
is particularly sensitive to these sex differential GH secretion patterns.  GH binds 
to the dimerized GH receptor on the cell surface and stimulates tyrosine 
phosphorylation of the signal transducer and activator of transcription 5 (STAT5A 
and STAT5B; collectively, STAT5), enabling it to translocate to the nucleus and 
activate transcription of STAT5 target genes (Holloway et al., 2007b; Waxman et 
al., 1995b).  STAT5b is intermittently activated and then translocates to the 
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nucleus  following each incoming pulse of GH in male, whereas STAT5 nuclear 
activity remain relatively stable in female liver (Davey et al., 1999; Gebert et al., 
1997, 1999).  The differential stimulation pattern of STAT5 leads to more than 
1000 genes that are differentially expressed between male and female mouse 
liver, including many cytochrome P450 genes involved in drug metabolism (Choi 
and Waxman, 2000; Waxman et al., 1991).  These sex differential gene 
expression can be abolished in male liver by perturbing the GH secretion pattern 
by continuous GH infusion or hypophysectomy, further demonstrating the GH 
dependence of liver sex-biased gene expression.   
 
GH-activated STAT5 regulates sex-biased liver gene expression by both direct 
and indirect mechanisms, which involve downstream secondary regulators (Wiwi 
and Waxman, 2004b) to impart a gradient of sex specificity to target genes.  Here, 
we hypothesize that miRNAs may be a class of regulatory small RNA molecule 
that participates in GH-mediated regulatory network in liver.  MiRNAs are highly 
conserved endogenous ~22nt small RNAs  that primarily repress genes based on 
partial complementary pairing of the miRNA seed region (nucleotide 2 to 8) to the 
seed match site in the 3UTR of target gene mRNAs (Bartel, 2009; Bartel and 
Chen, 2004; Carthew and Sontheimer, 2009).  miRNA sequences are transcribed 
as long primary transcripts, within which the miRNA hairpin structures are 
embedded.  The primary transcript is sequentially cleaved by RNase III proteins 
Drosha and Dicer to generate a mature ~21nt miRNA duplex where the guide 
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strand is incorporated into the argonaute complex (Ha and Kim, 2014).  miRNAs 
are perceived to have pervasive effects on gene expression, with 60% of human 
genes is proposed to be regulated by miRNAs (Friedman et al., 2009a).  Only a 
minority of miRNAs have been experimentally validated; the vast majority of 
miRNA catalogued in miRBase database (v21) (Kozomara and Griffiths-Jones, 
2014) are uncharacterized (Chiang et al.).   
 
Here, we investigate the hypothesis that sex-biased miRNAs preferentially play a 
role in imparting subtle post-transcriptional repression to sex-biased liver mRNAs.  
We identify the global repertoire of sex-biased miRNAs in male and female liver, 
and we characterized two of the miRNAs that exhibited sex-biased expression 





2.C.1: Identification of miR-802 and miR-1948 
Initially, we searched for sex specific mouse liver miRNAs by screening Mirbase 
(v21) to identify mouse miRNA loci found within 5 kb of any of the 4,179 mouse 
genomic regions that show significant sex differences in chromatin accessibility 
in mouse liver (Ling et al., 2010a) (Table 2.1).  These 4,179 genomic regions 
were identified as DNase hypersensitivity sites (DHS) and are enriched for key 
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regulatory regions and transcription factor binding sites controlling sex-biased 
gene expression in mouse liver (Ling et al., 2010a).  This analysis revealed that 
miR-1948 and miR-802 were situated in genomic regions with multiple, robust 
sex-biased DHS.  miR-1948 was nearby a male-biased DHS, and in the intron of 
a male-biased gene Ttc39c; miR-802 was directly at a prominent female-biased 
DHS (Figure 2.1A).   
 
The strong sex-specific chromatin environment surrounding miR-1948 and miR-
802 suggested that the expression of these miRNAs may be sex-dependent.  
Quantitative real-time PRC (qRT-PCR) showed that miR-1948 is expressed at a 
~7-fold higher level in 8 week old male compared to female liver, and that miR-
802 showed ~3-fold higher expression female liver (Figure 2.1B).  Of note, each 
miRNA locus produce two mature miRNAs: one from the 5' strand and one from 
the 3' strand of the precursor, designated as 5p and 3p respectively (Desvignes 
et al., 2015).  For qPCR, we employed primers targeting the mature transcripts of 
miR-1948-3p and miR-802-5p, which represent the more biologically active 
'guide strand' according to miRBase annotation (Kozomara and Griffiths-Jones, 
2014) and in our qRT-PCR analysis, generated robust, single-product melting 
curves.   
 




Next, we examined the expression of miR-1948-3p and miR-802-5p during post-
natal liver development, and in mouse models where GH levels and/or STAT5 
signaling are perturbed.  Levels of miR-122, the most abundant liver specific 
miRNA(Hu et al., 2012), were measured in parallel as control.  These analyses 
demonstrated that the sex differences in miR-1948 and miR-802 expression 
emerge around puberty, which is a pattern that characterizes the majority of sex 
specific genes (Conforto and Waxman, 2012) (Figure 2.2).   
 
To determine whether miR-1948 and miR-802 are dependent on pituitary 
hormones, we measured their expression levels in liver of hypophysectomized 
(Hypox) mice.  Hypox involves surgical removal of the pituitary gland, which 
obliterates the production of GH and all other pituitary derived hormones, and 
results in near global loss liver sex differences (Wauthier et al., 2010a).  
Following hypox of male mice, miR-1948 expression decreased while miR-802 
expression increased, indicating that both miRNAs are regulated by pituitary 
hormones (Figure 2.3A).  In contrast, hypox of the female mice had no 
significant impact on liver miR-1948 and miR-802 expression. Further, we 
examined livers from somatostatin (STT) knockout mice (Low et al., 2001) to 
characterize the dependence of miR-1948 and miR-802 on pituitary GH secretory 
pattern. Somatostatin, a peptide hormone produced in the hypothalamus, is an 
agonist of GH releasing hormone (GHRH), which suppresses GHRH-induced 
pituitary GH release, thereby ensuring that each pulse of pituitary GH release in 
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followed by a GH-free interval.  Loss of somatostatin results in a persistently 
elevated basal GH level, and consequently, feminization of male liver (Low et al., 
2001).  miR-1948 expression was down-regulated to female level and  miR-802 
was up-regulated to near male levels in the absence of SST (Figure 2.3B).   
 
These findings were verified in the continuous GH-infused male mouse model, 
where continuous infusion of GH in male mice using an Alzet osmotic mini pump 
overrides the normal male plasma GH pulses, leading to down regulation of a 
large fraction male-biased genes and up regulation of female-biased genes in 
male liver (Holloway et al., 2006a; Lau-Corona et al., 2017).  miR-1948 
expression was reduced and miR-802 expression was elevated following 
continuous GH infusion, confirming these miRNAs are plasma GH pattern 
regulated (Figure 2.3D) .   
 
The GH-activated transcription factor STAT5 is a major regulator of a substantial 
fraction of sex-biased genes in mouse liver, with sex differential gene expression 
largely abolished in mice with deletion of the STAT5 locus (STAT5 KO) 
(Clodfelter et al., 2006; Holloway et al., 2007a; Holloway et al., 2006b).  To test 
whether miR-1948 and miR-802 are targets of STAT5, we measured their 
expression in hepatocyte specific STAT5 KO mice (Holloway et al., 2007b) and 
found down-regulation of miR-1948 and up-regulation of miR-802 in male liver 
(Figure 2.3C).  No changes in expression were seen in STAT5 KO female liver.  
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We conclude that male pattern of GH secretion and liver STAT5 activation are 
required for hepatic expression of miR-1948 and miR-802 in sex-dependent 
manner in male liver.  
 
2.C.3: Small RNA-seq in male and female liver 
 
We performed small RNA-seq analysis of 8 wk male and female mouse livers 
(N=6) to identify the global repertoire of sex-biased miRNAs.  The dataset was 
strongly enriched for miRNAs among other non-coding RNA types, with read 
length distribution profile peaking at length of  23 nt (Figure 2.4).  Approximately 
34% of small RNA-seq reads did not map to annotated RNA categories, but 
overlap with protein coding RefSeq genes, some of which may represent novel 
un-annotated miRNAs, or mRNA degradation intermediates.  Differential 
expression analysis identified 13 unique miRNAs from 8 miRNA families that 
showed sex differential expression at a stringent cutoff (fold-difference >2, 
FDR<5E-3, log2CPM>1), among which miR-1948 and miR-802 were confirmed to 
be top candidates (Table 2.2).  Interestingly, mmu-miR-21a-3p/5p, which is a 
highly conserved oncomir whose expression is elevated in a variety of cancers 
(Feng and Tsao, 2016), also showed male-biased expression, consistent with a  
male-biased DHS nearby this gene (Table 2.1).  The elevated expression of miR-
21 in male liver could contribute to the greater predisposition of males to liver 
carcinogenesis than females.  These analyses also confirmed the female-biased 
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expression of miR-802-5p, whose overexpression has been implicated in obesity 
associated glucose deregulation (Kornfeld et al., 2013).   
 
2.C.4: Characterization of miR-1948 
 
The majority of cataloged miRNAs lack functional information, and it is unclear 
whether these uncharacterized miRNAs represent functional genes or fortuitously 
acquired hairpin RNA structures.  Most functional studies have focused on 
broadly conserved miRNA families, and it is often assumed that poorly conserved 
miRNAs are more likely to be non-functional.  As miRNA discovery has reached 
the point to which nearly all of the novel candidates are poorly conserved, the 
question becomes whether any of these poorly conserved miRNA have any 
consequential function (Chiang et al.).  miR-802-5p belongs to a broadly 
conserved microRNA family and its functional roles have been confirmed in 
several studies (Kornfeld et al., 2013; Wu et al., 2017).  In contrast, miR-1948 is 
not conserved and is listed as a random, mis-annotated miRNA according to 
TargetScan (Lewis et al., 2005).  To determine if miR-1948 is a bona fide miRNA, 
we characterized miR-1948 with regard to its: 1) abundance; 2) pairing 
characteristics of the predicted hairpin; 3) presence of corresponding miRNA* 
species; 4) 5' heterogeneity; 5) association with argonaute proteins; and 6) 




Mouse miR-1948 is an intronic miRNA within the male-biased protein coding 
gene Ttc39c.  Based on the UCSC Broswer whole genome alignment 
(Rosenbloom et al., 2015), the primary sequence of miR-1948 is limited to the 
mouse lineage, suggesting its relatively recent evolutionary emergence. 
Supporting the propsal that miR-1948 is functional is its comparatively high 
expression (Figure 2.5A).  Secondary structure prediction for the miR-1948 
precursor sequence by RNAfold (Lorenz et al., 2011) indicated a robust hairpin 
structure (Figure 2.5B).  Further, our small RNA-seq results showed 
overwhelming discrimination in arm usage, with the expression of 5p arm 53-fold 
higher than the 3p arm miRNA (Figure 2.5B).  This finding contradicts the 
miRBase annotation (Kozomara and Griffiths-Jones, 2014) that miR-1948-3p is 
the predominant isoform.   
 
Examination of the 5' sequence heterogeneity revealed three tandem cleavage 
positions for miR-1948-5p and a two for miR-1948-3p.  Thus, five mature miRNA 
isoforms are generated from the miR-1948 locus in mouse liver, with miR-1948-
5p contributing most to the heterogeneity (Figure 2.5B).  Because the 5' start 
position of a miRNA determines its seed sequences at positions 2-7, there is 
selective pressure for the majority of conserved miRNAs to enforce precise 
cleavage of the 5' terminus to prevent generating molecules with off-target seed 
sequences (Bartel, 2009).  However, miRNAs with multiple functional isoforms 
can be generated by utilizing both arms of the hairpin or by 5' processing 
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heterogeneity (Ruby et al., 2007; Wu et al., 2009), and miR-1948 may be such a 
case. 
 
To validate the authenticity of miR-1948, we examined its association with 
argonaute by performing argonaute RNA immunoprecipitation and found that 
mature miR-1948-5p and also miR-802-5p, were significantly associated with the 
argonaute complex (Beitzinger et al., 2007), suggesting that both miRNAs are 
functional (Figure 2.5C).  Next, we used adenovirus to ectopically express in 
human HEK293 cells the ~200 nt surrounding the primary sequence of miR-1948.  
Small RNA-seq of the adeno-miR-1948-infected HEK293 cells yielded high levels 
of the mature 22 nt miR-1948-5p and much lower levels of miR-1948-3p, 
consistent with the strong preference of 5p arm usage seen in mouse liver 
(Figure 2.5D).  No miR-1948 sequences were detected in the HEK293 cells 
infected with adenoviral-GFP (negative control), consistent with mouse lineage-
specific nature of miR-1948.  This ectopic expression assay confirmed that miR-
1948 and its flanking sequences contain the correct features for Drosha/Dicer 
processing into mature miRNA.    
 
2.C.5: Inhibition of miR-1948-5p and miR-802-5p  
 
We initially investigated the potential targets of miR-1948-5p and miR-802-5p 
using TargetScan (Lewis et al., 2005), a computational tool that predicts miRNA-
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gene interactions by combination of conservation and sequence match between 
the gene 3' UTR and the miRNA seed sequence (Grimson et al., 2007).  
TargetScan predicted gene targets did not show significant enrichment for liver 
sex-biased genes (miR-1948-5p: odds ratio: 1.44, p-value: 0.06; miR-802-5p: 
odds ratio: 0.42, p-value=0.04).  While miRNA target prediction tools are useful 
for identifying genes with specific canonical seed sequences in the 3' UTR, they 
exhibit high false positive rates and do not fully capture the complexity of miRNA 
targeting in vivo (Akhtar et al., 2015; Ekimler and Sahin, 2014).  As such, we 
assess the whole liver transcriptome response following inhibition of miR-1948-
5p and miR-802-5p in vivo using locked nucleic acid sequences (LNAs) anti-
sense to miR-1948-5p and miR-802-5p delivered to male and female mice, 
respectively, i.e., to the sex where these miRNAs were more highly expressed.  
LNAs are modified RNAs with phosphorothiate backbone that are nuclease 
resistant, form highly stable heteroduplexes with target RNAs, and are well 
tolerated in vivo with minimal toxicity (Elmen et al., 2008; Kauppinen et al., 2006; 
Stenvang et al., 2012).  When injected systemically, LNAs preferentially 
accumulate in clearance organs,  specifically liver and kidneys, where they bind 
target mature miRNA and inhibit miRNA-argonaute interactions (Straarup et al., 
2010) .  LNAs with random sequences not found in the mouse lineage were used 




We focused on sex-biased genes that were responsive to LNA mediated miRNA 
inhibition.  Statistically significant differences in the distribution of sex specificity 
(male or female biased) and response to miRNA inhibition (up or down-regulated) 
appeared at the sixth day time point for miR-802-5p and at the third day point for 
miR-1948-5p (Figure 2.6A).  At these time points, genes responsive to LNA miR-
802-5p and miR-1948-5p inhibition were highly enriched for gene ontology 
related to cytochrome P450 (Figure 2.7).  These LNA responsive genes were 
enriched for sex biased genes, comprising of 29% (149/508) of miR-802-5p 
responsive genes and 36% (141/390) of miR-1948-5p, which represented a 
significant enrichment considering that only ~7% of liver expressed Ref-seq 
genes were sex-biased genes (Figure 2.6B,C) (LNA-miR-802: odds ratio: 4.24, 
p-value < 2.2e-16; LNA-miR-1948: odds ratio: 5.41, p-value < 2.2e-16).  LNA 
responsive genes shared minimal overlap with TargetScan predicted target 
genes.  The enrichment of sex differential genes among the putative miR-1948-
5p and miR-802-5p targets was congruent with our hypothesis that these 
miRNAs, by virtue of their sex differential expression, contribute to the sex-
biased expression of liver-expressed genes.  Of the sex-biased genes 
responsive to miR-802-5p inhibition in female liver, the majority of up regulated 
genes were male-biased and the majority of down regulated genes were female-
biased, indicating that miR-802-5p functions to repress male-biased genes and 
up regulate female-biased genes in female liver (Figure 2.6B).  The opposite 
trend was observed for miR-1948-5p inhibition, which indicates that miR-1948-5p 
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Since the initial discovery of miRNA genes let-4 and lin-7 in nematodes (Lee et 
al., 1993), thousands of miRNAs have been discovered and many have been 
found to have a pervasive impact on gene expression by post-transcriptional 
regulation (Friedman et al., 2009b), and in some cases, play causal roles in 
disease states (Li and Kowdley, 2012 
).  The challenge now is to discern authentic miRNAs and dissect their biological 
functions.  Here, we characterized two mouse miRNAs, miR-1948 and miR-802, 
and assessed their potential to regulate sex-biased genes in adult male and 
female mouse liver.  We showed that miR-1948 and miR-802 are respectively 
activated and repressed by the male-specific pattern of pituitary GH secretion 
and by plasma GH-stimulated liver  STAT5 activity, which we found are required 
for the sex differential expression of each miRNA.  LNA anti-miR experiments 
indicated that miR-1948-5p and miR-802-5p are both functionally involved in 
regulating sex-biased genes in mouse liver.  
 
We initially identified miR-802 and miR-1948 based on their sex-biased 
chromatin accessibility, determined by DNase hypersensitivity analysis (Ling and 
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Waxman, 2012), without prior knowledge of their expression status.  The 
rationale was that the presence of open chromatin (DHS) nearby a miRNA gene 
is likely to indicate cis regulation by transcription factor(s) that bind to open 
chromatin and activate the miRNA promoter or nearby enhancer, thereby 
conferring robust regulation.  miR-802 and miR-1948 were both confirmed by 
small RNA-seq to be the top sex differential miRNAs in the liver, and to be 
regulated by GH and STAT5 in male liver.  Our finding suggest that inspection of 
chromatin accessibility, which is available for many mouse and human tissues 
and cell lines, may represent a powerful approach to identify functional miRNA 
candidates.  Second, we used several complementary approaches to validate the 
authenticity of miR-1948, to rule out the possibility that it represents a spurious 
hairpin RNA, given its low conservation and intronic origin.  Small RNA-seq 
analysis of ~23 nt RNA species revealed >50-fold greater abundance of miR-
1948-5p arm than 3p arm, suggesting that the miR-1948-5p is the primary strand, 
instead of 3p, as annotated in miRBase.  Small RNA-seq of HEK293 cells over-
expressing primary sequence of miR-1948 and the surrounding 200 bp flanking 
sequences showed the same, highly asymmetrical processing of miR-1948, 
confirming the 5p bias seen in mouse liver.  These analyses illustrate the 
importance of validating a miRNA in a given experimental system, especially 




We found that the male pattern of episodic pituitary GH secretion induces miR-
1948 and represses miR-802 expression in male mouse liver.  In contrast, the 
expression of both miRNAs was largely unaffected when plasma GH patterns 
were altered in females, where pituitary GH secretion is more continuous.  
Further, perturbation of GH-stimulated liver STAT5 signaling axis by ablation of 
pituitary GH secretion (hypophysectomy) (Wauthier et al., 2010b) or by 
elimination of GH free periods between GH pulses (continuous GH infusion (Lau-
Corona et al., 2017); somatostain knockout mice (Low et al., 2001)) or by genetic 
deletion of STAT5 (STAT5 KO) (Holloway et al., 2006b)  all led to downregulation 
of miR-1948 and de-repression of miR-802 in male liver, but had no effect in 
female liver.  These patterns of regulation are all consistent with the requirement 
for male GH pulses for the sex-biased expression seen in the majority of sex-
biased genes in liver (Waxman et al., 1991; Waxman et al., 1995a; Waxman et 
al., 1995b).  GH regulates the liver transcriptome by both direct and indirect 
mechanisms.  Sex-specific transcripts with regulatory potential are candidate 
mediators of the indirect effects of GH, and efforts to identify such regulatory 
transcripts have led to discovery of novel GH and STAT5-regulated transcription 
factors such as CUX2 (Laz et al., 2007) and BCL6 (Meyer et al., 2009).  For 
example, CUX2, a transcription factor that represses many male-biased genes 
and activates many female-biased specific genes in female liver (Conforto et al., 
2012), was identified not only by its strong female biased expression, but also by 
its responsiveness to hypophysectomy in female liver and to continuous GH 
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infusion in male liver (Laz et al., 2007).  Sex-biased expression of a regulatory 
gene alone is not sufficient to infer function; response to GH perturbation is what 
establishes its GH dependence.  Based on this rationale, we can infer that miR-
802 and miR-1948 are components of gene regulation by GH specifically in male 
liver, as neither miRNA was actively regulated by GH in female liver.   
 
The question of miRNA funaction has been easier to answer for some miRNAs, 
such as miR-1 and miR-124 (Lim et al., 2005), which down regulate many target 
genes, and difficult for others, with many miRNA perturbation studies showing no 
gross phenotypes or molecular effects (Miska et al., 2007; Park et al., 2010).  
This may be partially due to the built-in redundancy of  miRNA networks, where 
each gene may be regulated by multiple miRNAs (Friedman et al., 2009b) such 
that deletion of one miRNA is compensated under normal conditions (Vidigal and 
Ventura, 2014).  When stress or perturbation is applied to the system, 
phenotypes associated with miRNAs often become apparent as the ability of the 
system to maintain homeostasis is compromised.  For example, deletion of heart 
muscle-specific miR-208 in mouse heart produce no phenotype under normal 
circumstances, but results in failure to induce cardiac remodeling upon stress 
(van Rooij et al., 2007).  Studies like these lead to the conclusion that many 
miRNAs act as "buffer" against transcriptional fluctuations, sharpen cell 
transitions, and generally confer robustness to biological systems (Ebert and 
Sharp, 2012; Posadas and Carthew, 2015).  Functional studies of sex-biased 
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miRNAs, such as miR-802 and miR-1948, may show clear-cut reciprocal sex 
bias with target genes as hypothesized, or may lead to more variable gene 
changes if the miRNAs play a more subtle role in buffering transcriptional 
changes. 
 
To determine the in vivo impact of sex-biased miRNAs, we used LNA-based anti-
miRs to inhibit miR-802-5p and miR-1948-5p function in female and male mouse 
liver, respectively, based on the rationale that inhibition of the more abundant 
strand in the sex where it is more highly expressed will be more likely to induce 
gene expression changes.  LNA antimiRs are efficacious in many clinical trials, 
e.g., where tumorgenesis was reversed by suppressing oncoMiRs using LNAs 
(Rupaimoole and Slack, 2017).  Here, we found that LNA-responsive genes were 
significantly enriched for sex-biased genes.  Moreover, sex-biased genes 
responsive to LNA-miR-802-5p and LNA-miR-1948-5p showed distinct sex-
biased distributions.  In male liver, miR-1948-5p preferentially repressed female-
biased genes and promoted the expression male-biased genes.  Conversely, in 
female liver, miR-802-5p repressed male-biased genes and induced female-
biased genes in female liver.  It is unclear why these sex-biased distributions 
appeared at different times during the course of LNA-miRNA treatment (six days 
for miR-802-5p versus three days for miR-1948-5p) with few overlap of genes 
between the two time points (data not shown); it is possible that these LNA 
sequences exhibit different kinetics in vivo.  These findings need to be 
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interpreted with caution, however, as LNA-responsive genes were identified 
using a relaxed p-value cutoff (p-unadjusted < 0.05, see Supplementary Table).  
There are several possible explanations for the relative few low p-value 
responsive genes, despite our using a large number of biological replicates (N=5).  
In animals, miRNAs generally exert subtle repression (less than 2 fold) on target 
genes (Baek et al., 2008), primarily by mRNA destabilization via poly-A 
shortening (Guo et al., 2010) and by translational repression (Selbach, 2008).  
Unless these subtle repressive effects are amplified by feedback and 
feedforward loops, subtle gene expression changes may not be effectively 
captured by RNA-seq, and even if detected, variation in the extent of repression 
may lead to high p-values.  For many miRNAs, the impact of miRNA inhibition is 
often pronounced when stress is applied.  Here, miRNA inhibition was performed 
in mice under native conditions, and loss of a single miRNA may be 
compensated by built-in redundancies in the miRNA regulatory network.  
Nevertheless, the enrichment  for sex-biased genes, and the major differences in 
responsiveness of male-biased versus female-biased genes to miR-1948-5p and 
miR-802-5p inhibition provides strong support for miR-1948-5p and miR-802-5p 
playing functional roles in regulating sex-biased gene expression in male and 
female liver.  The up regulation of genes may be due to the ability to miRNAs to 
stabilize certain target genes via direct (Vasudevan, 2012) and indirect 




The poor overlap between gene targets identified by LNA in vivo inhibition and 
the in silico predictions by TargetScan (Lewis et al., 2005) suggests that in vivo 
targets identified by LNA inhibition are not confined to genes with 3'UTR seed 
matches.  This is consistent with the notion that many non-canonical 
mechanisms of miRNA targeting occur in animal cells, including heterogeneity in 
miRNA 5' processing (Wu et al., 2009), which generates different miRNA 
isoforms with different seed sequences as seen in our analyses; non-perfect 
seed pairing; non-canonical binding sites located in 5' UTR or exons that are 
outside of canonical 3'UTR; "seed-less" interactions; indirect targets and context-
dependent targeting (Helwak et al., 2013; Pasquinelli, 2012; Rigoutsos, 2009).  
Several biochemical methods have been developed to give more reliable and 
unbiased information on miRNA-mRNA interactions.  CLASH (crosslinking, 
ligation, and sequencing of hybrids) ligates the miRNA-mRNA interactions in 
argonaute pull-down and sequences the resultant chimeric reads (Helwak and 
Tollervey, 2014).  In the future, this method may be utilized to clarify the genome-
wide miRNA interactome in male and female liver cells, which may not only 
elucidate mRNA targets of miR-802-5p and miR-1948-5p, but also those of other 
sex specific miRNAs genes. 
 
In conclusion, miR-802 and miR-1948 represent two miRNAs that are regulated 
by intermittent GH and STAT5 in male liver.  While GH regulates the majority of 
its target genes at the level of transcription initiation via transcription factor action 
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at the chromatin level (Sundseth et al., 1992), this study demonstrates that GH 
regulation also involves post-transcriptional effects mediated by sex-biased 
regulatory miRNAs, which may serve to confer robustness to the complex 
network of sex-differentiated genes that underlie the widespread sex differences 
in liver metabolism and liver disease susceptibility (Humphries, 2014). 
 
 2.E: Methods 
 
Animal models 
Hepatocyte-specific STAT5A/STATB deficient mice were generated by mating 
C57BL/6 x 129J mice having a floxed Stat5a-Stat5b locus with albumin promoter-
regulating Cre transgenic mice (FVB/N) (Holloway et al., 2007a).  Livers from 8 to 
12-wk old hepatocyte STAT5ab-deficient males and females, and floxed controls, 
were provided by Lother Hennighausen (NIDDK,NIH).  Livers were excised, snap 
frozen in liquid nitrogen and stored at -80 °C until use.  Six biological replicates 
were analyzed for each genotype: floxed male and female controls, and 
STAT5A/STAT5B knockout (KO) mice.   
 
Animal treatments for hypophysectomy (Hx) were described previously (Wauthier 
et al., 2010b).  Briefly, male and female CD1 mice were hypoxed (M-Hx, F-Hx) or 
sham operated (M-sham, F-sham) at 8 wk of age and killed approximately three 
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weeks later for analysis.  Number of biological replicates, N=4 per group:  sham 
operated male; sham operated female; hypox male; hypox female. 
 
Continuous GH infusion (Holloway et al., 2006a) was carried as previously 
described.  Alzet osmotic pumps (models 1007D (7-d pump), purchased from 
Durect Corp., Cupertino, CA) were filled with recombinant  rat GH (purchased 
from Dr. A.F.Parlow, National Hormone and Peptide Program, Harbor University 
of California-Los Angeles Medical Center, Torrance, CA) dissolved in buffer [30 
mM NaHCO3 (pH 8.3) and 0.15 M NaCl containing 100 μg/ml rat albumin].  
Pumps were implanted subcutaneously into N=5 male mice and GH was infused 
at a rate of 20 ng/g body weight for 7 days.  Mice were killed by cervical 
dislocation and livers were snap frozen in -80 °C.   
 
Somatostatin knockout liver samples were a gift of Dr. R. D. Kineman (University 
of Illinois at Chicago) (Luque and Kineman, 2007).    Analyses were carried out 
using livers from N=6 wild-type males, N=5 knockout males, N=3 wild-type 
females and N=6 knockout females.   
 
A post-natal developmental series mouse of mouse livers was that described 
previously (Conforto and Waxman, 2012), with N=4 male and N=4 female livers 




qPCR measurements of microRNAs 
 
Total RNA was extracted from liver tissue and reverse transcribed by Qiagen 
miScript II RT kit (Qiagen Cat. no. 218160), using the 5X miScript HiSpec buffer 
to selectively reverse transcribe only the mature microRNA species.  qPCR was 
performed with ABI SYBR Green reagents.  Primers were purchased from 
Qiagen miScript Primer Assay for Hs_RNU6B (MS00029204), mm-miR-122a_1 
(MS00001526), mm-mir-802-1 (MS00003101) and  mm-mir-1948-
1(MS00017143).  qPCR CT values were normalized based on the content of a 
housekeeping nuclear small RNA Hs_RNU6B_2, which is conserved across 
human, mouse and rat.  Statistical significance was determined by student t-test. 
qPCR was performed on mmu-miR-1948-3P not mmu-miR-1948-5P because the 
sequence of the mature miR-1948-5p exhibited low CG content, which precluded 
optimal primer design, leading to poor melting curve and unreliable results. 
 
small RNA sequencing and data analysis 
 
Total RNA was extracted from 6 male and 6 female 8 wk old CD1 (ICR) mouse 
liver using TRIzol.  Small RNA-seq libraries were created using NEBNext small 
RNA kit (New England Biolabs) per the manufacturer's instructions and 
sequenced on Illumina HiSeq instrument, to give single-end 50 bp sequences.  
Raw sequence reads were first trimmed by TrimGalore! (version 0.4.3) to remove 
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adapter sequences, and the trimmed reads were mapped to the mouse mm9 
genome using Bowtie1 with default parameters.  Coordinates of mature mouse 
microRNAs were downloaded from MirBase version 21 (Kozomara and Griffiths-
Jones, 2014), and the Bedtools (Quinlan, 2014) intersect command was used to 
determine the number of reads at each mature microRNA locus (bedtools 
intersect parameters: -c -f 0.8 -r ).  EdgeR (Robinson et al., 2009) was used to 
perform differential expression analyses to determine a list of sex differential 
microRNAs.  Cutoff for differentially expressed microRNAs was: fold difference 
>2, FDR < 5E-3, log2CPM>1.  For analysis of 5' processing heterogeneity, 
sequences of reads falling within the primary sequence of the miRNA were 
extracted from the bam files and analyzed using custom Python scripts.  RNA 
secondary structure and visualization was carried by RNAfold (Gruber et al., 
2008).  
 
Argonaute pull-down experiment 
 
Liver was extracted from 8 wk  old wild type male ICR CD1 strain mice, quickly 
washed and snap frozen in liquid nitrogen.  Whole frozen liver was pulverized to 
fine powder with a mortar and pestle on dry ice.  The resultant liver powder was 
UV irradiated  (at least 200 mg of liver powder spread thinly on petri dish placed 
on dry ice) with 400 mJ/cm2 and again at 200mJ/cm2 (Instrument: UV Stratalinker 
2400).  Approximately 200 mg of UV crosslinked liver powder was homogenized 
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on ice in 1 ml of 1X PXL buffer supplemented with 2 mM beta-Mercaptoethanol  
(5X PXL: 5X PBS, 1% (v/v) ipegal, 0.5% (w/v) sodium deoxycholate, 0.1% SDS) 
using a Dounce homogenizer, and 30 U of DNase (Promega M6101) was added 
and incubated at 37 °C for 5 min with gentle mixing.  The lysate was centrifuged 
at maximum speed (18K rcf) for 20 min at 4 °C, and the clarified supernatant was 
removed; a 100 μl aliquot was flash frozen and saved as the input sample.  
Protein A beads (200 μl; Thermo Fisher Scientific 10001D)  were first bound with 
50 μl rabbit anti-mouse bridging IgG (Milipore 06-371), and then bound to 2 μg of 
Ago2A8 Millipore MABE56 antibodies in 1X BWB buffer (1x PBS, 0.02% (v/v) 
Tween-20) overnight at 4 °C with gentle agitation.  The bead prep step was 
carried out a day beforehand.  The clarified lysate (should be ~800 μl)  was 
added to the loaded beads and rotated end over end for 2 hr at 4 °C.  The beads 
were washed three times with 1 ml of 1X PXL, twice with 1 ml high salt buffer (1X 
PBS, 1M NaCl, 1% ipegal, 0.5% sodium deoxycholate, 0.1% SDS), twice with 1  
ml of high stringency buffer (1 mM Tris-HCl pH 7.5, 5 mM EDTA, 2.5 mM EGTA, 
1% ipegal, 1% sodium deoxycholate, 0.1% SDS, 120 mM NaCl, 25 mM KCl), and 
once with 1 ml of low salt wash buffer (15 mM Tris pH 7.5, 5 mM EDTA).  The 
washed beads were suspended in 250 ul of proteinase K buffer (300 mM NaCl, 
200 mM Tris pH 7.5, 25 mM EDTA, 2% SDS) containing 100 μg of proteinase K 
(Bioline Cat. 37084) and incubated at 65 °C for 15 min with gentle agitation.  
Trizol LS was added directly to the digested beads to extract RNA.  qPCR was 
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performed on the input, IP, and IgG control RNA to determine the enrichment of 
each miRNA of interest. 
 
Ectopic expression of primary miR-1948 sequence 
 
HEK293 cells were cultured to 80% confluence in 12 well plates and infected with 
4-7 x 106 infectious units of adenovirus harboring a CMV-driven GFP reporter 
fused with a 200 nt sequence flanking the miR-1948 hairpin structure, or with 
GFP only as control.  These adenoviral constructs were designed and expressed 
in adenovirus serotype 5 by Applied Biological Materials, British Columbia, 
Canada (ABM; control adenovirus Cat. m009; adeno-mmu-miR-1948: custom 
designed).  Adenovirus seed stocks were propagated in HEK293A cells and 
titered by plaque assays according to standard protocols (Green and 
Loewenstein, 2006).  Cells were infected for 48-55 hr to achieve a cytopathic 
effect and strong GFP fluorescence.  Total RNA was then extracted and used for 
small RNA-seq library preparation as described above. 
 
LNA miRNA in vivo inhibition of miR-1948 and miR-802 
 
To inhibit miR-1948-5p and miR-802-5p function in mouse liver in vivo, LNA 
constructs complementary to these miRNAs and a negative control were 
purchased from Exiqon and injected into male and female 9 wk ICR mice (mmu-
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miR-1948-5p:GGCAGAATACTCATA; mmu-miR-802-5p: GAATCTTTGTTACTG; 
negative control: ACGTCTATACGCCCA).  A pilot experiment was first 
performed to assess toxicity, by weight monitoring, behavioral monitoring and 
serum ALT assays, which showed little toxicity response.  Serum ALT levels was 
measured by Alanine Transaminase Colorimetric Activity Assay Kit (Cayman 
Chemical, Cat. no. 700260; normal serum ALT concentrations range from 8-40 
U/L).  In the large scale experiment reported here, mice were given two 
subcutaneous injections the LNA in 1X PBS solution of 25 mg/kg on Day 0 and 
Day 1 and killed and euthanized on Day 3 or Day 6 , to give a total of three days 
or six days of exposure in vivo.  Injections were carried out in the morning 
between 10 am - 12 pm.  LNA-miR-1948 was injected into male mice; LNA-miR-
802 was injected into female mice; LNA-negative was injected into both male and 
female mice for both 3 day and 6 day exposures, and served as controls.  At the 
end of the treatment, mice were killed by cervical dislocation, and livers were 
harvested for RNA extraction and RNA-seq analysis.   For each sex and at each 
time point, N=5 mice received LNA-anti-miRNA, and N=3 received LNA-negative. 
 
LNA miRNA inhibition RNA-seq and related data analyses 
 
Paired-end (50 bp) RNA seq raw FASTQ files were mapped by TopHap (Trapnell 
et al., 2009) to mm9 genome using default parameters.  FeatureCounts (Liao et 
al., 2013) was used to quantify the reads within gene bodies of Refseq genes 
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and EdgeR (Robinson et al., 2009) was used to calculate differential genes.  
Sex-biased genes were defined by differential analysis between (male liver 
treated with LNA-negative for 3 and 6 days, N=6)/(female liver treated with LNA-
negative for 3 and 6 days, N=6), and the cut-off for significance was |FC| > 1.5, 
FDR<0.05.  LNA responsive genes were identified in comparisons (LNA-anti-
miRNA, N=5/LNA-negative, N=3), with a significance cutoff of |FC| > 1.5, pvalue 
(unadjusted) < 0.05.  TargetScan miRNA target predictions were carried using 
TargetScan Mouse Version 7.1.  Mmu-miR-802-5p, being a conserved miRNA, 
showed ~300 predicted gene targets; whereas, thousands of mmu-miR-1948-5p 
targets were included in the output, due to its non-conserved nature.  Therefore, 
only the top 300 predicted mmu-mir-1948-5p ranked by "Cumulative weighted 
context score" were used in this analysis. 
 
GEO accession numbers 
 Small RNA-seq of adult male and female mouse liver (GSE103879) 
  RNA-seq expression analysis of mouse liver treated with locked nucleic 
acids (LNAs) that inhibit mmu-miR-802-5p and mmu-miR-1948-5p 
(GSE103880) 
 Small RNA-seq of human HEK293 cells overexpressing mmu-miR-1948 





Table 2.1: MicroRNAs with nearby male or female specific DHS peaks.  The 
number of sex-specific DHS peaks nearby (within 5 kb upstream or 5 kb 
downstream) of each microRNA gene is indicated.   mmu-miR-802 and mmu-
miR-1948 were located near female-biased and male-biased DHS, respectively.  
Global small RNA-seq analysis confirmed female-biased expression of mmu-
miR-802, and male-biased expression of mmu-miR-21a, mmu-miR-455 and 












Number female-biased DHS within 




Number male-biased DHS within 
5kb up and downstream of 
microRNA
mmu-miR-33 1 mmu-miR-21a 1
mmu-miR-802 3 mmu-miR-28b 1
mmu-miR-1247 1 mmu-miR-455 2
mmu-miR-1902 1 mmu-miR-1948 7
mmu-miR-6366 1 mmu-miR-5128 1
mmu-miR-6392 1 mmu-miR-6397 1
mmu-miR-6928 1 mmu-miR-6965 1
mmu-miR-6993 1 mmu-miR-7224 1











Figure 2.1.  miR-1948 and miR-1948 are located nearby sex-biased DHS and 
show sex differential expression in mouse liver.  (A)  Screenshot of 10 kb regions 
upstream and downstream of miR-1948 (top panel, highlighted blue) and miR-
802 (bottom panel, highlighted pink) annotated by DHS peaks, STAT5, BLC6, 
FoxA1, FoxA2, HNF6, Cux2 ChIP-seq peaks (blue: male-specific peaks; pink: 
female-specific peaks; grey: sex-independent peaks).  MiR-1948 is found in a 
broad genomic region that is more accessible in male liver; and miR-802 is 
directly located at a female-biased DHS.  (B) qRT-PCR validation of the sex-
biased expression of miR-1948 and miR-802 in male and female mouse liver 
(N=5), where the relative expression of lowest expressed sex in each group was 
set to 1.  MiR-1948 (Male): 8.14 ± 1.68; miR-1948 (Female): 1.04 ± 0.25; miR-
802 (male): 1.06 ± 0.22; miR-802 (female): 3.09 ± 0.30; miR-122 (male): 1 ± 0.19; 
miR-122 (female): 1.06 ± 0.1.  Student t-test was performed to assess the 









Figure 2.2.  miR-1948 and miR-802 do not show sex-dependent expression until 
puberty.  Developmental profile of miR-1948 (top), miR-802 (middle), and miR-
122 (bottom) expression in mouse liver at 3 wk, 4 wk and 8 wk of age (N=4).  
Lowest expression sample group in each time point was set to 1.  Sex-differential 
expression is first seen after puberty (8 wk of age), when miR-1948 is up 
regulated and miR-802 is down regulated in male liver. 
 
miR-1948 (3 wk male): 1.02 ± 0.39; miR-1948 (3 wk female): 1.64 ± 0.04;  miR-
1948 (4 wk male): 1.66 ± 0.76; miR-1948 (4 wk female): 1.25 ± 0.19; miR-1948 
(8 wk male): 6.86  ± 2.11; miR-1948 (8 wk female): 0.90 ± 0.08; miR-802 (3 wk 
male): 0.93 ±  0.4; miR-802 (3 wk female): 1.01 ± 0.21; miR-802 (4 wk male): 
0.78 ± 0.11; miR-802 (4 wk female): 1.13 ± 0.20 ; miR-802 (8 wk male): 0.33 ± 
0.06 ; miR-802 (8 wk female): 1.37 ± 0.13 ; miR-122 (3 wk male): 1.01 ± 0.41; 
miR-802 (3 wk female): 1.58 ± 0.38; miR-802 (4 wk male): 1.60 ± 0.48; miR-802 
(4 wk female): 1.40 ± 0.03 ; miR-802 (8 wk male): 2.08 ± 0.96 ; miR-802 (8 wk 












Figure 2.3.  miR-1948 and miR-802 expression are regulated by GH and STAT5.  
Expression levels of miR-1948, miR-802 and miR-122 were measured by qPCR 
in four mouse models that perturbed the GH-STAT5 axis: Hypophysectomy (A), 
somatostatin (SST) knockout (B), hepatocyte specific STAT5 KO (C) and 
continuous GH infusion (D).  These models show that ablation of GH and STAT5 
in male mouse liver leads to down regulation of miR-1948 to female levels and 
de-repression of miR-802 to male levels.  Here, "ctrl male" and "ctrl female" 
collectively indicates wildtype, untreated mouse liver in each model; "test male" 
and "test female" refers to the treated (as in the hypophysectomy model) or 
knockout mouse livers (SST KO, and STAT5 KO).  Lowest expressed 
experimental groups for each miRNA analysis was normalized to 1.  Student t-
test was performed to assess significance between control male and test male; 
and between control female and test female (* p<0.05; ** p<0.005; *** p<0.001; 











Figure 2.4.  Small RNA-seq statistics.  (A)  Distribution of small RNA-seq reads 
among different RNA classes.  The two largest sources of small RNA reads are: 
annotated microRNAs (33%) and unannotated reads from ref-seq loci (34%) (B) 
Read length distribution of small-RNA sequencing peaked at 23 nt, which 























































Table 2.2: Top sex differential microRNAs determined by small RNA-seq in 
wildtype male and female mouse liver.  The linear fold difference (M/F), 












mmu-miR-1948-5p 6.5 208.7 1.56E-38
mmu-miR-1948-3p 6.3 4.3 7.19E-12
mmu-miR-592-5p 5.1 122.0 1.38E-02
mmu-miR-3084-3p 4.7 17.1 5.52E-06
mmu-miR-101b-5p 4.7 5.1 5.62E-08
mmu-miR-3084-3p 4.5 17.8 2.64E-06
mmu-miR-881-3p 3.1 2.7 5.26E-03
mmu-miR-455-5p 2.5 616.1 5.55E-07
mmu-miR-3084-5p 2.2 3.7 1.38E-02
mmu-miR-455-3p 2.2 436.6 2.86E-08
mmu-miR-21a-5p 2.1 127427.6 5.42E-08
mmu-miR-21a-3p 2.1 12.5 5.63E-03
mmu-miR-182-5p 2.1 203.3 4.04E-02
mmu-miR-149-5p 2.0 18.8 9.86E-03
mmu-miR-674-3p -2.0 45.3 2.50E-05
mmu-miR-802-3p -2.1 23.6 7.39E-05
mmu-miR-3968 -2.2 3.5 2.29E-02
mmu-miR-802-5p -2.2 172.9 8.99E-07
mmu-miR-2137 -2.4 3.7 1.99E-02






















Figure 2.5.  Computation and experimental validation of mmu-miR-1948.   
 
(A)   Conservation levels of mmu-miR-802 and mmu-miR-1948 analyzing their 
primary DNA sequences (80-100 bp sequence) using  BLAT (BLAST-like 
alignment tool, available on the UCSC browser) against 8 different genomes.  
Percent sequence match are reported.  NM: no match. 
 
 (B)  Abundance of mmu-miR-1948 and mmu-miR-802 in male and female 
mouse liver, respectively, among the 603 liver expressed microRNAs.  603 liver 
expressed miRNAs (defined as microRNAs with log2(CPM)>=0) were ranked by 
their expression levels, and the relative positions of miR-1948 and miR-802 are 
marked.  As expected, miR-122 was the most abundant microRNA in the liver.  
The primary strands, miR-1948-5p and miR-802-5p, were moderately expressed 
in the liver, while the star strands, miR-1948-3p and miR-802-3p, showed much 
lower abundance. 
 
(C)  5' processing heterogeneity of miR-1948.  The 84 nt primary sequence miR-
1948 is predicted to form a duplex, as shown.  The mature ~23nt 5p (blue) and 
3p (green) arms of miR-1948 arising from the  primary sequence were analyzed 
in depth.  Specially, the start position at the 5' ends of 5p and 3p were tallied.  
miR-1948-5p showed three dominant 5' start positions; while the 3' arm showed 
66 
 
two start sites.  As the 5' start site of a miRNA determines its seed sequence, 5' 
heterogeneity indicates the potential to generate multiple miRNA isoforms. 
 
(D) miR-1948 and miR-802 associate with argonaute protein.  RNA 
immunoprecipitation with anti-ago antibody (IP) or IgG (control) were performed 
in biological triplicates(N=3).  Enrichment of miR-1948-5p, miR-802-5p, miR-122-
5p and nuclear small RNA HsRNU6b was assayed by qPCR.  Student T-test was 
used to assess the significance of difference between IP and control (* p<0.05, ** 
p<0.01; ***p<0.005). 
 
(E)   The primary miR-1948 sequence contains features required for correct 
Dicer/Drosha processing.  Human HEK293 cells, which normally does not 
express the mouse specific miR-1948 sequence, were infected with adenovirus 
carrying a CMV-driven expression cassette for the primary miR-1948 sequence 
plus the flanking 200 bp sequence.  Small RNA-seq that  was specific for mature 
miRNAs was performed on HEK293 cells infected with adenovirus expressing 
GFP control, as a control (HEK293+GFP), and two biological duplicates of 
HEK293 cells infected with adenovirus expressing miR-1948 (HEK293 + miR-
1948).  HEK293 cells infected with the GFP control contained no trace of mature 
miR-1948.  HEK293 cells infected with miR-1948 sequences showed high levels 
























































Figure 2.6.  Functional analyses of mmu-miR-802-5p and mmu-miR-1948-5p.  (A) 
Locked nucleic acids (LNA) complementary to mmu-miR-802-5p and mmu-miR-
1948-5p were injected into female and male mice, respectively. LNA with a 
random sequence was used as control.  The injected mice were euthanized three 
or six days after the first LNA injection, and liver tissue was analyzed by RNA-
seq.  Shown are the numbers of sex-biased genes as determined in livers treated 
with LNA-negative control that were significantly up-regulated or down-regulated 
by LNA inhibitors against miR-802-5p or miR-1948-5p after each time point.  
Data highlighted in yellow indicate statistically significant differences in the 
distribution of sex-biased genes and LNA inhibitor response, determined by 
Fisher's Exact test (p-value < 0.001).  The distribution at other time points were 
not as significant (LNA miR-802-5p 3 day: p-value = 0.0014 ; LNA miR-1948-5p 6 
day: p-value = 0.21).  (B)  Genes responding significantly to miR-802-5p 
inhibition in female liver after six days, and (C) Genes responding significantly to 
miR-1948-5p inhibition in male liver after three days.  Shown in the venn 
diagrams (right) is the overlap between sex-biased genes, TargetScan-predicted 
targets and LNA responsive genes are shown in the Venn Diagrams.  The subset 















Figure 2. 7.  DAVID gene ontology analysis LNA responsive genes: 508 genes 
responsive to mmu-miR-802 -5p LNA inhibition after three days (A) and 390 







































Table 2.3: List of 149 sex-biased genes responsive to LNA mediated inhibition of 




male (scramble, 3D+6D) / 
female (scramble, 3D+6D) 
Gene name log2FC pvalue (un-adj) log2FC FDR 
Cyp4a12a 2.99 7.40E-05 9.97 0.00E+00 
Mup20 0.72 5.18E-03 6.66 1.07E-102 
Cyp2d9 1.52 1.29E-05 4.94 1.93E-137 
Selenbp2 0.82 1.47E-02 3.74 3.23E-33 
Hsd3b5 1.20 3.43E-03 3.63 5.27E-34 
Clec2h 0.92 5.77E-03 3.51 1.40E-29 
Ihh 1.00 3.87E-02 2.89 4.36E-26 
Slc17a8 0.93 7.64E-04 2.45 9.95E-19 
Mup3 0.62 4.24E-02 2.39 2.13E-32 
Cyp2c67 0.64 1.22E-03 2.35 9.93E-39 
C730027H18Rik 1.14 1.55E-03 1.90 5.02E-12 
Nudt7 0.76 5.73E-04 1.79 7.86E-28 
Mthfd2 0.77 4.88E-02 1.71 7.85E-09 
Aqp4 -1.06 2.35E-02 1.59 6.47E-05 
Gria3 1.46 1.86E-05 1.51 4.04E-03 
Mup16 -0.69 2.84E-02 1.40 1.20E-02 
Serpina4-ps1 0.69 4.51E-03 1.39 4.37E-09 
Pdilt 0.64 1.01E-03 1.32 1.87E-16 
Serpina9 0.88 4.27E-03 1.20 3.41E-04 
Chac1 1.16 3.03E-03 1.17 2.44E-04 
Mpp7 0.76 2.63E-02 1.12 1.17E-04 
Ephx1 0.68 1.32E-04 1.10 6.18E-07 
Mn1 0.71 9.01E-03 1.09 4.80E-05 
Lrrc16a 1.08 2.70E-03 1.08 2.20E-03 
Serpina3a 1.35 1.21E-02 1.06 2.26E-02 
Etnppl 0.70 4.67E-06 1.06 7.93E-08 
Bach2 0.83 9.07E-04 1.01 1.18E-04 
Gm4788 0.67 3.03E-02 0.98 1.14E-02 
1810064F22Rik 0.87 2.46E-03 0.94 1.74E-02 
Cyp2j9 1.07 1.34E-05 0.93 3.68E-05 
Car1 1.21 2.37E-07 0.91 3.22E-03 
Cks1b 1.30 4.03E-05 0.89 3.15E-04 
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Mthfd1l 0.83 3.20E-02 0.85 4.01E-02 
Leng9 0.64 1.03E-02 0.82 6.44E-03 
Kcnt2 1.07 9.98E-04 0.74 2.56E-02 
C1rb 1.72 2.79E-02 0.67 3.53E-03 
Mir6236 0.63 3.96E-02 0.67 1.29E-02 
Nt5dc2 0.65 1.89E-02 0.63 3.50E-02 
Ero1lb 0.74 3.99E-05 0.59 2.58E-04 
Ccr5 -0.75 1.49E-02 -0.67 3.82E-03 
Rasgrp1 -0.66 1.88E-02 -0.69 2.15E-02 
Lsp1 -0.68 1.82E-02 -0.72 3.03E-02 
Ldlrad3 -0.73 4.38E-04 -0.73 8.57E-03 
Slc8a1 -0.81 6.71E-04 -0.73 1.63E-02 
Ccl24 -0.72 1.32E-02 -0.77 4.44E-02 
Was -0.64 4.51E-02 -0.79 3.33E-02 
Oas2 -0.74 1.55E-02 -0.79 2.04E-03 
Wnt4 0.60 3.11E-02 -0.80 3.28E-02 
Mthfs -1.04 2.14E-05 -0.83 5.55E-05 
9330159M07Rik -0.68 4.28E-02 -0.84 4.59E-02 
Fkbp5 0.60 2.80E-02 -0.85 1.36E-03 
Nab2 -0.65 1.56E-02 -0.85 3.49E-05 
Tnfsf10 -0.80 2.09E-02 -0.88 2.11E-02 
1700001L05Rik -0.89 2.79E-04 -0.91 2.35E-04 
Smoc2 -0.59 6.73E-03 -0.91 1.51E-04 
Psmb9 -0.59 9.87E-03 -0.92 2.02E-02 
Apbb1ip -0.74 6.76E-03 -0.94 2.14E-03 
Ntrk2 1.24 2.15E-02 -0.94 9.92E-03 
Slc7a5 0.60 1.08E-02 -0.97 3.43E-03 
Clec4a1 -0.67 2.47E-02 -0.97 3.46E-02 
Lyz2 -0.63 5.55E-04 -0.98 7.23E-05 
Plxnb1 -0.70 1.31E-03 -0.98 3.50E-03 
Siglec1 -0.62 6.27E-04 -0.98 2.92E-07 
Trpv2 -0.64 4.55E-02 -0.99 6.14E-03 
Ptgfrn -0.60 2.09E-02 -0.99 3.44E-06 
H2-Q7 -0.83 1.81E-03 -0.99 2.72E-03 
H2-Q9 -0.83 1.81E-03 -0.99 2.72E-03 
Prr36 -1.20 1.45E-03 -1.01 3.99E-03 
Il2rb -0.71 2.75E-02 -1.01 4.50E-04 
Chaf1b -0.73 2.82E-02 -1.01 4.76E-03 
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Plek2 -0.85 5.05E-04 -1.03 2.43E-03 
Sp140 -0.80 7.52E-03 -1.03 2.34E-03 
Lyz1 -0.83 1.32E-03 -1.03 1.17E-02 
Ell3 -1.50 4.85E-06 -1.04 3.89E-03 
Epsti1 -0.74 1.06E-02 -1.04 6.13E-03 
Il1rn -1.31 2.22E-03 -1.08 1.55E-02 
Siglech -0.85 4.13E-02 -1.09 1.64E-02 
Itpr3 -0.78 1.24E-03 -1.14 3.17E-05 
Rap1gap2 -0.87 1.29E-02 -1.14 7.65E-03 
Amica1 -1.02 1.37E-02 -1.14 3.05E-02 
Notum -0.63 8.31E-06 -1.19 2.58E-15 
Klra2 -0.64 4.71E-02 -1.21 3.28E-04 
Lysmd2 -0.75 4.84E-02 -1.28 1.80E-03 
Raet1e -0.93 2.98E-02 -1.30 2.33E-02 
Gucy2c -0.93 1.22E-02 -1.31 4.66E-03 
Cyp2b10 -0.70 6.83E-04 -1.33 1.79E-06 
Esrrg -0.59 2.51E-02 -1.33 1.46E-03 
Ciart 1.23 2.60E-02 -1.36 3.15E-02 
Oat -0.65 1.13E-02 -1.37 5.16E-11 
Chrne -1.29 4.69E-03 -1.38 1.11E-02 
Cdca7l -1.25 1.72E-02 -1.39 3.15E-02 
Gm1600 -1.16 3.20E-04 -1.42 2.06E-02 
Srrm4 -0.92 5.72E-03 -1.47 3.13E-07 
Chmp4c -0.77 2.05E-02 -1.52 3.44E-05 
Ifit3 -1.41 5.51E-06 -1.52 6.50E-03 
Sh2d4a -0.82 9.07E-04 -1.54 7.63E-11 
Trpm6 -0.60 2.74E-03 -1.57 3.20E-04 
Cxcl9 -0.71 5.42E-03 -1.59 1.37E-09 
Gm6277 -1.15 4.49E-02 -1.65 2.58E-02 
Akr1b7 -0.95 3.45E-02 -1.69 1.68E-02 
Chrm1 -0.95 3.52E-02 -1.71 4.03E-04 
Gm16063 -1.77 5.07E-04 -1.73 1.03E-02 
Plxna3 -0.86 1.64E-03 -1.73 6.39E-11 
1810046K07Rik -0.73 5.46E-03 -1.79 4.81E-14 
Gbp5 -0.62 3.16E-02 -1.81 7.02E-03 
Slc34a2 -1.08 2.07E-04 -1.86 5.91E-04 
Orm2 -0.90 3.51E-03 -1.87 1.50E-07 
Rcan2 -0.86 4.09E-03 -1.88 2.35E-09 
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Lcn2 -1.10 1.88E-03 -1.97 1.96E-05 
Ifi27l2b -1.01 3.86E-02 -2.09 5.68E-03 
Klrc1 -1.27 4.76E-02 -2.15 6.67E-04 
Mup6 -0.83 2.94E-03 -2.19 8.92E-11 
Serpinb1a -0.93 5.43E-03 -2.20 2.61E-05 
Il7 -1.18 6.40E-03 -2.23 3.09E-06 
Grid1 -1.65 2.09E-02 -2.33 2.04E-03 
Rfx4 -0.90 8.93E-07 -2.36 4.00E-12 
Setbp1 -1.19 8.25E-05 -2.45 4.89E-11 
Cyp2a5 -0.91 1.46E-06 -2.60 4.46E-13 
Gm12250 -0.71 4.91E-02 -2.60 9.39E-04 
Col4a3 -1.16 1.34E-02 -2.64 1.86E-11 
Cyp7a1 -1.39 8.68E-08 -2.84 3.79E-09 
Rims4 -1.93 8.80E-03 -2.95 1.62E-03 
Fam19a2 -2.63 2.12E-04 -3.16 9.41E-04 
Cyp2g1 -0.90 3.44E-02 -3.60 2.47E-21 
Cyp2a22 -0.87 3.42E-03 -3.60 1.35E-32 
Tox -0.94 6.97E-05 -3.61 1.19E-35 
Cdx4 -0.59 4.36E-02 -3.78 3.41E-26 
Tgtp2 -1.45 5.19E-04 -3.95 5.40E-06 
Mt1 -2.95 6.63E-34 -3.99 2.36E-29 
Tgtp1 -1.24 9.99E-03 -4.01 4.94E-06 
Pla2g4f -2.41 1.83E-02 -4.11 1.65E-02 
6030407O03Rik -2.62 7.58E-05 -4.26 1.50E-04 
Prom2 -1.21 1.58E-06 -4.28 2.81E-17 
Prom1 -0.92 3.88E-03 -4.43 1.40E-53 
Cyp3a41a -0.72 7.76E-03 -4.87 1.84E-05 
Mt2 -2.89 6.13E-10 -4.95 1.07E-26 
Atp6v0d2 -0.79 4.03E-05 -4.98 1.26E-70 
Vmn1r90 -3.61 5.42E-03 -5.24 2.52E-02 
Cyp17a1 -1.61 4.59E-03 -5.48 3.21E-17 
Eci3 -1.54 2.04E-03 -5.54 1.35E-19 
Cyp2a4 -0.98 4.87E-05 -5.58 1.56E-12 
Mir135a-1 -4.02 9.83E-04 -5.76 1.38E-03 
1700055N04Rik -1.34 2.17E-04 -5.92 1.67E-26 
Slc22a27 -0.71 4.80E-03 -6.22 5.25E-80 
Sult2a6 -1.39 1.63E-04 -9.04 1.34E-41 
Sult2a2 -0.74 4.57E-04 -10.20 1.16E-262 
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Sult2a4 -0.71 4.91E-03 -10.66 1.15E-107 
Sult2a5 -0.76 1.21E-03 -11.66 2.22E-163 






Table 2.4: List of 149 sex-biased genes responsive to LNA mediated inhibition of 




male (scramble, 3D+6D) / 
female (scramble, 3D+6D) 
Gene name log2FC pvalue (unadj) log2FC FDR 
Cyp4a12b -0.99 1.06E-02 9.59 3.07E-76 
Obp2a -1.16 7.92E-03 7.41 1.44E-20 
Sdr16c5 -1.31 2.28E-02 5.72 9.82E-09 
Mup21 -0.94 2.92E-03 5.05 1.19E-66 
Ugt2b38 -0.74 2.74E-03 4.59 2.47E-22 
Sema4f -1.38 3.13E-03 4.48 2.30E-11 
Ces2b -2.26 4.82E-06 4.46 1.09E-10 
Scara5 -1.15 1.50E-03 4.08 3.45E-21 
Selenbp2 -1.42 8.59E-04 3.74 3.23E-33 
C6 -0.94 1.26E-04 3.70 6.09E-110 
Slc15a5 -0.67 2.15E-02 3.62 1.36E-29 
Gm4956 -1.26 2.05E-02 3.29 5.81E-07 
Slc15a2 -3.11 7.71E-04 3.16 1.17E-02 
Serpina12 -1.32 3.06E-12 2.75 3.21E-11 
Fmn2 -0.79 2.39E-04 2.48 7.98E-09 
Ces4a -0.97 2.31E-02 2.25 1.38E-04 
Cyp21a1 0.80 2.14E-02 2.13 1.17E-02 
Zbtb7c -1.52 1.28E-03 2.08 5.07E-05 
Gm17830 -1.23 4.87E-02 2.02 2.05E-03 
Igf2bp3 1.28 1.13E-02 1.82 9.39E-06 
Tuft1 -0.82 1.34E-02 1.73 9.53E-11 
Abcb1b 2.44 3.76E-02 1.62 2.33E-02 
Egfr -0.66 2.44E-04 1.45 1.38E-08 
Arrdc3 -1.02 6.15E-03 1.36 4.70E-07 
Pdilt -0.83 1.07E-04 1.32 1.87E-16 
Gpc1 -0.87 8.04E-03 1.31 2.95E-07 
Gpr110 -0.96 3.69E-04 1.15 1.51E-02 
Bach2 -0.59 2.39E-03 1.01 1.18E-04 
B3galt1 -1.00 9.25E-03 0.97 4.75E-02 
Grem2 -0.80 1.58E-02 0.96 1.31E-02 
Mup13 -0.64 3.96E-03 0.92 1.79E-02 
Car1 -0.67 8.07E-04 0.91 3.22E-03 
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Grb10 -0.67 9.51E-04 0.78 2.23E-03 
Glo1 0.67 2.91E-02 0.69 3.40E-02 
E2f2 0.60 1.14E-02 0.63 3.24E-02 
Rac2 0.61 8.71E-03 -0.59 4.75E-03 
Ces1g 1.22 1.43E-07 -0.60 4.70E-02 
Folr2 0.62 1.90E-02 -0.64 2.22E-03 
Ank2 0.88 4.98E-03 -0.66 4.41E-02 
Naip5 0.84 1.28E-02 -0.68 3.07E-02 
Tmem229b 0.59 3.81E-02 -0.68 3.67E-02 
Phldb3 0.68 4.51E-02 -0.69 1.87E-02 
Cd5l 0.70 3.74E-03 -0.72 3.26E-05 
Mfsd7c 0.66 4.41E-03 -0.73 8.04E-04 
Fyb 0.65 1.90E-03 -0.73 1.09E-05 
Arhgef37 0.74 1.44E-03 -0.76 1.56E-02 
Cobl 0.60 1.65E-02 -0.76 3.97E-03 
Ifi203 0.69 4.11E-03 -0.79 4.52E-02 
C1qc 0.65 7.68E-04 -0.79 3.29E-08 
Oas2 0.99 1.72E-03 -0.79 2.04E-03 
Timd4 0.69 1.00E-02 -0.80 2.43E-03 
Adamts14 0.99 4.52E-03 -0.83 4.06E-02 
Nab2 0.60 3.66E-02 -0.85 3.49E-05 
Fermt3 0.82 1.20E-02 -0.85 1.98E-03 
Evc2 -1.12 3.60E-05 -0.86 8.49E-03 
Rtp4 0.83 2.36E-02 -0.86 1.33E-02 
Vav1 0.63 2.80E-02 -0.86 2.24E-03 
Ncf2 0.68 1.90E-02 -0.87 2.52E-03 
Ctss 0.59 1.45E-02 -0.91 5.99E-13 
Ly86 0.83 1.98E-02 -0.92 2.37E-03 
Fgd2 0.82 1.66E-02 -0.92 8.11E-05 
Psmb9 0.66 2.79E-02 -0.92 2.02E-02 
9930111J21Rik
1 
0.87 2.66E-03 -0.92 3.52E-03 
Cfp 0.62 5.04E-03 -0.94 1.17E-11 
Ddit4l 1.15 3.05E-02 -0.94 3.56E-02 
Nlrc5 0.59 2.28E-03 -0.96 6.27E-04 
Slfn2 1.20 3.23E-03 -0.97 4.27E-02 
Lyz2 0.61 3.29E-03 -0.98 7.23E-05 
Plcg2 0.69 4.28E-02 -0.98 5.17E-04 
Siglec1 0.99 3.32E-04 -0.98 2.92E-07 
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Oas1a 1.44 9.19E-03 -0.98 2.87E-02 
Atp2b2 0.98 9.85E-04 -0.99 1.09E-04 
Evc -1.08 9.63E-03 -1.01 1.80E-03 
Chaf1b 0.99 1.75E-02 -1.01 4.76E-03 
Cers6 0.97 1.50E-03 -1.03 9.81E-05 
Themis2 0.60 3.98E-02 -1.03 7.15E-04 
Ikzf1 0.97 1.87E-03 -1.05 1.38E-05 
Oasl2 1.09 3.38E-03 -1.05 3.94E-03 
Clec7a 0.92 2.19E-02 -1.06 1.16E-04 
Slfn8 1.11 1.15E-02 -1.09 2.10E-02 
Elf4 1.13 6.92E-04 -1.09 9.29E-05 
Rap1gap2 0.86 3.53E-02 -1.14 7.65E-03 
Abcb1a 0.84 2.58E-02 -1.15 2.68E-03 
H2-Aa 0.89 2.10E-02 -1.15 2.54E-06 
Cd300lf 0.98 2.35E-02 -1.16 4.03E-03 
Slc5a1 0.95 2.48E-02 -1.17 1.16E-03 
Klra2 1.06 1.58E-02 -1.21 3.28E-04 
Pira11 0.88 1.63E-02 -1.21 4.32E-03 
Mpeg1 0.82 3.30E-02 -1.22 9.15E-06 
Cyp2c54 0.68 4.80E-05 -1.22 1.86E-11 
Fgl2 1.17 3.11E-04 -1.26 4.56E-05 
Rad51b 1.10 1.15E-04 -1.34 1.39E-04 
Nqo1 0.76 1.07E-02 -1.35 7.18E-10 
Ppl 0.68 3.66E-02 -1.39 2.54E-10 
Ifi27l2a 2.05 1.47E-06 -1.39 2.01E-03 
Pira6 1.27 1.52E-03 -1.40 1.41E-05 
Ifi44 2.13 1.22E-03 -1.46 1.16E-03 
Xcr1 1.61 5.50E-03 -1.48 1.28E-02 
Panx1 2.14 1.30E-02 -1.51 4.22E-02 
Ifit3 1.60 1.79E-02 -1.52 6.50E-03 
Srgap3 -1.15 3.17E-02 -1.56 5.71E-03 
Cxcl9 0.75 2.87E-02 -1.59 1.37E-09 
Gm14548 1.49 5.06E-03 -1.60 1.40E-03 
Mmd2 -0.85 3.57E-02 -1.61 1.51E-04 
Cxcl13 1.52 2.87E-02 -1.68 1.05E-02 
Gbp2b 0.71 4.39E-02 -1.80 2.92E-05 
Gbp5 0.88 2.09E-02 -1.81 7.02E-03 
Cd72 1.67 2.82E-04 -1.82 1.11E-04 
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Acot4 0.70 1.45E-03 -1.90 1.63E-27 
Gbp3 0.88 2.64E-02 -2.01 6.86E-06 
Ifi27l2b 1.92 4.85E-02 -2.09 5.68E-03 
Klrc1 2.46 2.63E-03 -2.15 6.67E-04 
Cyp2c38 0.69 2.33E-03 -2.23 3.16E-19 
BC089597 0.80 1.83E-02 -2.36 1.37E-35 
Hao2 1.95 1.17E-08 -2.49 2.86E-07 
Acnat2 1.17 5.75E-09 -2.56 1.34E-41 
Kbtbd13 4.46 5.92E-03 -2.60 2.49E-05 
Gm12250 1.52 1.71E-03 -2.60 9.39E-04 
Cyp26b1 1.76 4.72E-05 -2.69 1.90E-04 
Cyp7a1 -0.81 1.24E-02 -2.84 3.79E-09 
9030619P08Rik 0.79 4.63E-02 -3.13 2.27E-49 
Cyp2c39 0.59 1.30E-02 -3.23 1.00E-53 
Abcd2 0.78 4.83E-03 -3.25 1.38E-99 
Slc16a5 0.94 3.82E-02 -3.27 1.50E-27 
Cyp2c37 0.84 4.97E-08 -3.64 4.20E-139 
Tgtp2 2.09 2.58E-04 -3.95 5.40E-06 
Mt1 1.25 9.75E-04 -3.99 2.36E-29 
Tgtp1 1.99 1.13E-03 -4.01 4.94E-06 
Nipal1 1.41 1.16E-02 -4.10 8.70E-66 
Prom1 0.88 2.43E-02 -4.43 1.40E-53 
Cyp3a41a 4.41 1.64E-04 -4.87 1.84E-05 
Mt2 1.92 1.09E-05 -4.95 1.07E-26 
Atp6v0d2 1.13 1.76E-02 -4.98 1.26E-70 
Acot3 2.41 8.21E-06 -5.28 5.14E-32 
Cyp17a1 0.91 4.90E-02 -5.48 3.21E-17 
Cyp2a4 1.70 4.80E-02 -5.58 1.56E-12 
Cyp3a41b 3.77 8.36E-04 -5.65 5.25E-80 
Cyp2b9 1.21 1.97E-02 -5.69 7.20E-26 
1700055N04Rik 3.86 3.50E-02 -5.92 1.67E-26 
Slc22a26 1.25 3.64E-02 -6.75 4.53E-182 
Cyp3a44 1.17 3.17E-02 -7.51 9.37E-114 
Fmo3 2.55 1.78E-05 -8.72 5.05E-203 
Cyp2b13 1.75 4.81E-03 -9.57 1.18E-126 
A1bg 1.82 1.21E-04 -9.77 3.34E-55 
Gm4794 2.48 5.55E-03 -10.58 3.09E-36 








Growth hormone (GH) stimulates childhood growth and helps maintain 
homeostasis throughout life.  GH also imparts sex differences in gene expression 
to the liver in many species including humans, leading to sex differences in liver 
disease susceptibility and metabolism in humans.   Here, we investigated the role 
of DNA methylation in GH responses in the liver, by performing reduced 
representation bisulfite sequencing to identify differentially methylated regions 
(DMRs) in liver tissues from three mouse models where GH secretion is 
perturbed.  In untreated male and female liver, sex-biased DMRs were 
associated with sex-biased chromatin opening, transcription factor binding and 
gene expression.  Preferential hypermethylation of enhancer elements was 
observed in livers of lit/lit male mice, a model for congenital GH deficiency by a 
hypothalamic mutation, but not in hypophysectomized male adult mice, where 
GH secretion was abolished by surgical removal of the pituitary gland later in 
adulthood.  Continuous GH infusion, which overrides the male pattern of 
intermittent GH secretion and leads to widespread changes in chromatin 
accessibility in male liver, induced very few DMRs near DNase hypersensitivity 
sites, suggesting that CpG methylation was not required for the majority 
chromatin remodeling by GH.  Exogenous GH replacement in 
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hypophysectomized mice identified sex biased DMRs whose methylation level 
rapidly oscillate with GH pulses, indicating that GH regulates DNA methylation in 
a precise and rapid manner.  This study provides an overview of DNA 
methylation dynamics taking place in liver where normal GH was perturbed, and 










Growth hormone (GH) is a protein hormone of 191 amino acids secreted by the 
anterior pituitary that exerts systemic effects on growth and metabolism.  GH 
secretory patterns are determined by the balance of two hypothalamic peptides: 
GH releasing hormone (GHRH) and the GH release-inhibiting hormone 
somatostatin (Lichanska and Waters, 2008; Waters and Brooks, 2012).  The liver 
is a major target organ of GH stimulation through the JAK-STAT signaling 
pathway , which mediates the production of insulin like growth factor (IGF-1) that 
promotes longitudinal bone growth in children, and maintains normal body 
composition in adulthood (Baik et al., 2011; Choi and Waxman, 2000).  The 
pattern of GH secretion is sex differential in many species, including humans, 
and is the main driver of sex-biased growth patterns and liver function (Cheung 
et al., 2006; Clodfelter et al., 2006; Jansson et al., 1985b).  The sex biased 
effects of GH are especially prominent in mice and rats.  Adult male mice display 
low frequency, high amplitude pulsatile GH secretion every 3-4 hr, followed by 
prolonged trough periods in which plasma GH values are low.  GH is secreted at 
a higher frequency in adult female mice, with brief trough periods during which 
plasma GH levels are low but detectable (Jansson et al., 1985b).  These sex-
biased GH secretory patterns are established by neonatal exposure to 
testosterone, which programs the hypothalamic regulation of pituitary GH 
secretion at the onset of puberty and during adulthood in males  (Cadario et al., 
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1992; Chowen et al., 2004; Ramirez et al., 2010).  Female mice exposed to 
neonatal testosterone ultimately display masculinized levels of GHRH, body 
weight and hepatic enzyme expression in adulthood, even in the absence of 
adult testosterone exposure (Ramirez et al., 2010).  In adults, testosterone 
continues to modulate low trough periods of GH in males (Chowen et al., 1993), 
while estrogen is responsible for elevated baseline GH levels seen in females 
(Mode et al., 1982).  These sex-biased GH release patterns impart differential 
temporal stimulation to GH-sensitive transcription factors, particularly STAT5b in 
the JAK-STAT pathway, which is strongly activated with each incoming pulses of 
GH in male liver and kept in a more persistently active state in female liver (Laz 
et al., 2009; Zhang et al., 2012).  These sex-biased GH contribute to the sex 
differentiated expression of > 1000 genes in mouse liver, including many drug 
metabolizing P450 enzyme genes (Waxman and O'Connor, 2006a).  Liver sexual 
dimorphism is the basis for differences in hepatic disease susceptibility, 
metabolism and pharmacokinetics between men and women (Waxman and 
Holloway, 2009b), and understanding the molecular mechanisms underlying this 
phenomenon is of significant clinical value. 
 
In this study, we investigate the impact of GH on liver DNA methylation profiles.  
DNA methylation represents covalent addition of a methyl group at the fifth 
position of cytosine.  Methylated cytosines are usually associated with gene 
repression, especially  in the context of CpG islands .  The exact role and impact 
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of DNA methylation in post-natal gene regulation is less clear than its role in 
long-term irreversible repression of pericenter and repeat regions (Ambrosi et al., 
2017; Smith and Meissner, 2013; Spruijt and Vermeulen, 2014).  Sex differential 
DNA methylation has been reported for a limited number of genes and genomic 
sites in liver (Yokomori et al., 1995a; Yokomori et al., 1995b).  Recently, a more 
extensive study on sex differential liver DNA methylation in liver showed that the 
male mouse liver undergoes loss of DNA methylation with age that was 
prevented by castration at young age, suggesting that  sex-biased DNA 
methylation is testosterone dependent (Reizel et al., 2015).  However, the 
possible role of GH, either directly or acting downstream to testosterone, was not 
considered.   
 
To investigate the role of GH on liver DNA methylation landscape, we used 
reduced representation bisulfite sequencing (RRBS) (Gu et al.) to interrogate 
liver DNA methylation profiles in three mouse models where circulating profiles 
are perturbed in different ways and for different durations.  Lit/Lit mice provide a 
genetic model of GH deficiency due to missense mutation of the conserved 
Asp60 residue in the GHRH receptor; this mutation is transmitted in an 
autosomal recessive manner .  This defect leads to unresponsiveness to  GHRH, 
GH deficiency, IGF-1 deficiency and phenotypically, dwarfism, delayed puberty 
and abnormal body composition, despite normal secretion of other pituitary 
hormones (Beamer and Eicher, 1976; Donahue and Beamer, 1993; Eicher and 
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Beamer, 1976, 1980).  Hypophysectomy (Hypox) refers to surgical removal of the 
pituitary gland, here performed in 8 week old mice.  Hypox effectively obliterates 
pituitary and pituitary-dependent hormones, including GH, and results a major 
loss of liver sex specificity (Connerney et al., 2017; Wauthier et al., 2010a).  GH 
replacement at near physiological doses partially restores GH responsive gene 
expression in hypox mice (Wauthier et al., 2010a).  Finally, reversal of liver liver 
sex bias can be achieved by overriding the endogenous GH pulses using a 
subcutaneous pump that continuously releases GH (Holloway et al., 2006a; Lau-
Corona et al., 2017).  Continuous GH infusion in male mice exerts widespread 
changes in liver chromatin accessibility, closing the majority of male-biased 
DNase hypersensitivity sites (DHS) and opening a subset of female-biased DHS 
in male liver (Ling et al., 2010b).  These models represent different modes of GH 
perturbation that substantially ablate liver sex specificity.   
 
The effect of GH on DNA methylation remains unexplored, which is purported to 
be a relatively stable mark compared to histone modifications and confers long 
lasting epigenetic memory (Hathaway et al., 2012).  While the repertoire of sex-
biased genes in mouse liver has been extensively characterized, less clear are 
the epigenetic mechanisms underlying these gene changes.  Previous study 
showed that a majority of sex-biased histone marks occur at distal DHS rather 
than at gene promoters (Sugathan and Waxman, 2013b).  It is possible that DNA 
methylation, whose levels do not always correlate with histone marks (Cedar and 
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Bergman, 2009), may be an important additional regulatory control in liver sex 
differences.  Here, we showed that sex-biased hypomethylation is positively 
associated with sex-biased chromatin opening, transcription factor binding, and 
gene expression in wild type male and female liver.  We discovered preferential 
hypermethylation in the lit/lit male liver genome that corresponded to enhancers 
and sites of STAT5 binding.  DMRs that responded to hypox and GH 
replacement were also identified, a subset of which were rapidly responsive to 
GH in a sex-dependent manner.  Using the continuous growth hormone model, 
we demonstrate that chromatin closing and opening in response to GH does not 
require DNA methylation changes at the site.  Together, these findings illustrate 




3.C.1:  Experimental overview and salient features of DMRs 
To determine the impact of GH on liver DNA methylation, we performed RRBS 
on liver tissue from three mouse models where plasma GH patterns are 
abolished or perturbed.  To account for individual variations in DNA methylation, 
five biological replicates per experimental condition were sequenced.  A total of 
eight pair-wise differential analyses were conducted to identify differentially 
methylated regions (DMRs), ie., genomic sites whose CpG methylation showed  
significant change in response to GHRHR mutation (litM/M), continuous GH 
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infusion for 7 days (cGHM/M), hypox of male and female mice compared to sham 
operated controls (HxM/M, HxF/F), and response to two physiological doses of 
GH spaced 4 hr apart in hypox males and females (HxM+GH/HxM, 
Hx_F+GH/Hx_F).  Together, these 8 comparisons identified 6826 unique DMRs, 
compiled from differential analyses performed at both the 100 bp tile level and at 
the level of individual CpGs.  Interestingly, the lit/lit model identified substantially 
more DMRs than any of the other comparisons, with strong bias for 
hypermethylated DMRs, indicating that GH deficiency in the lit/lit model has a 
greater impact in leading to more extensive hypermethylation than when the 
plasma GH patter is ablated in young adult mice by hypox, or is feminized by 
continuous GH infusion (Figure 3.1A).  Only CpGs that were captured in all 
samples at a sufficient depth were included in this analysis.   Nevertheless, a low 
extent of overlap among the DMRs was observed across the different 
comparisons, with most DMRs responsive in only one condition (Figure 3.1B,C), 
suggesting that factors such as mouse strain and age differences (which differe 
between the models) could be at play.   
 
To  elucidate the genomic distribution of CpGs, we mapped them to chromatin 
state maps of adult male liver (Sugathan and Waxman, 2013b).  Chromatin state 
maps were previously generated by ChromHMM, which segments the genome 
into 14 chromatin states based on spatial patterns of DNase hypersensitivity sites 
(DHS) and histone modifications (H3K4me1, H3K4me3, K27ac, K9me3 and 
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K27me3).  The aggregate of all CpGs captured by RRBS in these experiments 
was enriched for promoter states relative to whole genome distribution (Figure 
3.1D: blue), consistent with the enrichment of CpG islands.  In contrast, DMRs in 
most of the conditions examined were markedly depleted of promoter states, and 
in several cases were enriched for enhancer states (Figure 3.1D: green; Figure 
3.1E).   
 
3.C.2: Sex-biased DNA hypomethylation is positively associated with 
chromatin opening, transcription factor binding and gene expression 
 
In order to understand the role of DNA methylation in liver sex bias, we analyzed 
the genomic distribution of 1071 sex-biased DMRs (comparison: M/F) in relation 
to sex-biased chromatin accessibility, TF binding and gene expression.  
Comparison to the sets of sex-biased DHS representing differentially accessible 
chromatin regions in male and female liver (Sugathan and Waxman, 2013a) 
revealed a strong association between CpG hypomethylation and DHS chromatin 
opening.  DMRs that were hypomethylated in males (M/F < 0) were associated 
with male-biased DHS, and DMRs hypomethylated in females (M/F > 0)  were 
associated with female-biased DHS.  Thus, sex-biased loss of DNA methylation 




To determine if DNA demethylation is associated with sex-biased transcription 
factor (TF) binding, we counted the occurrence of male-biased, female-biased 
and sex- independent ChIP-seq peaks for three GH-responsive TFs: STAT5, 
HNF6, FOXA2 previously implicated in liver sex bias regulation, in a 10 kb 
window surrounding each sex biased DMR (Conforto et al., 2015; Li et al., 2012; 
Zhang et al., 2012).  Enrichment scores were calculated compared to a 
background of non-differential methylated regions.  All three TFs showed strong 
enrichments consistent with the pattern seen for DHS, namely, sex differential 
transcription factor activity was preferentially associated with sex-biased 
hypomethylation; whereas sex-independent transcription factor activity showed 
no such preference for sex-biased hyper or hypomethylation (Figure 3.2B).   
 
We found very few genes with sex-biased DMRs in the gene body or promoter 
regions (5 kb upstream of TSS) of sex-biased genes (Figure 3.2C).  Sex 
differences of DNA methylation levels of gene body DMRs, but not promoter 
DMRs, showed significant association between hypomethylation and positive 
gene expression (Fisher exact test: p=0.003).  This suggests that DNA 
methylation is largely not involved in promoter regulation of sex-biased genes, 
consistent with the general depletion of promoter chromatin states in DMRs 
(Figure 3.1).  Gain of DNA methylation in gene body is known to be positively 
correlated with gene expression, and it is believed to suppress spurious 
intragenic promoters and facilitate splicing (Jjingo et al., 2012; Yang et al., 2014).  
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Our observation that loss of DNA methylation in sex-biased gene body is 
associated with higher gene expression is congruent with the relationship of sex-
biased DMRs with sex-biased DHS (Figure 3.2 A) and TF binding (Figure 3.2 B), 
suggesting that these gene body DMRs may be implicated in intragenic 
enhancers.  Indeed, 51% of gene body DMRs corresponded to enhancer states 
and only 14% were in transcribed state (data not shown). 
 
3.C.3: lit/lit mouse liver shows preferential hypermethylation of enhancer 
elements and STAT5 binding sites 
 
The Lit/lit mouse is a model for congenital GH deficiency. 75% of the 3,749 
DMRs identified in lit/lit mouse liver were hypermethylated, as visualized in a 
heatmap (Figure 3.3A).  Hypermethylated, but not hypomethylated DMRs, were 
strongly enriched for regions of active enhancer chromatin states and DHS 
identified in intact mouse liver, specifically chromatin state 6, which is 
characterized by co-localization of DHS, histone  H3K4me1 and H3K27ac 
(Figure 3.3B).  Hypermethylated DMRs were also highly enriched for the 
occurrence of STAT5 DNA motif (Figure 3.3C).  This finding was validated by 
ChIP-seq data showing STAT5 binding preferentially enriched at DMRs 
hypermethylated in lit/lit mice  (Figure 3.3D).  These data conclude that absence 
of GH in lit/lit mouse liver leads to hypermethylation of liver enhancer elements 




3.C.4: Hypox and GH pulse replacement reveal dynamic, GH-responsive 
DMRs 
 
Hypophysectomy (hypox), surgical removal of the pituitary gland, is analogous to 
the lit/lit model in that they both abolished GH secretion, but with these two 
crucial differences: 1) Hypox abolishes all pituitary and pituitary-dependent 
hormones in addition to GH, such as thyroid hormone and corticosteroids; 2) 
Hypox was performed on adult 8 wk of age, at which time adult mouse liver gene 
expression networks are already established.  In contrast, in lit/lit mice pituitary 
GH secretion is deficient from birth.  Hypox abolished sex specificity for 95% of 
the male-specific genes and 91% of the female-specific genes; the major 
changes are suppression of male-biased genes and induction of female-biased 
genes in the male liver (Connerney et al., 2017; Wauthier et al., 2010a).  Here, 
the extent of DNA methylation change was much greater in lit/lit male (3749 
DMRs) than in hypox male liver (789 DMRs) (Figure 3.1A), and only 107 DMRs 
were altered in common.  Further, in hypox males, only 97 DMRs were found 
within 5 kb of a sex-biased gene and we did not find any association between 
directionality of DMR and sex specificity of genes  (data not shown). The low 
overlap of DMRs between lit/lit and hypox male suggests that either the two 
methods of GH ablation target different chromatin regions, or that differences in 
mouse strains and age were confounding factors.  In the hypox model, 
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enrichment of chromatin state 6 and DHS at hypermethylated DMRs was 
observed in female but not male liver (Figure 3.4A,B).  This suggest that 
enhancer elements in adult female liver was more susceptible to DNA 
methylation changes in the absence of GH.   
 
DMRs were identified in livers of hypox mice given two physiological pulse 
injections of GH spaced 4 hr apart.  This treatment restores expression of a 
subset of sex-biased genes, which were presumed to be direct targets of GH 
(Wauthier et al., 2010a).  Here, approximately 39% of sex-biased DMRs 
responded to hypox in either male or female liver, abolishing of 86% of sex 
biased DMRs (Figure 3.4C).  The directionality of response by sex biased DMRs 
to hypox was strongly sex dependent, where hypox  increased or decreased 
methylation levels at DMRs to that of the opposite sex (Table 3.1).   
 
Further supporting the GH dependence of DNA methylation was the response of 
a set of 102 sex-biased, hypox-responsive DMRs to GH pulse replacement (2 
GH pulses, 4 hr apart).  GH replacement reversed the effect of hypox and 
restored the methylation levels to pre-hypox levels in a majority of these 102 
DMRs (Figure 3.5A,B).  For example, DMRs hypomethylated in male liver were 
largely methylated in hypox male liver and were demethylated by GH pulse 
replacement to pre-hypox levels.  These responses to GH replacement occurred 
within 4.5 hr of first GH  pulse, indicating GH induced DNA methylation changes 
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rapidly and dynamically; albeit the magnitude DNA methylation changes in 
response to hypox and GH replacement was weakly correlated (Figure 3.5C).  
Thus, liver sex-biased DNA methylation can be regulated by GH in a precise and 
dynamic manner. 
 
3.C.5: Continuous GH (cGH) treatment showed minimal DNA methylation 
changes at DHSs 
 
Continuous infusion of GH overrides the endogenous male GH pulses and 
significantly feminizes male liver chromatin accessibility (Ling et al., 2010b) and 
gene expression (Lau-Corona et al., 2017).  Specifically, 82% of 850 male-biased 
DHS are suppressed by cGH treatment for 7 days and 26% of 434 female-biased 
DHS are induced in male liver; whereas 97% of sex-independent DHS remain 
unchanged.  Here, cGH treatment for 7 days led to hypermethylation of 627 
DMRs and hypomethylation of 417 DMRs in male liver (Table 3.2).  To determine 
if these DMRs were involved in the widespread loss of sex-biased DHS that 
results from continuous GH treatment, we associated the DMRs with DHS sites 
found within 5 kb.  Of 47,050 DHS with nearby methylation tiles that were 
captured by RRBS (comprising 729 female-biased, 1310 male-biased  and 
47,050 sex-independent DHS), 777 DHS (1.6%) have DMRs that responded 
significantly to cGH, which includes 13 female-biased DHS and 64 male-biased 
DHS.  The small number of sex-biased DHS with nearby cGH responsive DMRs 
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suggests that DNA methylation does not play a major role in mediating the near 
complete closure of male-biased DHS following cGH treatment in male liver.  The 
36 DMRs nearby the 64 male specific DHS were slightly enriched for 
hypermethylated DMRs compared to the overall distribution (z statistic= 2.205, 
significance level: p=0.0275) (Table 3.2), suggesting that continuous GH induces 




Here, we characterized DNA methylation changes in three mouse liver models 
where plasma GH levels and sex-biased liver gene expression are perturbed.  
We found that intact normal male and female liver, sex-biased hypomethylation is 
positively associated with sex-biased chromatin opening and transcription factor 
binding (Fig. 3.2).  DNA methylation is not involved in promoter regulation of sex-
biased genes; however, hypomethylation of intragenic DMRs in gene body of 
sex-biased genes is associated with increased gene expression.  These sex-
biased DMRs are likely the epiphenomenal result of sex-biased transcription 
factor activities, rather than an instructive force in shaping these active genomic 
features (Bestor et al., 2015).  The impact of total GH ablation on the methylome 
was much more extensive in the congenial GH deficiency lit/lit model, where GH 
is ablated from birth, than in livers of mice hypoxed at adulthood (Fig. 3.3, 3.4).  
Widespread hypermethylation of enhancer elements was observed in lit/lit mouse 
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liver, and to a lesser extent in hypox female mouse liver, but not in hypox male 
liver.  GH pulse replacement in hypox male and hypox female liver identified 
DMRs whose methylation level was rapidly regulated by GH in a sex dependent 
manner (Fig. 3.5).   
 
The lit/lit model was utilized to determine the impact of GH abolishment from birth. 
The GHRH receptor mutation abolishes GH secretion, while other pituitary 
hormones and gonadal hormones remain unaffected (Beamer and Eicher, 1976).  
The extensive hypermethylation of enhancer elements seen in lit/lit mice (Fig. 3.2) 
and their coincidence with STAT5 DNA motifs and STAT5 binding events 
strongly  suggest that GH plays a central role inducing chromatin opening at key 
regulatory elements during development.  A prior study found that while male and 
female mouse liver are equivalently methylated at birth, but in males, the liver 
undergoes progressive demethylation of enhancer elements during postnatal 
development, resulting overall demethylation of male liver relative to female liver 
in adulthood.  This male-specific demethylation was inhibited by neonatal 
castration, leading the authors to conclude that this process was androgen 
dependent (Reizel et al., 2015).   Testicular androgen is thought to have little or 
no direct impact on the liver; rather, it imprints the male hypothalamic-pituitary 
axis to secrete GH episodically at puberty, which initiates sex differential liver 
gene expression (Kramer et al., 1979).  Our findings with lit/lit model indicate that 
GH is an essential upstream regulator of male-specific liver CpG demethylation, 
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as the absence of GH from birth resulted in inhibition of normal liver 
demethylation, leading to hypermethylation.  Further, our results imply that GH 
plays a role in hormonal imprinting.  Hormonal imprinting refers to the process 
whereby a tissue is irreversibly imprinted by exposure to hormonal stimuli during 
a critical window of development, thereby programming the tissue to express the 
imprinted function when stimulated  by the same hormone later in development 
(Csaba, 2016).  As an example, exposure of the brain to testosterone during the 
perinatal period programs male sexual behavior under the stimulatory influences 
of testosterone later during adulthood (Monks and Swift-Gallant, 2017; Shapiro et 
al., 1980).  Similarly, perinatal imprinting of male liver by GH has been proposed 
to prime the liver to respond to adult masculine GH profile.  In one study,  primary 
hepatocytes derived from adult male rats that were exposed during neonatal 
development to monosodium glutamate (MSG), to induce lesions in hypothalamic 
neurons that permanently eliminated GH secretion.  The treatment resulted in 
failure to express CYP2C11, a GH pulse-inducible male-biased gene, when 
stimulated by episodic GH; whereas primary hepatocytes from male rats 
simultaneously treated with MSG and GH did, indicating that exposure of GH 
during  perinatal period wires the liver to respond to GH in adulthood (Das et al., 
2017).    Conceivably, the absence of GH in lit/lit mice during a critical post-natal 
development window may result in preservation of DNA methylation at regions 
that would otherwise become enhancer elements and binding sites for STAT5 in 
post-pubertal, sex-differentiated liver.  Given that DNA hypermethylation is 
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generally associated with repression and blockage of transcription factor 
activities (Jones, 2012), global hypermethylation of enhancer elements 
potentially inhibits normal responses to GH in lit/lit mice even when GH is 
provided as replacement therapy later in adult life.    
 
Many fewer DMRs were identified in hypox than in lit/lit mouse liver (Fig. 3.1), 
even though both treatments eliminate pituitary GH secretion, possibly because 
hypox took place at adulthood, well after the time when epigenetic programming 
of the liver would have been established by perinatal GH imprinting.  
Hypermethylation at enhancer elements and at DHS was prominent in lit/lit mlae 
liver, but was only observed in hypox female liver but not in hypox male liver (Fig. 
3.4A).  This suggests that male liver is more refractory to changes in DNA 
methylation at enhancer elements than female liver.  Paradoxically, male liver is 
more responsive to hypox in terms of changes in gene expression and chromatin 
accessibility, where the extensive loss of sex biased gene expression was largely 
achieved by feminization of male liver rather than by the masculinization of 
female liver, as previously described (Wauthier et al., 2010a).  This raises the 
possibility that hypermethylation of enhancer elements compromises the 
flexibility of response to GH as seen in female liver; whereas in male liver, the 
ability to respond to changes in GH stimulation was enabled in part by resisting 
hypermethylation at enhancers.  This is consistent with several studies that 
conclude that hypomethylated DNA lend to increased cellular plasticity (based on 
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random reading, need citations).  Similarly, the vast majority of DMRs responsive 
to cGH treatment in adult male liver were far from the many  male-biased DHS 
whose accessibility was nearly completely suppressed by cGH treatment (Table 
3.2), demonstrating that chromatin remodeling by cGH did not require changes in 
DNA methylation proximal to DHS.  These findings raise the possibility that in 
adult male liver, DHS accessibility and gene expression are dynamically 
regulated in response to changes to GH precisely by maintaining the 
demethylated state at key enhancer elements established by an imprinting 
mechanisms during early postnatal development.  However, since in this study, 
the hypox and continuous GH treated mice were analyzed 2 weeks and 7 days 
post-treatment, respectively, another possibility is that 1-2 wk this may not give 
sufficient time for the male liver to fully overcome the kinetic barriers to alteration 
of the established DNA methylation profile, and that further hypermethylation 
would eventually ensue if given sufficient time.  Time-course experiments are 
needed to assess this possibility. 
 
The directionality of DMR response to hypophysectomy followed by GH 
replacement provides strong evidence that a subset of sex-biased DNA 
methylation is responsive to GH in a rapid manner (Fig. 3.5).  39% (415) of the 
sex-biased DMRs responded to the elimination of GH by hypox, with hypox 
increasing DNA methylation at DMRs that were demethylated by GH, while 
decreasing methylation at sites that were hypermethylated by GH.  In 25% (102) 
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of these sex-biased, hypox responsive DMRs, the effect of hypox was reversed 
within 4.5 hr of exogenous GH pulse injection, where methylation levels were 
restored to pre-hypox levels.  While hypox and GH replacement per se induced 
many DMRs, it was the small intersection of sex-biased, hypox and GH 
replacement responsive DMRs that revealed this clear-cut dynamic GH response.   
Little is known about how GH targets these genomic loci for de novo methylation 
and demethylation.  DNA methyltransferases (Okano et al., 1999) and TET 
enzymes (Kohil and Zhang, 2013) are ultimately responsible for the addition and 
removal of DNA CpG methylation, respectively; however, as these enzymes lack 
intrinsic DNA sequence specificity, the question remains as to which transcription 
factors are responsible for recruiting these DNA methylation enzymes to specific 
loci.  Interestingly,  DMRs sensitive to GH replacement were not enriched for 
enhancer chromatin states, nor were they enriched for proximity to sex-biased 
genes (Fig. 3.1D, data not shown).  This suggests that DMRs induced by GH 
pulses largely occur outside of established enhancers and TF binding sites, 
either as the result of stochastic events or that pioneering factors such as FOXA1 
(Li et al., 2012) are involved in guiding TF activity to condensed chromatin.  This 
discovery of rapid DNA methylation changes in response to GH echoes other 
studies describing the dynamic and plastic nature of liver chromatin.  Liver 
chromatin accessibility is by no means static, and has been found to "breathe", or 
open and close in response to peak and troughs of episodic GH secretion 
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(Connerney et al., 2017).  This study here demonstrates for the first time, that 
DNA methylation is also a part of the dynamic nature of liver regulation. 
 
The functional impact of DNA methylation was more difficult to gauge compared 
to other chromatin features that showed greater responsiveness to GH and 
correlation to gene expression activity, such as histone marks and DHS.  In intact 
adult mouse liver, sex-biased gene expression is dramatically altered under 
several conditions that perturb the GH secretion pattern, including hypox and 
cGH treatment.   However, we observed almost no DNA methylation changes in 
gene promoters (within 5 kb of TSS, Fig. 3.1D).  This is consistent with the 
general finding that promoter DNA methylation is not necessary for gene 
activation and deactivation in somatic cells, which are largely achieved by 
transcription factors and histone marks alone (Bestor et al., 2015).  Here, we 
hypothesize that DNA methylation may play a more indirect role, perhaps by 
conferring overall plasticity and epigenetic memory to liver chromatin.   
 
Although methylation patterns in somatic cells are largely determined during 
embryonic development and remain relatively immutable through life (Smith and 
Meissner, 2013), additional changes may occur as the result of hormonal 
environmental or other influences.  Our studies demonstrate that disruption of 
circulating GH pattern in the mouse model results in distinct changes in liver DNA 
methylation profiles which vary depending on the stage of development and 
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duration of GH perturbation.  By studying the characteristics of DNA methylation 
changes in relation to chromatin features, our data suggest that GH confers long-
term  programming of DNA methylation status at key enhancer elements and 
continued to regulate specific CpG loci during adulthood in a sex specific manner.  
Thus, DNA methylation is an important feature of the dynamic epigenetic fabric 
underlying liver response to GH.   
3.E: Methods 
 
Animal procedures were approved by the Institutional Animal Care and Use 
Committee at Boston University. 
 
Lit/lit mice 
Livers from lit/lit male mice and control male mice were a  gift from Ethan Weiss 
(University of California, San Francisco, San Francisco, California) (Nordstrom et 
al., 2011).  Little mice carry the Ghrhrlit mutation and were purchased from the 
Jackson Laboratory. The mice are on a 100% C57Bl/6 background and were 
maintained as female litm/m mated to male litm/+ intercrosses.     
 
Hypophysectomy and GH replacement  
Animal treatments for hypophysectomy (Hx) and GH replacement were 
described previously (Wauthier et al., 2010a).  Briefly, male and female CD1 
mice were hypoxed (HxM, HxF) or sham operated (M, F) at 8 wk of age.  Two 
weeks later, hypox male and female mice were given two i.p. injections of rat GH 
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(125 ng/g body weight) spaced 4 hr apart and killed 30 min after the second 
injection, and livers were flash frozen.  Each of the six experimental group (M, F, 
HxM, HxF, HxM+GH, HxF+GH) contained five biological replicates.   
 
Continuous GH treatment 
Continuous GH treatment was carried as previously described (Holloway et al., 
2006a).  Male mice of the ICR strain were housed in temperature and humidity 
controlled environment with a 12 hr light and 12 hr dark cycles.  Alzet osmotic 
pumps (models 1007D (7-d pump), purchased from Durect Corp., Cupertino, CA) 
were filled with recombinant  rat GH (purchased from Dr. A.F.Parlow, National 
Hormone and Peptide Program, Harbor University of California-Los Angeles 
Medical Center, Torrance, CA) dissolved in buffer [30 mM NaHCO3 (pH 8.3) and 
0.15 M NaCl containing 100 μg/ml rat albumin].  Pumps were implanted 
subcutaneously into five male mice under ketamine and xylazine anesthesia.  GH 
were infused at a rate of 20 ng/g body weight for 7 days.  Mice were killed by 
cervical dislocation and livers were snap frozen in -80 °C.  Untreated, age-
matched ICR male mice (not sham operated) were used as controls. 
 
Reduced representation bisulfite sequencing (RRBS) 
RRBS libraries were prepared from frozen liver tissues as previously described, 
with modifications (Gu et al., 2011).  Briefly, a small sample of frozen liver tissue 
(~50 mg)  was homogenized by vigorous pipeting in 370 μl TE buffer (10 mM Tris, 
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1mM EDTA, pH 8) containing 10 μl of proteinase K solution (10mg/ml), and 20 μl 
of 10% (v/v) SDS was quickly added to achieve 0.5% SDS final concentration.  
The homogenate was incubated at 50 °C for 2 hr,  and purified by 400 ul phenol 
chloroform extraction with the addition 32 ul of 5M NaCl, using large-bore pipet 
tips and gentle inversions (no vortexing).  Intact genomic DNA was spooled from 
the aqueous phase following the addition of equal volume 100% ethanol.  The 
spooled gDNA was subjected to RNase treatment in PBS buffer (298 ul 1X PBS, 
2 μl of 10 mg/ml RNase A) for 1 hr at room temperature.  The RNA-free gDNA 
was washed in ethanol and thoroughly resuspended in TE buffer for Qubit 
quantification of DNA, taking care to first sample a large volume (10 μl) and to 
then shear the DNA by vigorous pipeting to ensure that the subsequent 2 μl input 
for Qubit is as homogenous as possible.  500 ng of intact gDNA was digested 
with 2.5 μl of MspI (20,000 units/ml; NEB Cat. no. R0106S) in supplied digestion 
buffer (40 μl total volume) at 37°C (with lid at 40°C) overnight, directly subjected 
to end-repair in the same reaction and purified by phenol chloroform extraction.  
450 ng of MpsI digested, end-repaired material quantified by Nanodrop 
measurement was ligated to Illumina adaptors supplied in NEB DNA-seq kit 
(NEB cat. E7370S, using 1/20 diluted adaptor) and NEB Quick DNA ligase kit 
(NEB cat. E6056S) by incubation at 16°C overnight without a heated lid.   After 
USER enzyme digestion and cleanup with Zymo's DNA clean and concentrator -
5 (Zymo Cat. D4003T), the adaptor-ligated MspI fragments were bisulfite treated 
for two consecutive rounds using Zymo's EZ Gold bisultfit kit (Zymo Cat. D5005) 
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per the manufacturer's instructions.  Of the 12 μl bisulfite-treated DNA, 5 μl was 
amplified using the KAPA hifi HS Uracil+ polymerase system (Kapa Cat. KM2800) 
for 12-15 PCR cycles, with the optimal cycle determined empirically to attain the 
lowest number of cycles that yield sufficient material without over-amplification.  
Finally, size selection for 160-340 bp was accomplished by performing a double 
SPRI purification of 0.65X and 0.55X (To 50 μl reaction volume, 32.5 ul of SPRI 
beads were added.  The supernatant was saved.  Then 27.5 μl of SPRI was 
added to supernatant.  Beads were washed and eluted in 0.1X TE buffer).  The 
final libraries were analyzed on a 1% agarose SYBR green gel, quantified by 
Qubit and sequenced on an Illumina HiSeq instrument (paired-end, 50 bp reads) 
with no more than 1/3 of a lane being RRBS material.   
 
A total of 50 RRBS libraries were prepared, consisting of five biological replicates 
per experimental condition: 1) Sham male (M) , 2) Hypox male (HxM), 3) Hypox 
male + GH (HxM+GH), 4) Sham female (F), 5) Hypox female (HxF), 6) Hypox 
female + GH (HxF+GH), 7) continuous GH treated male (cGHM), 8) ICR wild 
type male (control for condition #7) (M), 9) lit/lit male and (litM), 10) Male control  
for condition #9 (M). 
 
RRBS data processing 
About 15 million paired end sequence reads were obtained for each RRBS 
sample.  Raw FASTQ files were first processed by Trim Galore (version 0.4.3) 
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using options: (--rrbs --paired).  The trimmed paired end read1 and paired end 
read2 files were mapped by Bismark (Krueger and Andrews, 2011) using default 
parameters.  PileOMeth  was used to extract and quantify all CpG dinucleotides 
in the bam files, outputting the location, total coverage, number of thymines and 
number of cytosines of each CpG in MethylKit compatible format (parameter: --
methylKit), while avoiding double counting reads where paired end reads overlap.  
The PileOMeth results were directly input into MethylKit, two sample groups at a 
time, for pair-wise differential analysis.  MethylKit (Akalin et al., 2012) differential 
analysis was performed at the level of both 100 bp tiles and individual CpGs 
levels using default parameters and the following: context="CpG", 
filterByCoverage count=10, destrand=T.  A total of 4 comparisons were 
performed in a Treatment  vs. Control configuration, yielding differential 
methylation (diff.meth), where the absolute value indicates the magnitude of 
change, and positive or negative signs indicate hypermethylation or 
hypomethylation of the treatment group relative to the control group, respectively. 
Significantly changing tiles and individual CpGs are defined using a threshold 
fold difference of 15% and qvalue < 0.05, and were combined such that individual 
CpGs not captured at the tile level were also included.  Significant tiles and 
significant individual CpGs exhibit significant overlap and are summarized in the 






Rationale for merging of tile and individual CpG statistics 
Pair-wise differential analyses was calculated by MethylKit using two different 
methods: tile or individual CpG method.  Here is an example MethylKit code for 
tile and individual CpG differential analysis  
 
#my.list refers to file locations for 11 PileOmeth output 
files 

















#calculate differential 100 bp tiles 
myDiff_tiles_1<-calculateDiffMeth(tiles_1)  
 
#calculate differential individual CpG 
myDiff_cpg<-calculateDiffMeth(meth_1) 
 
The tile and individual CpG differential analyses each has its own advantages.  
Tile analysis affords higher power due to aggregating signals from multiple CpGs 
within a 100 bp region.  For example, if a tile contains 3 CpGs, all of which are 
only slightly differential, the tile statistics will report a small differential methylation 
value and low FDR, whereas individual CpG analysis would report a high FDR 
for each CpG.  In a different scenario, if a CpG is highly differentially methylated 
but it is situated nearby CpGs that are not differentially methylated, the signal 
from the highly differential CpG would be "diluted" in the tile analysis but picked 
up by the individual CpG analysis.  Because most tiles contain only one CpG, 
results of the tile and individual CpG analyses are similar for the most part.  The 
final list of differential CpGs includes all significant tiles, as well as individual 
CpGs that were captured by the individual CpG analysis but not by the tile 
analysis, as detailed in the supplementary table.  This list of DMRs was used all 




Distribution of CpGs at the 14 chromatin states (Figure 3.1D) 
Individual CpGs were mapped to one of the 14 chromatin states previously 
identified in male mouse liver (Sugathan and Waxman, 2013a).  Chromatin 
states in female liver generated similar results (not shown).  A total of 1,206,153 
individual CpGs were covered by all 50 RRBS samples in this study.  To 
generate this set of individual CpGs, raw PileOmeth files were destranded using 
a custom Python script, which combines CpG coordinates from opposite strands 
into a single coordinate.  Each CpG is symmetrical in the genome, which means 
that a given CpG will have two coordinates (e.g. chr1:100 (+) and chr1: 101 (-)), 
the destranding script aggregates the position from + and - strands into a single 
position.  Next, the occurrence of CpG in each of the 50 samples was counted, 
and only CpGs that are covered 50 times were considered.  These ~1.2 M CpGs 
were mapped to the male 14 chromatin states using the Bedtools (Quinlan, 2014) 
Intersect command and the distributions were plotted in Excel.   
 
Calculation of chromatin state enrichment scores (Figure 3.1E) 
The 14 ChromHMM chromatin states were grouped into five super states: 
inactive (states 1, 2, 3), enhancer (states 5, 6, 8, 9, 10), bivalent (state 12), 
transcribed (states 13, 14) and promoter states (states 7, 8).  Enrichment of 
differentially methylatedCpGs for these five super states relative to "all CpGs" 
(the ~1.2 million CpGs captured by RRBS) was calculated as follows: (number of 
differential CpG in chromatin state x / total number of differential CpGs) / 
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(number of all CpGs in chromatin state x / 1,206,152).  Statistical significance 
was determined by two proportion Z-test in R, using the prop.test  function. 
 
GSEA analysis (Figure 3.2A) 
For GSEA analysis, only tiles were used, as it concerns biological regions rather 
than precise CpG positions.  A q-value cutoff of <0.05 generated a spectrum of 
diff.meth values that were ranked from high (hypermethylated tile) to low 
(hypomethylated tile).  This list of ranked DMRs, as well as list of DMRs with 
nearby (10 kb) sex-biased DHS, was inputted into GSEA desktop application 
(Subramanian et al., 2007) for pre-ranked test analysis, with the number of 
permutations set to 1000.   
 
Transcription factors and genes nearby DMRs (Figure 3.2B,C) 
Mouse liver transcription factor ChIP-seq peak lists were downloaded from 
published sources (Conforto et al., 2015; Li et al., 2012; Zhang et al., 2012) and 
classified into male-biased, female-biased and sex-independent peaks.  To count 
the number of DMRs that have at least one TF peak within 10 kb distance, 
Bedtools window command with parameters: -w 10000 -c, was used.  A set of 
1000  random non-differential methylated tiles was generated and used as 
background set.  Enrichment values were calculated as follows: [(number of 
DMR with nearby TF peak/total number of DMR)]/[(number of random tile with 
nearby TF peak/1000)].  Significance was evaluated using Fisher's exact test to 
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determine if the distribution of male-biased and female-biased TF peaks were 
significantly different between hypomethyated and hypermethylated DMRs.   
 
Gene promoters were defined as 5 kb upstream of transcription start site of 
genes.  Coordinates of promoter region were determined as follows:  for genes 
on the + strand, coordinates are (start position - 5000, start position); for genes 
on the - strand, coordinates are (end position, end position + 5000).  DMRs that 
are positioned in promoter and gene body were determined by Bedtools intersect 
command.  Sex-biased genes were defined in a previous male liver and female 
liver RNA-seq dataset  (Lau-Corona et al., 2017), using cutoff of linear fold 
difference |M/F| > 1.5, FDR < 0.05.    
 
Generation of raw methylation levels heatmaps (Figure 3.3A) 
The heatmap in Figure 3.3A presents the raw methylation values of tiles (not 
individual CpG) that are differential between lit/lit male and control male liver.  To 
obtain raw methylation values of 100 bp tiles, raw PileOMeth files were inputted 
into MethylKit and the intermediate file from the following command was obtained: 
tileMethylCounts(pileometh_input,win.size=100,step.size=100) 
This intermediate file contains raw methylation values for all tiles.  A custom 
Python script was used to retrieve raw methylation values for only the differential 
tiles, which were visualized as a heatmap in R.  These raw methylation values 
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were also graphed as box plots and student t-test was used to evaluate the 
significance.   
 
Histone mark and chromatin state frequency plots (Figure 3.3B) 
Frequency plots for chromatin states: 2 kb upstream and 2 kb downstream of 
DMRs were divided into 100 bp bins to generate a total of 41 bed files.  To find 
the frequency of overlap to chromatin states, bedtools intersect was performed 
on each of the 41 bedfiles and the bedfile containing the 14 chromatin states in 
male liver.  Custom Bash commands and R scripts were used to calculate the 




Frequency plots from histone marks: histone mark ChiP-seq and DHS-seq BAM 
files were converted into BigWig files and inputted into Deeptools (Ramirez et al., 
2016) using the following commands.  The Deeptools suite automatically 
normalizes the reads from BigWig files into RPKM signal.  The output files from 
Deeptools was visualized by R ggplot.   
 
computeMatrix reference-point --referencePoint center -b 
2000 -a 2000 -bs 100 -R <input_DMR.txt> -S 




plotProfile -m <output.mat.gz>  --outFileNameData 
output_for_R_plot.txt 
 
Centdist DNA motif analysis 
Genomic coordinates were inputted into Centdist (Zhang et al., 2011b) and 
analyzed using default parameters and max comotif distance of 2000.   
 
GEO accession numbers 
 RRBS (reduced representation bisulfite sequencing) analysis of lit/lit male 
mouse liver (GSE103882) 
 RRBS (reduced representation bisulfite sequencing) analysis of livers from 
continuous growth hormone infused (cGH) adult male mice (GSE103883) 
 RRBS (reduced representation bisulfite sequencing) analysis of liver from 
hypophysectomized (hypox) male and female mice followed by growth 
hormone (GH) pulse replacement to identify differentially methylated 














Figure 3.1:  Overview of RRBS experiments.  Reduced representation bisulfite 
sequencing (RRBS) was performed on liver samples from three mouse models: 
lit/lit male mice, hypophysectomy (hypox) male and female mice followed by 
growth hormone pulse replacement (GH), and continuous GH treated male mice.   
Differentially methylated regions (DMRs) of 100 bp tiles were identified in eight 
pair-wise comparisons that passed a significance threshold, as described in 
Methods.  DMRs were either hypermethylated or hypomethylated in each 
treatment/control comparison, where hypermethylation (positive % diff.meth 
values) indicated higher methylation in the treatment group, and hypomethylation 
(negative % diff.meth value) indicates higher methylation in the control group.   
 
(A)  Number of DMRs in each comparison grouped into hypermethylation and 
hypomethylation tiles of high (differential methylation > |25%|) or low (|15-25%|) 
magnitude.  The hypermethylation/hypomethylation ratio for each comparison is 
also shown.  It can be seen that the LitM/M exhibited the highest ratio.  
 
(B)  Heatmap representation of the overlap among the DMRs in the eight 
comparisons.  Hypermethylated DMRs are in orange and hypomethylated DMRs 
are in blue.   
 
(C)  Venn diagram representation of DMR overlap.  For simplicity, DMRs in the 
hypox and GH replacement comparisons were aggregated.   
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(D)  Chromatin states at differentially methylated CpGs.  The male wild type 
mouse liver genome was classified into 14 ChromHMM-derived chromatin states 
based on histone mark ChIP-seq data, as indicated by different colors (Sugathan 
and Waxman, 2013a).  Significantly differential individual CpGs in each 
comparison group defined in Methods were mapped to one of the 14 chromatin 
states; the distribution of which was plotted  separately for hypermethylated and 
hypomethylated CpGs in each comparison, as well as for the total of ~1.2 M 
CpGs that were captured by the overall RRBS experiment.   
 
(E)  Enrichment scores of differential CpG in the following five broad categories 
of  ChromHMM chromatin states: inactive (states 1, 2, 3), enhancer (states 5, 6, 
9, 10, 11), bivalent (state 12), transcribed (state 13, 14) and promoter states 
(states 7, 8), relative to all CpGs captured by RRBS.  Significant enrichment is 


















Figure 3.2:  Sex-biased DMRs in wild type male and female liver are associated 
sex-biased DNase hypersensitivity sites (DHS), transcription factor (TF) binding 
and gene expression. 
 
(A)  A list of 1319 DMRs tiles (100 bp) with q < 0.05 between intact male and 
female liver were ranked from hypermethylation (red) to hypomethylation (blue).  
GSEA pre-ranked test was performed to determine whether DMRs with female-
biased DHS within a 10 kb distance (Top), or DMRs with male-biased DHS within 
a 10 kb distance (bottom) were significantly associated with the hypermethylated 
or hypomethylated ends of the ranked DMR tiles.  The strong NES (normalized 
enrichment score) and FDR values obtained  indicate that in both sexes, sex-
biased hypomethylation is strongly associated with sex-biased chromatin 
opening. 
 
(B)  Enrichment score of DHS and TF binding within 10 kb of hypermethylated 
and hypomethylated sex-biased DMRs.  Here, a list of 1071 DMRs calculated 
from both tile and individual CpG statistics that were differential between intact 
male and female liver with cutoff of q < 0.05 and |% diff. meth| < 15% were used. 
ChIP-seq peaks for STAT5, HNF6 and FOXA2 were classified into male-biased 
(M), female-biased (F) and sex-independent (SI) peaks, and the number of 
occurrences of each within 10 kb of hypomethylated sex-biased DMRs (blue bars) 
or hypermethylated sex-biased DMRs (orange bars) were counted.  Binding 
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events for a random selection of 1000 non-differential methylated region were 
used to calculate the enrichment scores.  Hypomethylation was consistently 
associated with increased TF binding frequency; the significance of this 
association was determined by Fisher's test (***p<0.001; **p<0.01). 
 
(C)  Sex-biased DMRs (1071, same list as in B) that were in promoter (5 kb 
upstream of TSS) or gene body of sex-biased genes (980) are counted.  The 
relationship between the DNA methylation response (hypermethylated or 
hypomethylated, male relative to female) and gene expression response (male or 
female-biased) are plotted, and the significance was determined by Fisher's 
























Figure 3.3: GHRH mutation in lit/lit male mouse liver leads to preferential 
hypermethylation at active enhancers and STAT5 binding sites 
 
(A)  Heatmap of CpG methylation levels ranged from 0% (blue) to 100% (yellow) 
of tiles that were differential between lit/lit male (litM) and control male (M) liver 
by at least |25%| and clustered by hierarchical clustering.  Boxplot (right) of DNA 
methylation levels in control male and lit/lit male showed statistically significant 
differences (p<0.001, t-test).   
 
(B)  Hypermethylated DMRs, but not hypomethylated DMRs, in lit/lit male liver 
were enriched for enhancer chromatin states.  (Left) Frequency of occurrence of 
the 14 chromatin states in 2 kb windows surrounding hypermethylated DMRs and 
hypomethylated DMRs in male and female liver.  (Right)  Normalized RPM for 
DHS, K27ac, K27me3, K36me3, K4me1, K4me3, and K9me3 ChIP-seq reads in 
2 Kb surrounding DMRs.   
 
(C)  Hypermethylated, but not hypomethylated, DMRs in lit/lit male liver showed 
enrichment for STAT5 DNA motif centered at the DMR.  CentDist was used to 
analyze the 2 kb regions surrounding hypermethylated and hypomethylated 
DMRs in lit/lit male for enrichment of transcription factor DNA binding motifs in 
the Transfac database.  Significance was evaluated by rank (among the 616 TF 
family) and center distribution score (CDS), which is a measure of frequency of 
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DNA motif occurrence at the DMR (position 0) relative to the surrounding 2 kb 
regions, as plotted.   
 
(D)  Hypermethylated, but not hypomethylated, DMRs in lit/lit male liver showed 
enrichment for STAT5 ChIP-seq peaks.  Cumulative frequency plot of distance to 
the nearest STAT5 peak  for hypermethylated DMRs (orange), hypomethylated 














































Figure 3.4:  Changes in DNA methylation following ablation of growth hormone 
by hypophysectomy (hypox)  
 
(A)  Frequencies of 14 ChromHMM-derived chromatin states in the 2 kb region 
surrounding differentially methylated regions (DMRs) identified in litM/M, HxM/M, 
HxF/F comparisons, corresponding to DMRs responding to the lit/lit mutation in 
male liver, hypox in male liver and hypox in female liver, respectively.  Enhancer 
state 6 was highly enriched at lit/lit hypermethylated DMRs, modestly present at 
female hypox hypermethylated DMRs, and absent in male hypox DMRs.   
 
(B)  Cumulative frequency curves of the distance to the nearest DHS for DMRs in 
lit/lit male, hypox male and hypox female, with direction of the responses: 
hypermethylation or hypomethylation, considered separately.  Hypermethylated 
DMRs from lit/lit and hypox female livers showed elevated enrichment of DHS. 
 
(C)  Hypox resulted in loss of 86% of 1071 sex-biased DMRs (556 
hypomethylated; 515 hypermethylated DMRs).  Shown is a heatmap 
representation of all sex-biased DMRs (M/F) and hypox male and female DMRs 
(HxM/HxF) showing that hypophysectomy abolishes a majority of sex-biased 
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Figure 3.5:  Dynamic regulation of DNA methylation by growth hormone (GH)  
 
(A)  Number and overlap of DMRs in hypophysectomy (hypox) and GH 
replacement mouse model.  Adult 8 wk male and female mice were either 
hypoxed or sham operated.  Hypoxed male and female were given two 
physiological replacement doses of GH spaced 4 hr apart and killed 30 minutes 
later.  Five pair-wise differential analyses were performed to identify DMRs in the 
following conditions:  M/F (sex biased DMRs in untreated liver), HxM/M and 
HxF/F (DMRs that responded to hypox in males and females), HxM+GH/HxM 
and HxF+GH/HxF (DMRs responding to GH pulse replacement in hypoxed males 
and females).  The number of DMRS in each comparison and the overlap 
between them is shown in this modified Venn diagram (Groups A,B,C,D,I,J are 
independent from groups E,F,G,H,K,L) .   
 
(B)  Heatmap of sex-biased DMRs responsive to hypox and GH replacement in 
either male or female liver showing their distinct GH and sex dependence (DMRs 
from groups D, H in panel A Venn diagram).  The heatmap shows the  % 
differential methylation in the five indicated comparisons, where red represents 
hypermethylation and blue represents hypomethylation of the treatment group 
(numerator of the comparison group) compared to its control (denominator of the 
comparison group).  Loss of GH by hypox led to either a decrease or  an 
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increase in methylation in a sex dependent manner, while short term GH pulse 
replacement reversed the effects of hypox. 
 
(C)  Scatter plots showing the relationship in DNA methylation changes between 
sex-biased DMRs and their response to hypox in male liver (top left; corresponds 
to regions B,D in panel A Venn diagram) and in female liver (bottom left; regions 
F, H).  Also shown is the relationship between DNA methylation response to 
hypophysectomy and GH pulse replacement in male liver (top right; regions A, D) 
and female liver (top left; regions H, E).  Red numbers in the center of the scatter 
plots indicates the number of DMRs in each quadrant of the plot.  These 
numbers were analyzed by Fisher's exact test, which shows significant 
directionality in DNA methylation responses.  Linear regression R2 values were 
calculated on absolute values of % differential methylation values, which showed 











Table 3.1:  Response of sex-biased DMRs to hypophysectomy in male and 
female liver.  Hypomethylated and hypermethylated sex-biased DMRs 
determined in the M/F comparison are further classified by their response in 
three other comparisons: HxM/M (hypox in male liver), HxF/F (hypox in female 














Response #DMR % Response #DMR % Response #DMR %
Hypo 8 1.4 Hypo 89 16 Hypo 101 18.2
Hyper 129 23.2 Hyper 10 1.8 Hyper 36 6.5
UC 419 75.3 UC 457 82.2 UC 419 75.4
Hypo 50 9.7 Hypo 4 0.8 Hypo 24 4.7
Hyper 5 1 Hyper 168 32.6 Hyper 52 10.1









Table 3.2:  Distribution of hypermethylated and hypomethylated DMRs 
responsive to continuous GH treatment that were within 5 kb of a sex-biased 
DHS.  A Z-test revealed that DMRs nearby male specific DHS showed modestly 
different distribution of hypermethylation and hypomethylation responses than 
the overall distribution in all DMRs (z=2.205; p=0.0275), suggesting that although 
very few DMRs were nearby sex-biased DHS, those nearby male biased DHS 
were more likely to be hypermethylated. 
 
cGH_Male/ctrl_Male DMRs Hypermethylated Hypomethylated Total 
All DMRs 627 417 1044 
DMRs nearby male DHS 28 8 36  









Chapter 4:  RNA expression and DNA methylation in hepatocyte-specific 





The GH responsive transcription factor STAT5 is a key regulator of sex 
differential gene expression of several hundred genes in male and female mouse 
liver. To determine the impact of STAT5 on the liver transcriptome and 
epigenome, we performed RNA-seq and RRBS analysis of livers from 
hepatocyte-specific STAT5a/STAT5b-deficient male and female mice and 
wildtype controls. STAT5 deficiency resulted in a substantial, albeit incomplete 
loss of sex-biased gene expression in the knockout animals via activating and 
repressive mechanisms in both male and female liver.  Very few of these genes 
contained differentially methylated regions (DMRs) at the promoter regions, 
suggesting that proximal DNA.  A much stronger association was observed 
between DMR hypomethylation and chromatin opening at enhancer elements. 
Liver STAT5 deficiency resulted in more extensive hypermethylation than 
hypomethylation. Hypermethylated DMRs, but not hypomethylated DMRs, were 
strongly enriched for enhancer histone marks and elevated levels of DHS, 
STAT5 DNA motifs and STAT5 binding. Together, these data showed that 
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STAT5 exerts widespread effects on liver DNA methylation, in particular at  





The mammalian STAT (signal transducer and activator of transcription) family is 
comprised of seven transcription factors that regulate many biological processes, 
including cellular immunity, proliferation and apoptosis in a variety of cell types 
(Levy and Darnell, 2002). One member of the STAT family, STAT5, is a latent 
cytoplasmic transcription factor that includes two genes juxtaposed in the 
genome: STAT5A and STAT5B, sharing 96% similarity at the protein level 
(Grimley et al., 1999).  STAT5A is primarily expressed in mammary tissues (Liu 
et al., 1997) while STAT5B is most abundant in liver and muscle.  In liver, STAT5 
mediates GH signaling to the nucleus and regulates metabolism and body growth 
through production of IGF-1 (Davey et al., 2001; Herrington et al., 2000).  
STAT5b is also a key mediator of the sex differential transcriptional networks that 
GH regulates, as seen in mouse liver (Udy et al., 1997b). GH binding to its cell 
surface receptor activates the receptor-associated tyrosine kinase JAK2, which 
phosphorylates GH receptor on multiples intracellular sites and creates docking 
sites for many signaling proteins, including STAT5b. JAK2-catalyzed 
phosphorylation of STAT5b on Tyr699 enables STAT5b to dimerize in the 
cytoplasm, and then translocate to the nucleus where it binds to STAT5 motifs 
enriched at open chromatin regions and stimulates gene transcription (Herrington 




Liver STAT5 activity is highly responsive to GH stimulation (Baik et al., 2011). In 
many species, including humans (Veldhuis and Bowers, 2003), the temporal 
pattern of pituitary GH secretion differs between males and females, as best 
characterized in mice and in rats, where GH is secreted episodically with strong 
pulses every 3-4 hr in males and in a more continuous manner in females 
(Jansson et al., 1985b). Liver STAT5 activity mirrors the sex differential GH 
patterns, and consequently, oscillates between active and inactive states in male 
liver, but is more persistently active in female liver (Choi and Waxman, 2000; 
Gebert et al., 1997). This difference in STAT5 activity is a major contributor to the 
sex-biased expression of hundreds of genes in mouse liver, including drug 
metabolizing enzymes of the cytochrome P450 super family (Clodfelter et al., 
2006). Perturbation of STAT5 activity by altering the plasma GH patterns via 
hypophysectomy (Wauthier et al., 2010a) or continuous GH infusion (Lau-Corona 
et al., 2017) largely abolishes sex differences in gene expression. Importantly, 
while exogenous GH replacement substantially restores sex-specific liver 
transcription in hypophysectomized mice, this restoration is not achieved in 
hypophysectomized STAT5b knockout mice, demonstrating the essential nature 
of STAT5 for sex differentiated liver transcription (Davey et al., 1999). In humans, 
sex differences in liver disease susceptibility, drug metabolism and 
pharmacokinetics are key considerations in clinical settings (Seton-Rogers, ; 
Waxman and Holloway, 2009b), underscoring the importance of understanding 
the molecular mechanisms regulating liver sex differences. 
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Here, we characterize the transcriptome and the DNA methylation profiles of 
mouse liver with hepatocyte-specific deletion of the Stat5a/Stat5b locus (liver 
STAT5 KO) (Cui et al., 2007). While STAT5 KO liver has been previously 
characterized by qPCR on a low-throughput scale (Holloway et al., 2007a), 
genome wide RNA-seq profiling has not been reported. DNA methylation 
represents a fundamental epigenetic mark that plays a critical role in 
development and disease (Bestor et al., 2015; Schubeler, 2015), and 
complements the RNA-seq data in providing a more comprehensive picture of 
the regulatory actions of STAT5 on the genic and epigenetic levels. Early studies 
have characterized DNA methylation changes in promoters of select sex-biased 
genes such as Cyp2d9 and Slp (Yokomori et al., 1995a; Yokomori et al., 1995b).  
The advent of next generation sequencing has increased the throughput of DNA 
methylation quantification (Plongthongkum et al., 2014).  Reizel et al measured 
mouse liver DNA methylation during development, and found that male and 
female liver are equivalently methylated at birth, but the male liver undergo 
progressive demethylation with increasing age (Reizel et al., 2015).  Our recent 
RRBS studies in mouse models with disrupted GH secretion indicate that GH 
plays a major role in establishing the DNA methylation landscape in liver.  In lit/lit 
adult male mouse liver, the absence of GH from birth results in extensive DNA 
methylation that was not recapitulated by ablation of GH via hypophysectomy in 
adult mice, suggesting that GH mediated epigenetic programming during a 
critical developmental period.  In this study, the hepatocyte-specific knockout 
134 
 
mouse affords a valuable tool to understand the role of STAT5 in mediating GH 




4.C.1: Impact of hepatocyte specific STAT5 KO on male and female mouse 
liver gene expression 
Prior studies showed that global loss of STAT5b leads to widespread loss of sex-
biased liver gene expression primarily in the male liver.  To ascertain whether 
hepatocyte-specific deletion of STAT5ab (hereby referred to as STAT5) also has 
an extensive impact on sex-biased gene expression in mouse liver, we carried 
out RNA-seq analysis of liver RNA purified from wild-type male control (WTM), 
wild-type female control (WTF), STAT5 knockout male (KOM) and STAT5 
knockout female (KOF) mice.  A total of 274  genes were differentially expressed 
between the male and female controls (WTM/WTF comparison, FDR<0.05); 
these sex-biased genes represented 130 male-biased and 144 female-biased 
genes.  Genes that were responsive to STAT5 KO in male liver and in female 
liver were determined in two comparisons: KOM/WTM and KOF/WTF, 
respectively.  The overlap across the three groups of genes is presented in 
(Figure 4.1A).  56% of the sex biased genes responded to STAT5 deficiency.  
Male-biased genes whose expression was altered were primarily down regulated 
in  STAT5 KO male liver or up regulated in STAT5 KO female liver.  Conversely, 
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female-biased genes whose expression was altered were primarily upregulated 
in STAT5 KO male liver or were down regulated in STAT5 KO female liver (Table 
4.1).  This relationship between sex specificity and response to STAT5 deficiency 
is visualized in a heatmap (Figure 4.1B), and in quantitative scatter plots 
showing strong differences in the response of male and female-biased genes to 
STAT5 KO loss in male liver (Figure 4.1C, Fisher exact test p < 2.2 E-16) and a 
marginally significant  difference in female liver (Figure 4.1D, Fisher exact test p 
= 0.003).    The extent of sex bias and magnitude of response to STAT5 was 
weakly correlated in male liver (R2=0.4, p = 1.2e-13), but no correlation was 
observed in the female liver (R2=0.07, p = 0.01).  These findings suggest that 
STAT5 regulates sex-biased gene expression via activating and repressive 
mechanisms, strongly in male liver and weakly in female liver, to impart sex 
specificity to subset of hepatic genes. 
 
4.C.2: Sex-independent genes that were responsive to STAT5 loss 
 
While liver STAT5 deficiency impart widespread changes to sex-biased genes, 
analysis of sex-independent genes responsive to STAT5 knockout offer 
additional insights to the biological changes taking place.  Using a stringent cutoff 
to identify sex-independent genes (sex difference < 1.2, FDR>0.1), we identified 
106 sex-independent, STAT5 responsive genes (Figure 4.2A).  Notably, the 
transcription factor STAT1 was among the top five up regulated genes (Figure 
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4.2B).  STAT5 KO lead to a ~4.5 fold increase in STAT1 expression (Figure 
4.2C), suggesting that increased STAT1 signaling may have contributed to the 
gene expression changes in STAT5 KO liver. 
 
4.C.3: STAT5 binding contributes to sex-biased gene expression and 
STAT5 response 
 
To investigate whether sex-biased gene expression is associated with sex-
biased STAT5 binding in liver, we analyzed STAT5 ChIP-seq data previously 
generated (Zhang et al., 2012).  A significant subset (36%) of sex-biased genes 
was associated with nearby (10 kb) sex-biased STAT5 ChIP-seq peaks (Figure 
4.3A).  Notably, female-biased genes were predominantly associated with 
female-biased STAT5 peaks; whereas male-biased genes were associated with 
male-biased STAT5 peaks (p=0.0001, Fisher Exact test).   This suggests that 
sex-biased direct STAT5 binding imparts sex-biased expression to nearby genes, 
primarily by activation of gene expression.  In STAT5 KO male liver, down 
regulated genes were enriched for nearby male-biased STAT5 peaks, consistent 
with the down regulation being due to the direct loss of the activating action of 
STAT5.  More perplexing is the enrichment of female-biased STAT5 peaks near 
genes up regulated in STAT5 KO male liver.  These genes, which have lower 
STAT5 binding activity in wild type male liver than in female liver, became 
activated upon loss of STAT5.  This may be explained by the involvement of a 
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STAT5 dependent repressor, such as BCL6 (Meyer et al., 2009; Zhang et al., 
2012), in male liver.  Loss of the repressor in STAT5 KO male liver could result in 
de-repression (or activation by loss of repression) of these genes.  In  female 
liver, the association between gene sex specificity and STAT5 specificity was not 
as clear (p=0.0025), which is visually evidenced in Figure 4.3B.   
 
By analyzing the number of sex-biased genes with or without nearby (10 kb) 
STAT5 ChIP-seq peaks and their response in STAT KO liver (Table 4.2), we 
found that sex-biased genes were significantly more responsive to STAT5 KO 
than sex-independent genes (Percentage of genes responsive in STAT5 KO liver: 
66% male-biased genes, 43% of female-biased genes; 2.2% sex-independent 
genes).  Moreover, male-biased and female-biased genes were uniformly likely 
to be responsive to STAT5 deficiency regardless of presence or absence of 
nearby STAT5 binding.  Female-biased genes were slightly more likely to be 
responsive to STAT5 deficiency when nearby sex-biased STAT5 ChIP-seq peak, 
than when nearby sex-independent STAT5 peaks (p=0.09) (Figure 4.3C).  
Together, the observations that a subset of sex-biased genes showed distinct 
distribution of nearby sex-biased STAT5 binding (Figure 4.3A), and that nearby 
sex-biased STAT5 binding is associated with but not required for response to 
STAT5 deficiency (Figure 4.3C), suggests that STAT5 regulates sex dimorphic 




4.C.4: DNA methylation in STAT5 knockout male and female mouse liver 
 
Previously, we found that ablation of GH from birth by mutation in the growth 
hormone releasing hormone receptor in lit/lit mutant male mice led to preferential 
hypermethylation of enhancer elements -- a pattern that was not replicated in 
total GH ablation achieved in adult male mice by surgical removal of the pituitary 
gland (Chapter 3).  These results suggest that GH played a role in shaping the 
DNA methylome during a critical developmental period, and prompted us to 
wonder the epigenetic impact of the absence of STAT5 gene, the primary 
mediator of the effects of GH in the liver, by hepatocyte specific Cre-lox deletion 
initiated in early neonates on liver DNA methylation in adult male and female 
mouse liver.  As such, we carried out reduced representation bisulfite sequencing 
(RRBS) to identify sex-biased and STAT5 responsive differentially methylated 
regions (DMRs) in three pair-wise comparisons (WTM/WTF, KOM/WTM, 
KOF/WTF).  DMRs refers to 100 bp genomic regions (tiles), which may be either 
hypermethylated or hypomethylated as indicated by positive and negative 
diff.meth values respectively.  The number of DMRs in each comparison group is 
presented in Figure 4.4A, and their overlaps are presented in Figure 4.4B.  
Notably, DMRs that were responsive in STAT5 KO male and STAT5 KO female 
liver were disproportionately hypermethylated relative to wild type liver.  This is 
illustrated in the example heatmap of the raw methylation values of all biological 
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replicates for tiles that were highly differential (diff.meth > 25%) in the KOM/WTM 
comparison (Figure 4.4C).   
 
~50% sex-biased DMRs (based on the WTM/WTF comparison) were responsive 
to loss of STAT5 (Figure 4.4B).  In both male and female liver, loss of STAT5 
resulted in hypermethylation and hypomethylation of DMRs in a sex-biased 
manner (Table 4.3).  For example, in male STAT5 KO liver, male-biased DMRs 
(higher methylation level in wild type male liver than in wild type female liver) 
became hypomethylated whereas female-biased DMRs became 
hypermethylated.  Quantitative scatter plots illustrate that this reversal of sex-
biased DNA methylation levels in both male and female STAT5 KO liver is 
statistically significant (Fisher's exact test p<2.2E-16) and exhibit significant level 
of correlation (male STAT5 KO liver: R2 = 0.53; female STAT5 KO liver: R2 = 0.72; 
p-value<2.2E-16), such that the extent of the methylation differences between 
sexes determines the level of DNA methylation changes in the STAT5 KO livers 
(Figure 4.4D).  These findings suggest that STAT5 plays a role in methylating 
and demethylating select genomic regions in a sex-specific manner.  
 
4.C.5: Chromatin states and chromatin accessibility at DMRs  
 
To understand the genomic distribution of DMRs in the context of histone 
modifications, we mapped DMRs to the 14 ChromHMM derived chromatin states 
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learned from male and female mouse liver histone mark ChIP-seq data (Figure 
4.5A, left).  A large fraction of the ~1.2 million CpGs captured by RRBS were in 
promoter state (blue), due to intrinsic selectivity of RRBS protocol for promoter 
CpG islands.  CpGs in sex-biased and STAT5 responsive DMRs showed a 
significant depletion of promoter states (blue) and variable levels of enrichment 
for enhancer states (green) (Figure 4.5A: right, middle).  Notably, frequency 
profiles of the 14 chromatin states in a 2 kb window surrounding the DMRs 
revealed specific enrichment of enhancer state 6 for DMRs that were 
hypermethylated, but not hypomethylated, in response to STAT5 KO (KOM/WTM 
and KOF/WTF comparisons)  (Figure 4.5B).  A slight enrichment of enhancer 6 
was also seen in DMRs hypomethylated in wild type male relative to wild type 
female. Enhancer state 6 represents active enhancers characterized by high 
probabilities of K4me1, K27ac histone marks and DHS.  This finding shows that 
loss of STAT5 leads to preferential hypermethylation of active enhancers, 
consistent with the pattern seen in lit/lit male mouse liver reported earlier.  Note 
that these chromatin states were defined in wild type, adult male and female liver; 
therefore, the actual impact of DNA methylation changes on the status of 
chromatin states in STAT5 KO liver is unknown.    
 
DNase hypersensitivity sites (DHS sites) are open chromatin regions primarily 
associated with promoters and enhancers.  Consistent with the patterns seen in 
the chromatin state profiles (Figure 4.5B), we found that a higher proportion of 
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hypermethylated DMRs in STAT5 KO male liver and STAT5 KO female liver that 
were within 5kb of at least one liver DHS (60-70%) than all other DMR groups 
(30-50%) (Figure 4.6A, p-value < 2.2E-16).  The vast majority (93%) of the 
aggregate of 5050 unique DHS nearby 4746 sex-biased and STAT5 responsive 
DMRs  were sex-independent DHS (Figure 4.6B).  Of the sex-biased DHS within 
10 kb of sex-biased DMRs, GSEA analysis showed that sex-biased DHS were 
non-randomly distributed in wildtype liver.  Male-biased DHS were associated 
with hypomethylated DMRs in wild type male liver (normalized enrichment score 
NES: 3.2, FDR=0), and female-biased DHS were associated with 
hypomethylated DMRs in the wild type female liver (NES=1.58, FDR=0.53) 
(Figure 4.6C, left panel).  This suggests that sex-biased chromatin opening is 
associated with sex-biased CpG demethylation in the maintenance of natural sex 
differentiation in normal liver.  In STAT5 KO male and KO female liver, both male 
and female biased DHS were more highly associated with hypermethylated than 
hypomethylated DMRs (Figure 4.6C, center and right panels).  
 
4.C.6: STAT5 binding nearby DMRs 
 
The sets of DMRs for each of the 3 comparisons (WTM/WTF; KOM/WTM; 
KOF/WTF) was scanned for enrichment of TF family DNA motifs in the Transfac 
database using the Centdist software (Zhang et al., 2011b). We found a 
significant enrichment of the motif for STAT5 in several of the DMR groups 
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(Figure 4.7A).  Strongest enrichment of the STAT5 motif was found at 
hypermethylated DMRs in STAT5 KO liver, but not at hypomethylated DMRs, 
suggesting hypermethylation of direct STAT5b binding sites.  To corroborate this 
observation with experimental data, we examined whether STAT5 ChIP-seq 
binding sites identified in wild type male and female mouse liver (Zhang et al., 
2012), are enriched at the DMRs hypermethylated in STAT5 KO livers.  First, we 
determined that 57% of STAT5 ChIP-seq peaks, which includes sex-independent, 
male-biased and female-biased binding sites (Figure 4.7B, left), were captured 
by RRBS in this study (Figure 4.7B, right).  Cumulative frequency plots of 
distance to the nearest sex-independent STAT5 binding site showed that DMRs 
hypermethylated in the KOM/WTM and KOF/WTF comparisons contain the 
higher fraction that were directly at or nearby STAT5 binding site, consistent with 
the motif analysis.  Furthermore, the distribution of male-biased and female-
biased STAT5 binding sites differed between DMR groups.  Male-biased STAT5 
binding was most highly enriched at DMRs hypermethylated by STAT5 KO in 
male liver, followed by hypomethylated DMRs in wild type male liver; while 
female-biased STAT5 binding was most enriched in hypermethylated tiles found 
in STAT5 KO female liver (Figure 4.7C).  These data show that STAT5 binding 
sites are preferentially hypomethylated in wild type male, but not female liver; 
and that STAT5 loss resulted in methylation of STAT5 binding in both male and 




4.C.7:  DMRs are primarily not found in promoter regions of sex-biased, 
STAT5 responsive genes 
 
Very few sex-biased, STAT5 responsive genes have nearby (5kb) DMRs (Figure 
4.8A), among them, Cyp7b1 gene showed strong promoter DNA methylation 
changes (Figure 4.8B).  DNA methylation in promoter of Cyp7b1 gene is lower in 
wild type male liver than in female liver, and becomes elevated in STAT5 KO 
liver, consistent with the male-biased and STAT5 dependent expression of the 
Cyp7b1 gene.  This is visualized in IGV browser of the Cyp7b1 promoter showing 
the methylation levels at 5 individual CpG dinucleotides captured by two DMR 
tiles, coinciding at a STAT5 ChIP-seq peak (Figure 4.8C).  While proximal DNA 
methylation is not required for the majority of sex-biased and STAT5 responsive 
gene expression in liver, Cyp7b1 gene may represent an intriguing model for 
understanding the role of promoter CpGs in STAT5 binding and sex-biased gene 
expression.   
 
4.D: Discussion  
 
We investigated the roles of STAT5 in regulating liver sexual dimorphism by 
characterizing the disruption in gene expression and DNA methylation in mouse 
liver with hepatocyte-specific deletion of the STAT5ab locus (Cui et al., 2007).  
We found that STAT5 exerted both activating and repressive actions in both the 
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male and female liver.  STAT5 was required for the expression of substantial 
fraction (~50%) of sex-biased genes, which showed sex-biased binding patterns 
of nearby STAT5 ChIP-seq peaks.  We also identified sex-biased, STAT5-
responsive DMRs, whose genomic distribution showed depletion of promoter 
chromatin states and variable enrichment of enhancer states.  Notably, DMRs 
that were hypermethylated, but not hypomethylated, in response to STAT5 KO in 
both male and female liver were highly enriched for enhancer elements, DHS, 
STAT5b DNA motif, and STAT5b ChIP-seq peaks, indicating that the loss of 
STAT5 results in hypermethylation of key regulatory elements.  Thus, RNA 
expression and DNA methylation profiling offered complementary insights into 
the molecular mechanisms underpinning STAT5 regulation in liver. 
 
Previous conclusions about the requirement of STAT5 for liver sexual 
dimorphism were primarily based on a microarray study conducted in whole body 
STAT5b knockout mouse model(Clodfelter et al., 2006), created by inserting 
chimeric clones with disrupted STAT5b gene locus into mouse blastocysts 
(Clodfelter et al., 2006; Udy et al., 1997b).  The whole body STAT5b KO model 
showed that STAT5b deficiency resulted in near-complete loss (90%) of sex-
biased gene expression by down regulation of male-biased genes and up 
regulation of female-biased genes that takes place exclusively in male liver.  In 
contrast, the vast majority of sex-biased genes were unaffected in the female 
liver (Clodfelter et al., 2006).  Here, results from the hepatocyte specific STAT5 
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KO liver differed from previous observations in whole body STAT5b KO.  Namely, 
approximately only 50% of the sex-biased genes responded to STAT5 KO, and 
the response occurred by activation and repression in both male and female liver.   
However, response to STAT5 KO in female liver appeared slightly weaker than 
that in male liver judging by the fewer genes involved (Figure 4.1B), by the non-
existent correlation between sex specificity and STAT5 response (Figure 4.1D) 
and by the weaker association with sex-biased STAT5 proximal binding (Figure 
4.3).  Nevertheless, RNA-seq analysis from hepatocyte-specific STAT5 KO 
suggested that, contrary to the perfunctory role previously assumed, STAT5 does 
exert a certain extent of regulation on sex-biased genes in female liver.  This may 
be due in part to the loss of STAT5A, which is required for the expression of 23% 
of female-biased genes in the female liver (Clodfelter et al., 2007).  Our current 
results are more in line with the STAT5 ChIP-seq data, which indentified number 
of peaks in male and female liver (Zhang et al., 2012).   
 
RNA-seq from hepatocyte specific STAT5 KO showed that STAT5 directly 
regulates a smaller fraction of sex-specific genes than previously thought based 
on whole body knockout (~50%  versus ~90%), implying fundamental differences 
between whole body and hepatocyte-specific STAT5 deletion.  Whole body 
STAT5b disruption results in decreased circulating IGF-1 and stunted growth in 
male but not female mice (Hennighausen and Robinson, 2008; Udy et al., 1997b).  
This is due to decreased IGF-1 and disruption of STAT5 signaling in the 
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hypothalamus (Bennett et al., 2005), leading to increased GH secretion.  
Elevated plasma GH  potentially contributes to the widespread feminization of 
male liver in whole body STAT5b KO mice, as male liver is known to be 
substantially more responsive to plasma GH concentration than female liver, as 
demonstrated in continuous GH treatment experiments (Lau-Corona et al., 2017).  
In contrast, the hepatocyte specific  STAT5 KO model used here did not result 
growth retardation despite lower IGF-1 levels (Hennighausen and Robinson, 
2008), suggesting less severe hypothalamic GH perturbation, and hence less 
extensive gene changes.  Another factor may be the time of  onset of STAT5 
deletion in these models.  Whole body STAT5b knockout is a congenital deletion, 
while hepatocyte-specific STAT5 knockout was achieved by Cre transgene under 
the control of albumin gene promoter (Cui et al., 2007), which is activated in liver 
beginning at late gestational stage (Weisend et al., 2009).  Our RNA-seq data 
showed that the STAT5b mRNA levels decreased by less than three-fold in 
hepatocyte-specific STAT5 knockout liver (Figure 4.2C).  This could be indicative 
of incomplete knockout, or due to other factors such as contribution from 40% of 
liver cells that are not hepatocytes.  A note on STAT5B versus STAT5A/STAT5B 
deletion: like STAT5B, STAT5A is also GH responsive, but it is expressed at 
much lower levels in mouse liver.  In addition, the STAT5A knockout has minimal 
effects on sex-biased hepatic genes (Clodfelter et al., 2007; Smit et al., 1997).  
Therefore, the impact of the STAT5ab deletion in liver can be largely attributed to 
loss of STAT5B, which is the dominant functional STAT5 member in liver.  In 
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sum, the molecular mechanisms underlying discrepancies between whole body 
versus hepatocyte-specific STAT5 deficiency in liver are not entirely clear and 
differences in strain background cannot be excluded.  Nevertheless, hepatocyte 
specific STAT5 deficient liver provided a revised, and perhaps more realistic, 
depiction of the role of STAT5 in regulating sex-biased liver genes.   
 
The absence of STAT5 in hepatocytes is non-lethal, and cells attempt to adapt 
by activating other STAT family members.  STAT1 is normally activated by 
interferon-γ (Au-Yeung et al., 2013); however, in the absence of STAT5, STAT1 
is up-regulated (Figure 4.2C) and is perhaps recruited by GH receptors.  The 
activation of STAT1 does not truly "compensate" for loss of STAT5, as STAT1 
regulates distinct target genes, leading to impaired regulatory networks and 
adverse phenotypic consequences of liver STAT5 deficiency, including impaired 
cell proliferation and development of fatty liver (Cui et al., 2007).  Hence, many 
sex-independent STAT5 KO responsive genes may represent aberrant gene 
expression by adaptive mechanisms in the liver, and are enriched for immune-
specific genes (data not shown).  However, the distinct response in the subset of 
sex-biased genes, specifically the high level of correlation between sex specificity 
and magnitude of response and the association with nearby sex-biased STAT5 




While a substantial fraction of sex-biased, STAT5 responsive gene promoters (5 
kb upstream of TSS) contained tiles captured by this RRBS experiment, very few 
have differentially methylated CpG tiles (Figure 4.8).  Thus, DNA methylation is 
largely not involved in promoter gene regulation, but may play a more prominent 
role at enhancer regions, as indicated by the positive association of sex-biased 
CpG hypomethylation with sex-biased DHS sites (Figure 4.6).  We identified 
CpG methylation changes with high correlation between sex-bias and STAT5 
responsiveness (Figure 4.4D), demonstrating the STAT5 dependency of DNA 
methylation at select loci.  Loss of STAT5 resulted in both CpG hypermethylation 
and hypomethylation.  Strikingly, hypermethylated sites were significantly more 
strongly enriched for enhancer chromatin states (Figure 4.5), DHS (Figure 4.6) 
and STAT5 binding (Figure 4.7) than hypomethylated sites.  This suggests that 
de-methylation at key regulatory elements is dependent on STAT5, and that loss 
of STAT5 from early development resultes in preservation of DNA methylation at 
regions that would otherwise become demethylated, active enhancer elements 
and STAT5 binding sites in normal, sex-differentiated adult liver.  Whether DNA 
demethylation plays an instructive role in promoting TF binding, or is a passive 
consequence of TF binding activity is unknown.   This result is reminiscent of the 
findings in lit/lit mouse model, a genetic model for GH deficiency via mutation of 
the GHRH gene, which also showed similar hypermethylation patterns but to a 
much wider extent.  This is consistent with the centrality of STAT5 in conveying 
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signals from GH, such that ablation of upstream GH and downstream STAT5 
resulted in similar characteristic hypermethylation of liver enhancers.  
 
Future work is needed to elucidate the effect of CpG methylation on direct 
STAT5 binding sites, as briefly illustrated in Figure 4.8C.  STAT5 DNA response 
is defined by a TTCN3GAA consensus sequence (Hennighausen and Robinson, 
2008), which may or may not contain a CpG.  It is unknown whether methylation 
status at CpG containing STAT5 DNA recognition sequence affects the binding 
of STAT5.  While hypomethylation is generally more conducive for transcription 
factor activity, there are also many transcription factors that prefer CpG-
methylated sequences (Yin et al., 2017).  Correlating STAT5 binding sites with 
and without CpG-containing recognition sequences with ChIP-seq and RRBS 
data presented herein will be a powerful approach to determine the impact of 




Knockout mice  
Hepatocyte-specific STAT5ab-deficient mice were generated by mating C57BL/6 
x 129J mice having a floxed Stat5a-Stat5b locus with albumin promoter-driven 
Cre transgenic mice (FVB/N).  Livers from 8 to 12-wk old hepatocyte STAT5ab-
deficient males and females, and floxed controls, were excised, snap frozen in 
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liquid nitrogen and stored at -80C until use.  STAT5 knockout mouse liver 
samples was generous gift from Dr. Lother Hennighausen (NIDDK, NIH) (Cui et 
al., 2007). 
 
Reduced representation bisulfite sequencing (RRBS) 
RRBS libraries were prepared from frozen liver tissues as previously described, 
with modifications (Gu et al., 2011).  Briefly, a small sample of frozen liver tissue 
(~50 mg)  was homogenized by vigorous pipeting in 370 μl TE buffer (10 mM Tris, 
1mM EDTA, pH 8) containing 10 μl of proteinase K solution (10mg/ml), and 20 μl 
of 10% (v/v) SDS was quickly added to achieve 0.5% SDS final concentration.  
The homogenate was incubated at 50 °C for 2 hr,  and purified by 400 ul phenol 
chloroform extraction with the addition 32 ul of 5M NaCl, using large-bore pipet 
tips and gentle inversions (no vortexing).  Intact genomic DNA was spooled from 
the aqueous phase following the addition of equal volume 100% ethanol.  The 
spooled gDNA was subjected to RNase treatment in PBS buffer (298 ul 1X PBS, 
2 μl of 10 mg/ml RNase A) for 1 hr at room temperature.  The RNA-free gDNA 
was washed in ethanol and thoroughly resuspended in TE buffer for Qubit 
quantification of DNA, taking care to first sample a large volume (10 μl) and to 
then shear the DNA by vigorous pipeting to ensure that the subsequent 2 μl input 
for Qubit is as homogenous as possible.  500 ng of intact gDNA was digested 
with 2.5 μl of MspI (20,000 units/ml; NEB Cat. no. R0106S) in supplied digestion 
buffer (40 μl total volume) at 37°C (with lid at 40°C) overnight, directly subjected 
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to end-repair in the same reaction and purified by phenol chloroform extraction.  
450 ng of MpsI digested, end-repaired material quantified by Nanodrop 
measurement was ligated to Illumina adaptors supplied in NEB DNA-seq kit 
(NEB cat. E7370S, using 1/20 diluted adaptor) and NEB Quick DNA ligase kit 
(NEB cat. E6056S) by incubation at 16°C overnight without a heated lid.   After 
USER enzyme digestion and cleanup with Zymo's DNA clean and concentrator -
5 (Zymo Cat. D4003T), the adaptor-ligated MspI fragments were bisulfite treated 
for two consecutive rounds using Zymo's EZ Gold bisultfit kit (Zymo Cat. D5005) 
per the manufacturer's instructions.  Of the 12 μl bisulfite-treated DNA, 5 μl was 
amplified using the KAPA hifi HS Uracil+ polymerase system (Kapa Cat. KM2800) 
for 12-15 PCR cycles, with the optimal cycle determined empirically to attain the 
lowest number of cycles that yield sufficient material without over-amplification.  
Finally, size selection for 160-340 bp was accomplished by performing a double 
SPRI purification of 0.65X and 0.55X (To 50 μl reaction volume, 32.5 ul of SPRI 
beads were added.  The supernatant was saved.  Then 27.5 μl of SPRI was 
added to supernatant.  Beads were washed and eluted in 0.1X TE buffer).  The 
final libraries were analyzed on a 1% agarose SYBR green gel, quantified by 
Qubit and sequenced on an Illumina HiSeq instrument (paired-end, 50 bp reads) 




RRBS libraries were prepared from the following samples and number of 
biological replicates: Control male (6); control female (5); knockout male (6); 
knockout female (6). 
 
RRBS data processing 
About 15 million paired end sequence reads were obtained for each RRBS 
sample.  Raw FASTQ files were first processed by Trim Galore (version 0.4.3) 
using options: (--rrbs --paired).  The trimmed read1 and read2 files were mapped 
by Bismark (Krueger and Andrews, 2011) using default parameters.  PileOMeth  
was used to extract and quantify all CpG dinucleotides in the bam files, 
outputting the location, total coverage, number of thymines and number of 
cytosines of each CpG in MethylKit compatible format (parameter: --methylKit).  
The PileOMeth results were directly inputted into MethylKit, two sample groups at 
a time, for pair-wise differential analysis.  MethylKit (Akalin et al., 2012) 
differential analysis was performed at the level of both 100 bp tiles and individual 
CpGs levels using default parameters and the following: context="CpG", 
filterByCoverage count=10, destrand=T.  A total of 4 comparisons were 
performed in a Treatment  vs. Control configuration, yielding differential 
methylation (diff.meth), where the absolute value indicates the magnitude of 
change, and positive or negative signs indicate hypermethylation or 
hypomethylation of the treatment group relative to the control group, respectively. 
Significantly changing tiles and individual CpGs are defined using a threshold 
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fold difference of 15% and qvalue < 0.05, and were combined such that individual 
CpGs not captured at the tile level were also included.  Significant tiles and 
significant individual CpGs exhibit significant overlap and are summarized in the 
supplementary excel file.  This list of 100 bp regions containing significantly 
differentially methylated tile and individual CpG statistics are used in all analyses 
unless indicated otherwise. 
 
RNA-seq data processing 
Paired-end RNA seq raw FASTQ files were mapped by TopHap (Trapnell et al., 
2009) to mouse mm9 genome using default parameters.  FeatureCounts (Liao et 
al., 2013) was used to quantify the reads within gene bodies of Refseq genes 
and EdgeR (Robinson et al., 2009) was used to calculate differential genes.  A 
list of 9175 genes were considered liver expressed genes, based on the criteria 
of >1 FPKM average expression in one or both sample groups (male, female). 
 
Criteria for sex-specific genes (WTM/WTF) or responsive genes (KOM/WTM; 
KOF/WTF) : FDR<0.05.   
Criteria for non-responsive genes (KOM/WTM, KOF/WTF):  FDR>0.05.   
Criteria for stringent sex-independent genes (WTM/WTF):  |fold difference| < 1.2; 
FDR > 0.1. 
 
STAT5 ChIP-seq peaks nearby genes (Figure 4.3) 
154 
 
Genomic coordinates of male-biased, female-biased and sex-independent 
STAT5 ChIP-seq peaks were downloaded from the Supplementary Materials of 
Zhang et al study (Zhang et al., 2012).  To find STAT5 ChIP-seq peaks within 10 
kb upstream or downstream to genes of interest, the following Bedtools (Quinlan, 
2014) command was used:  bedtools intersect -c -w 10000.  The 
results were used to generates the panels in Figure 4.3. 
 
Calculation of correlation (Figure 4.1C,D; Figure 4.4D) 
Gene expression fold change values (Figure 4.1 C, D) and differentially 
methylated values (Figure 4.4D) contain both positive and negative values.  
When calculating correlation of between two conditions, fold change and 
differentially methylated values were first converted to absolute values to avoid 
artificial overestimation of correlation.  Linear regression was performed in R, and 
R2 and p-values are reported. 
 
Generation of raw methylation heatmaps (Figure 4.4C) 
The heatmap in Figure 4.4C presents the raw methylation values of tiles (not 
individual CpG) that are differential between STAT5 KO male liver and wild type 
male liver.  Method to obtain tile level raw methylation values are explained in 
Chapter 3.  Only tiles with > 25% differential methylation are shown.  Raw 
methylation values in WTF, KOM and KOF samples were tested against WTM 




Distribution of CpGs at the 14 chromatin states (Figure 4.5) 
Individual CpGs were mapped to one of the 14 chromatin states in male liver.  
Chromatin states in female liver generated similar results (not shown).  A total of 
1,206,153 individual CpGs were covered by all 23 samples in this study.  To 
generate this set of individual CpGs, raw PileOmeth files were destranded using 
a custom Python script, which combines CpG coordinates from opposite strands 
into a single coordinate, as described in Chapter 3 Methods.  These ~1.2 M 
CpGs were mapped to the male 14 chromatin states using Bedtools (Quinlan, 
2014) Intersect and the distributions are plotted in excel.  Enrichment scores of 
DMR distribution in five ChromHMM chromatin super states: inactive, promoter, 
transcribed, enhancer and bivalent states were calculated relative the distribution 
of all (~1.2M) CpGs, with p-values generated by two proportion Z-test.  In Figure 
4.4B, frequency plots of the 14 ChromHMM chromatin states in 2 kb surrounding 
hypomethylated and hypermethylated DMRs were calculated using Bedtools 
intersect command in 100 bp windows.  These computational methods are 
detailed in Chapter 3 Methods. 
 
GSEA analysis (Figure 4.6C) 
For GSEA analysis, only tiles were used, as it concerns biological regions rather 
than precise CpG positions.  A q-value cutoff of <0.05 generated a spectrum of 
diff.meth values that are ranked from high (hypermethylated) to low 
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(hypomethylated).  This list of ranked DMRs as well as list of DMRs with nearby 
(10 kb) male-biased and female-biased DHS were inputted into GSEA desktop 
application (Subramanian et al., 2007) for pre-ranked test with number of 
permutations set to 1000.   
 
Centdist DNA motif analysis (Figure 4.7A) 
Genomic coordinates were inputted into Centdist (Zhang et al., 2011b) and 
analyzed using default parameters and max comotif distance of 2000.   
 
Cumulative frequency plots of STAT5 ChIP-seq peaks nearby DMRs (Figure 4.7) 
DMRs (100 bp regions from both tiles and individual CpG statistics) from three 
comparisons (WTM/WTF; KOM/WTM; KOF/WTF) were separated into 
hypomethylated and hypermethylated DMRs.  An additional file containing 1000 
randomly selected non-differential methylated regions was included to generate a 
total of 7 input files.  Sex-independent, male-biased and female biased STAT5 
ChIP-seq peaks were from Zhang et al 2012.  The following Bedtools command: 
bedtools closest -d -t was used to find the distance to the nearest STAT5 
peak for each DMR.  For each of the seven lists of DMRs, DMRs were first 
ranked by distance to the nearest STAT5 peak from low to high, then cumulative 
values (which range from 0 to 1) were assigned to the ranked DMRs as follows: 
(position in ranked list / total number in list).  Next, make the cutoff for the 
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distance to nearest STAT5 peak at 10,000 bp.  Plot distance on x axis and 
cumulative frequency values on y axis for all 7 sets of DMRs.   
 
DMRs in gene promoters (Figure 4.8) 
Gene promoters were defined as 5 kb upstream of transcription start site of 
genes.  Coordinates of promoter region were determined as follows:  for genes 
on the + strand, coordinates are (start position - 5000, start position); for genes 
on the - strand, coordinates are (end position, end position + 5000).  DMRs that 
are positioned in promoter were determined by Bedtools intersect command.   
 
GEO Accession numbers 
 Gene expression profiling of mouse liver with hepatocyte specific knockout 
of STAT5a/STAT5b genes (STAT5ab KO) (GSE103885) 
  RRBS (reduced representation bisulfite sequencing) analysis of hepatocyte-
specific STAT5a/STAT5b Knockout (STAT5ab KO) mouse liver to identify 







Table 4.1: Genes with significant expression changes in hepatocyte specific 
STAT5 knockout mouse liver.  Shown is the number of genes meeting criteria 
described in Methods, sorted by sex specificity and secondarily sorted based on 
their response to STAT5 knockout in male and female liver.  There was a clear 
pattern in the STAT5 responsiveness of sex-biased genes.  Male-biased genes 
tend to be down regulated in male liver and up regulated in female liver in the 
absence of STAT5.  In contrast, female-biased genes were primarily up-





Response to STAT5 KO in 
male liver (KOM/WTM) 
Response to STAT5 KO in 
male liver (KOF/WTF) 
 
 Count % Count % 
Male-biased      
Increase 6 4.8 33 25 
Decrease 56 42.4 12 9.1 
No change 70 53 87 65.9 
Total 132  132  
Female-biased      
Increase 51 35.9 13 9.2 
Decrease 3 2.1 21 14.8 
No change 88 62 108 76 
Total 142  142  
Stringent sex-
independent 
    
Increase 65 1 58 0.9 
Decrease 41 0.6 29 0.5 
No change 6217 98.3 6236 98.6 





Table 4.2: Analysis of gene sex specificity, response to STAT5 deficiency in 
relation to STAT5 ChIP-seq peaks.  (Top)  Gene are classified into male biased 
(FDR<0.05), female-biased (FDR<0.05) and stringent sex independent (SI, |fold 
change| < 1.2; FDR > 0.1).  These gene groups are further categorized based on 
the presence of nearby (10 kb) STAT5 ChIP-seq peaks.  M: genes with male-
biased and no female-biased STAT5 peaks nearby; F: genes with female-biased 
and no male-biased STAT5 peaks nearby; M+F: genes with both male and 
female-biased peaks nearby; SI: genes with only sex-independent STAT5 peaks 
nearby; none: genes with no STAT5 peaks nearby.  (Bottom)  Subgroups in Top 
table (column) are further categorized based on their response to STAT5 loss 
(row).  For example: M-M indicates male-biased genes with male-biased and no 
female-biased nearby STAT5 peaks; F-M+F indicates female-biased genes with 
male-biased and female-biased nearby STAT5 peaks; SI-None: stringent sex-
independent genes with no nearby STAT5 peaks.  These 15 groups of genes 
(column) are further grouped by their response in STAT5 KO model (row) as: M: 
significantly (FDR <0.05) responsive in male STAT5 KO liver only; F: significantly 
responsive in STAT5 KO female liver only; M+F: significantly responsive in both 
male and female STAT5 KO liver; No responsive: unresponsive (FDR > 0.05) in 
both male and female STAT5 KO liver.  Data presented as number of genes 




















Fisher exact test p< 2.2e-16 
R2=0.4; p=1.2e-13





Figure 4.1:  Characterization of gene expression changes in STAT5 Knockout 
mouse liver.   
(A)  Venn diagram showing 612 significantly changing genes identified in wild 
type (WT) and STAT5 knockout (KO) male (M) and female (F) mouse liver in 
three comparisons: WTM/WTF (wild type male versus wild type female; sex-
biased genes); KOM/WTM (knockout male versus wild type male; STAT5 
responsive genes in male liver) and KOF/WTF (knockout female versus wild type 
female; STAT5 response genes in female liver).  Significantly changing genes 
were defined as passing a cutoff of FDR<0.05.   
 
(B)  Heatmap representation log2 Fold change of 1198 genes that showed sex 
specific expression in wild type male and female liver (WTM/WTF) and their 
corresponding changes in STAT5 KO female (KOF/WTF) and STAT5 KO male 
(KOM/WTM) livers.  Overall, ~50% of sex-biased genes showed sex-biased 
responsiveness to STAT5 loss. 
 
(C,D) Scatter plots of sex-biased genes (WTM/WTF) that responded significantly 
to STAT5 loss in male liver (C: 116 genes) and female liver (D: 78 genes).  The 
number of genes in each quadrant of the plot are analyzed by Fisher's exact test 
to assess whether the proportions of male and female biased genes that were up 
regulated and down regulated by STAT5 loss are significantly different.  Linear 
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regression was performed on the absolute values of fold change values to 


























log2FC FDR log2FC FDR
Cxcl1 2.77 1.22E-05 1.40 2.80E-03
Prg4 2.63 5.49E-17 1.88 5.83E-10
Mpeg1 2.62 7.44E-26 2.04 5.19E-07
Shisa5 2.54 1.31E-21 2.08 1.20E-13
Stat1 2.11 7.12E-07 2.18 8.05E-07
Serpina3k -1.86 6.17E-06 -1.45 5.17E-04
Sult5a1 -1.86 4.94E-04 -0.95 3.35E-02
Ar -1.98 1.03E-05 -1.28 6.20E-02
Gm16551 -2.16 5.98E-10 -1.42 1.05E-01
Serpina4-ps1 -2.80 1.17E-09 -4.11 2.32E-07
KOM/WTM KOF/WTF
Top 5 sex indep. Genes upregulated in STAT5KO










Figure 4.2:  Sex-independent genes responsive to STAT5 knockout (KO)   
 
(A)  A stringent cut-off of fold change < 1.2 and FDR > 0.05 was applied to obtain 
a list of 6323 stringent sex-independent genes, 106 of which responded 
significantly to STAT5 KO in male and/or female liver, as shown in the heatmap. 
 
(B)  Top five up regulated and five down regulated stringent sex-independent 
genes that were responsive to STAT5 KO in both male and female liver.  Notably, 
STAT1  was significantly up regulated.  
 
(C)  Expression levels of seven STAT family members determined by paired-end 
RNA-seq, expressed as FPKM (fragments per kilobase of transcript per million 
mapped reads) values.  The partial down regulation of STAT5a and STAT5b is 
consistent with prior reports and likely reflects the expression fo STAT5 in non-

























































Figure 4.3:  Relationship between STAT5 transcription factor binding and gene 
expression in liver.   
 
(A)  STAT5 ChIP-seq peaks within 10kb upstream or 10 kp downstream of genes 
were counted. (Left) In wild type liver, female-biased genes were associated with 
female-biased STAT5 ChIP-seq peaks; while male-biased genes were 
associated with male-biased STAT5 peaks.  p-value was determined by Fisher 
exact test.  (Middle)  In male liver, genes down-regulated by STAT5 KO were 
significantly enriched for male-biased STAT5 binding, and genes up regulated by 
STAT5 KO were enriched for female-biased STAT5 peaks.  (Right)  In female 
liver, STAT5 responsive genes followed the same pattern as those in male liver; 
however, the distinction was less dramatic, as indicated by the higher p-value.  
Numbers on the top of the plots represent number of genes with nearby sex-
biased STAT5 peaks over the total number of genes in each specific comparison 
(refer to Venn Diagram in Figure 4.1A). 
 
(B)    Shown are the number of STAT5 ChIP-seq peaks (male-biased: blue, 
female-biased: red, or sex-independent: green) within a 10 kb distance of each 
individual gene that is differentially regulated between: WTM/WTF (274 genes, 
left), KOM/WTM (365 genes, middle) and KOF/WTF (278 genes, right), ranked 
from low to high fold change.  This is a visual representation of the results 





(C)  9176 genes expressed > 1 PRKM were categorized into male-biased, 
female-biased, and sex-independent genes.  These gene groups were further 
grouped by the characteristic of the STAT5 ChIP-seq peaks within 10 kb distance, 
as follows: SS: genes with nearby sex-specific STAT5 ChIP-seq peak (can be 
either male, or female-biased), SI: genes with sex-independent STAT5 ChIP-seq 
peaks; None: genes  with no nearby STAT5 ChIP-seq peak.  Plotted is the 
proportion of genes (with numbers indicated) in each category that were 
significantly altered in either male or female STAT5 KO liver (responsive, FDR < 
0.05) or not significantly altered (FDR > 0.05).  Fisher's exact test p values were 
performed between groups as indicated, to determine whether presence of 
















































Figure 4.4: DNA methylation changes in STAT5 knockout male and female 
mouse liver. 
 
(A)  Shown are the numbers of DMRs that were hypermethylated (orange) or 
hypomethylated (blue) at moderate (|15-25|%) or high (>|25|%) differential 
methylation in each of the indicated comparisons (WTM/WTF, KOM/KOF, 
KOM/WTM, KOF/WTF).  The ratios of hypermethylated/hypomethylated DMRs 
are shown at the bottom.  DMRs that were responsive to loss of STAT5 in male 
and female liver (KOM/WTM; KOF/WTF) contained more hypermethylated than 
hypomethylated regions. 
 
(B) (Top) Venn diagram of illustrating the overlap of sex-biased DMRs and 
STAT5 responsive DMRs (> 15% diff. meth).  (Bottom) Venn Diagram of sex-
biased DMRs in wild type liver (WTM/WTF) and in knockout liver (KOM/KOF). 
 
(C) (Top) 710 DMR tiles that exhibited at least 25% diff.meth between STAT5 
knockout male and wild type male were selected for this heatmap.  Raw 
methylation levels are shown from 0 (blue, 0% methylation) to 1 (yellow, 100% 
methylation), and all 23 individual datasets were subjected to hierarchical 
clustering, which broadly separated the wild type from the knockout individuals 
by their methylation levels.  (Bottom) Box plots of methylation levels in each of 
the four groups showed that STAT5 loss responsive DMRs largely results in 
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hypermethylation.  Student t-test was performed between each KO group 
andWTM (**** p-value < 0.0005). 
 
(D) Scatter plots showing the relationship between sex-specificity and STAT5 
responsiveness of DMRs.  (Top) 454 DMRs that were sex specific and also 
STAT5 responsive in male liver.  The majority of DMRs that are hypermethylated 
in wild type male liver became demethylated in STAT5 KO male liver; while the 
majority of DMRs that are hypomethylated in wild type male became 
hypermethylated in STAT5 KO male (Fisher exact test: p<2.2E-16).  (Bottom) For 
419 sex-biased DMRs responsive to STAT5 in female liver, STAT5 deficiency 
results in methylation and demethylation of DMRs in a sex specific manner 
(Fisher exact test: p<2.2E-16).  Linear regressing using absolute values of diff. 











Table 4.3: Differential methylated regions in hepatocyte specific STAT5 knockout 
liver.  1493 sex-biased DMRs are classified into male-biased DMRs (787) and 
female-biased (DMRs), which are further sorted by their responsiveness (hypo, 






















Figure 4.5:  Chromatin states at DMRs responsive to STAT5 KO in liver. 
 
(A) Individual CpGs in DMRs were mapped to the 14 chromatin states previously 
determined by ChromHMM emission probabilities (left).  The mouse genome is 
mostly covered by state 2, an inactive state (whole genome).  CpGs captured by 
RRBS (All CpGs) were enriched for promoter states relative to the whole genome 
distribution (right).  DMRs identified in each of the 3 comparisons show relative 
depletion of promoter states and variable proportions in enhancer states.  For 
example, hypermethylated DMRs in KOM/WTM and KOF/WTF comparisons 
showed an elevated proportion of enhancer states.  Enrichment scores for 
inactive, enhancer, bivalent, transcribed and promoter chromatin states in each 
DMR group relative to the all CpGs captured by RRBS are presented, where 
significant enrichment is green, significant depletion is purple (p value cutoff: 1E-
5, two proportion z-test). 
 
(B)  The frequency of occurrence of each of the 14 chromatin states in male and 
female liver was calculated in 100 bp windows 2 kb surrounding the 
hypermethylated and hypomethylated DMRs in each comparison.  Chromatin 
state 6, an enhancer state characterized by elevated levels of K4me1, K27ac and 
DHS, showed a prominent peak in hypermethylated DMRs for the KOM/WTM 
and KOF/WTF comparisons, in both male (M) and female (F) liver, and to a less 


















Figure 4.6:  STAT5-responsive DMRs and nearby DHS 
 
 (A)  Proportions of hypermethylated (>0) and hypomethylated (<0) DMRs having 
one or more DHS within 2 kb (blue), or between 2 kb-5 kb (green), or having no 
nearby DHS (grey).  The % of DMRs with DHS within 5 kb are indicated at the 
top of each bar, and two proportion Z-test was performed to assess if this % is 
significantly different between hypermethylated and hypomethylated DMRs in 
each comparison.   
 
(B)  The vast majority of the 5050 DHS occurring nearby DMRs (5 kb) were sex-
independent. 
 
(C)  DMRs in the three comparisons (WTM/WTF; KOM/WTW; KOF/WTF) were 
ranked from hypermethylation (red) to hypomethylation (blue).  GSEA analysis 
was conducted to determine if  sex-biased DHS are preferentially found within 10 
kb of the hypermethylated or the hypomethylated end of the ranked DMR 
spectrum.  FDR of less than 5% was considered significant.  NES: normalized 
enrichment score.  For example, DMRs that were hypomethylated in male liver 
were enriched for male biased DHS (NES: -3.2, FDR=0); while DMRs 













Figure 4.7: STAT5 binding nearby DMRs responsive to STAT5 knockout in liver 
 
(A) Centdist was used to scan the DMRs and surrounding 2 kb regions for 
enrichment of 616 known transcription factor (TF) family motifs in the Transfac 
database.  The program ranks the TFs by center distribution score (CDS).  These 
plots present the frequency of occurrence of the STAT5 motif at the DMR 
(position 0) and the surrounding 2kb, quantified by rank and CDS.  Sex-biased 
DMRs showed modest enrichment of STAT5.  Hypermethylated, but not 
hypomethylated, DMRs in STAT5 knockout liver showed strong enrichment for 
STAT5b DNA binding motif.  
 
(B)  (Left) Distribution of male-biased, female-biased and sex-independent 
STAT5 binding sites, identified by ChIP-seq peaks as described in (Zhang et al., 
2012).  (Right) Proportion of STAT5 binding sites within 5 kb of one or more of 
the 319,380 RRBS captured 100 bp tiles, determined from the ~1.2 million 
individual CpGs. 
 
(C) Cumulative frequency plots of hypermethylated and hypomethylated sex-
biased and STAT5-reponsive DMRs and their distance to the nearest sex-
independent (top), male-biased (middle) and female-biased (bottom) STAT5 













Figure 4.8:  Relationship between sex-biased, STAT5 responsive genes and  
DMRs in promoter regions.   
 
(A)  Differentially expressed genes in each of the three comparisons: WTM/WTF; 
KOM/WTM; KOF/WTF are analyzed for presence of DMRs in the promoter 
regions, defined as 5 kb upstream of TSS.  Since RRBS samples a fraction of the 
genome, the number of differential genes with RRBS data in the promoter is 
indicated (% genes with RRBS tiles in promoter).  Only a small fraction of 
differentially expressed genes have DMR in the promoter region.   
 
(B)  Details on the differentially expressed genes with promoter DMRs.   
 
(C) IGV browser screenshot of (Top) Cyp7b1 gene body and promoter region.  
Tracks for STAT5 ChIP-seq peaks and 100 bp DMR tiles are shown.  Region 
with promoter DMRs are boxed.  (Bottom) Zoom-in view of boxed region in top 
panel, showing promoter region of the Cyp7b1 gene with 5 individual differentially 
methylated CpGs that comprise the two juxtaposed 100 bp DMR tiles, directly at 
















Supplementary Figure 4.1: Top transcription factor family binding motifs at sex-
biased, STAT5 responsive DMRs. 
 
(A) Centdist was used to scan the DMRs and surrounding 2 kb regions for 
enrichment of 616 known transcription factor (TF) family motifs in the Transfac 
database.  The program ranks the TF motif enrichment by center distribution 
score (CDS).  Shown  are the top TF motifs in each comparison and their CDS. 
 





Chapter 5: Ribosome profiling of mouse male and female liver reveals sex 




Ribosome profiling leverages high throughput sequencing to interrogate 
ribosome protected fragments (RPF) corresponding to global ribosome 
occupancy sites on cytosolic RNAs.  The global set of RPF provide an accurate 
estimation of the protein content of the cell, and can help elucidate novel ORFs 
and regulation taking place at the translational level.  Here, we applied ribosome 
profiling in male and female mouse liver to discover sex differences in 
translational control and how they impact the sex differential expression of 
hepatic genes under the regulation of sex-biased pituitary growth hormone 
secretion patterns.  We included RNA-seq datasets from total, cytoplasmic and 
nuclear fractions of liver lysate to understand the impact of the cellular 
localization on the calculation of translational efficiency of genes.  We found that 
the majority of stringent sex-biased genes were regulated in the nucleus via 
transcriptional regulation and their sex-biased expression was maintained during 
translation in the cytoplasm.  A small number of sex independent genes were 
identified that display sex biased ribosome occupancy, suggesting sex biased 
translation; albeit these genes were lowly expressed.  In summary, ribosome 
profiling ascertained liver sex dimorphism on a translational level, further 
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emphasizing the functional impact of growth hormone mediated differences in 




5. B: Introduction 
 
The conversion of genetic information stored in mRNAs into functional proteins is 
one of the fundamental processes of life.  In eukaryotes, protein translation is 
carried out by mega-dalton ribonucleoprotein complexes called ribosomes, which 
are located in the cytoplasm and on the outer membranes of the rough 
endoplasmic reticulum.  Ribosomes, consisting of a large 60S subunit and a 
small 40S subunit, scan mRNAs for open reading frames (ORF) and assemble 
polypeptide chains according to the codon code dictated by the mRNA template.  
As most mRNAs exhibit long half-lives (>2hr) (Raghavan et al., 2002), rapid 
modulation of protein levels in the cell can be achieved by controlling 
translational efficiencies and protein degradation rates.  Translational control can 
occur during the four stages of ribosome activity: initiation, elongation, 
termination and recycling (Hershey et al., 2012).   Recruitment of the mRNA to 
the 40S ribosomal subunit is thought to be the rate-limiting step of protein 
translation and is frequently regulated by phosphorylation of initiation factors 
(Sonenberg and Hinnebusch, 2009).  On the other hand, elongation and 
termination appears to be relatively uniform across transcripts (averaging about 
5.6 codons/second), though it can be affected by peptide secondary structures 
(Dever and Green, 2012).  Modulation of protein translation can occur globally, 
e.g., translational repression in response to heat shock or starvation (Zid and 
O'Shea), or can specifically affect a subset of transcripts, through the action of 
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trans-acting proteins (Gebauer et al.) or microRNAs binding to cis-elements in 
the mRNA (Selbach et al., 2008) .  
 
Ribosome profiling is a method that utilizes high-throughput next generation 
sequencing to sequence the ~28nt, or footprints, protected by ribosomes from 
RNase digestion to elucidate the location and density of translating ribosomes in 
the cell (Ingolia, 2014b; Ingolia et al., 2009; Ingolia et al., 2011).  While ribosome 
profiling does not provide the absolute quantification of protein levels afforded by 
mass-spectrometry, it is thought to serve as a better proxy for protein abundance 
than RNA-seq alone .  Moreover, ribosome profiling identifies the locations of 
ribosomes on mRNAs genome-wide, which can help identify novel ORFs, 
discover regulation of translation via upstream open reading frames or elongation 
pausing.  Furthermore, translational efficiency (TE) can be estimated by counting 
the number of ribosome footprints associated with a given mRNA and 
normalizing it by the total mRNA abundance.   
 
Here, we employ ribosome profiling to interrogate the global ribosome 
localization in male and female mouse liver to examine the role of translational 
control in regulating liver sex bias.  Liver sex bias refers to the male and female 
differences in liver physiology, disease susceptibility and metabolism caused by 
the sex differential expression of large number of hepatic genes, many of which 
encode drug metabolizing enzymes (Waxman and Holloway, 2009a; Waxman 
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and O'Connor, 2006b).  Studies in mouse as a model have confirmed that sex 
biased expression of liver genes are largely regulated by temporal pituitary 
secretion pattern of growth hormone (GH), whose intermittent secretion in males 
and persistent secretion in female dictates the sex-differential activation patterns 
of transcription factors in the liver, most centrally STAT5, leading to genome wide 
sex-biased transcription (Holloway et al., 2007a; Udy et al., 1997a; Wiwi and 
Waxman, 2004a).  Previous attempts to study liver sex bias on a protein level 
utilized 2D gel electrophoresis to resolve nuclear proteins in rat liver to show sex 
biased, GH dependent protein abundance (Laz et al., 2004); however, the 
methodology was low-throughput, laborious and imprecise.  Here, the 
combinations of ribosome profiling and matching total RNA-seq confirmed liver 
sex-bias on the translational level, and identified a small subset of genes that 




5.C.1: Cytoplasmic or nuclear localization of liver mRNAs 
RNA-seq analysis was performed on 5 different sample types derived from male 
and female mouse liver, pertaining to localization: nuclear RNA (Nuc), 
cytoplasmic RNA (Cyto) and total RNA (Tot); and pertaining to ribosome 
protected fragments (RPF) and matching total RNA controls (ctrl).  Localization 
samples (Nuc, Cyto, Tot) and RPF samples (RPF, ctrl) were derived from two 
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separate mouse experiments.  A total of 13 pair-wise comparisons were carried 
out to identify differentially expressed genes, defined as FC > 2 and FDR < 0.05, 
to elucidate liver gene sex specificity, gene localization, and translational 
efficiency (TE).  As a starting point, an initial heatmap was created (Figure 5.1A) 
to inspect the 13 comparisons (Table 5.1).  RNA from the total, cytoplasmic and 
nuclear fractions of liver tissues were sequenced with the intention of using these 
datasets to assign cellular localization of genes.  The most straightforward 
method being to compare the ratios and significance of gene RPKMs (Reads Per 
Kilobase of transcript per Million mapped reads) between different cellular 
compartments; however, we show here these ratios were highly skewed by gene 
abundance.  Specifically, the Nuc/total ratio was largely determined by gene 
abundance in the total fraction, as genes in the nuclear measurement exhibited 
low dynamic range (Figure 5.2).  With the exception of a few genes, most genes 
with high nuc/total ratios were those with near 0 RPKM, such that a small 
elevation in nuclear RPKM resulted an inflated ratios.  The observation that 
nuclear RPKM and total/cytoplasmic RPKM were not directly comparable was 
due to several confounding factors.  Firstly, the nuclear compartment contains 
more diverse transcripts than cytoplasmic transcripts, including non-coding RNAs, 
intronic reads, etc, due the near ubiquitous transcription of the genome.   
Moreover, the half-life of transcripts in the nuclear compartment may be short, 
due to the fact that many transcripts are either being actively degraded 
(intermediates) or exported into the cytoplasm.  Consequently, nuclear RNA-seq 
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resulted in overall low RPKM of all genes, because 1) interrogation of more RNA 
species in fixed sequencing depth, 2) Many genes are dynamically removed from 
the nucleus and do not accumulate, 3) nuclear retained transcripts naturally tend 
to be lowly expressed.  Finally, the absolute proportion of RNA in the cytoplasm 
and nucleus will require an empirically derived normalization factor that accounts 
for the relative number of cells represented by 1 μg of cytoplasmic RNA and 
nuclear RNA.  Currently, a precise normalization factor has not been elucidated, 
except that we know that the vast proportion of RNA in the cell resided in the 
cytoplasm.  Taken together, cellular localization could not be reliably determined 
from RNA-seq of nuclear, cytoplasmic and total RNAs. 
 
5.C.2: Calculation of liver RNA translational efficiencies 
 
Ribosome footprints needed to be normalized by total RNA abundance because 
abundant genes produce more footprints.   There was concern that using total 
RNA would skew the calculation of translational efficiency due to the inclusion of 
nuclear RNAs occluded from ribosome occupancy in the calculation of TE.  To 
address this concern, we calculated Total/Cyto ratio for genes ranked by 
expression levels (Figure 5.3).  For extremely lowly expressed genes, total/cyto 
ratio was artificially elevated because these transcripts were only identified in the 
nucleus (for example, ratios like 0.025/0 are artificially high), and hence 
prompting a cutoff of RPKM>1. At low to intermediate expression levels, the 
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Total/Cyto ratio was close to 1, indicating that using total or cytoplasmic values 
for TE calculation will yield comparable results for these genes.  For genes with a 
high expression level, the total/cyto ratio drops to about 0.8, indicating that the 
"true" TE for these genes was over-estimated by about ~1.25-fold by using the 
total RNA value.  Consequently, TE, calculated as log2 fold difference between 
RPF and total RNA abundance, increased with increasing RPKM of the gene 
(Figure 5.4). Whether this RPKM dependent bias had a technical or biological 
basis was difficult to ascertain.  Nevertheless, this analysis indicated that any 
bias from using total RNA-seq for normalizing RPF was limited, and that by 
attempting to "correct" total RPKM by a "normalization factor" will probably 
introduce even more uncertainty.  Taking a step back, TE is a relative 
measurement that has no significance on its own.  What is significant here is the 
statistically significant differential TE between experimental conditions, in this 
case being male versus female liver, and not the absolute values of TEs.   
 
5.C.3: Regulation of sex bias at the translation level 
 
The majority of stringent set of 175 genes identified as sex specific by total RNA-
seq (criteria: FC>2, FDR<0.05 in both comparisons 3 and 10) were also sex 
specific at the nuclear (78%), cytoplasmic (95%) and RPF levels (95%), 
indicating that the majority of sex biased genes were regulated at the 
transcription stage and maintained through translation, with preservation of the 
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magnitude of sex bias, as indicated by correlation analyses (Figure 5.6).  The 
22% of sex specific genes that were not significantly sex biased at the nuclear 
level could be attributed to sex differential regulation in the cytoplasm such as 
RNA degradation rate; however, one cannot overlook the observation that the 
nuclear samples were not as sensitive as total, cytoplasmic and RPF samples at 
detecting differential transcripts (Figure 5.5).   
 
We identified 33 sex-independent RNA transcripts that were sex-biased at the 
RPF level, suggesting that the protein abundance of these genes were sex-
differential by means of translational regulation (Table 5.2).  These 33 genes 
were identified by stringent criteria of |FC|>2 and FDR<0.01 for RPF(M)/RPF(F) 
comparison and FDR>0.5 for the control (M)/control(F) comparisons, in addition 
to the requirement that the fold change at the RPF and total levels must differ by 
more than 2 fold.  We then investigated the TE (defined by RPF/ctrl total) in male 
and female liver.  Increased TE in the male liver characterized 73% (16/22) of 
genes that were more highly translated in the male liver, whereas only 36% (4/11) 
female-preferential translated genes displayed significantly elevated TE in the 
female liver.  These results demonstrate the utility of using RPF data to identify 
differentially translated genes that were not apparent from total RNA-seq alone.  
However, the vast majority of these translational sex biased genes exhibited 
extremely low total RPKM, raising the possibility that these were artifacts.  Cela1 
(Chymotrypsin-like elastase family member 1) was one of few genes with 
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RPKM>1that displayed sex biased ribosome occupancy, as illustrated in the 
screenshot (Figure 5.7).   
 
5. D: Discussion 
 
Here we employed ribosome profiling to show for the first time that liver sex 
differential gene expression were largely established at the transcriptional level in 
the nucleus and maintained in protein translation in the cytoplasm, indicating that 
the extent of sex-biased RNA expression reflected the extent of sex-bias in the 
proteome, where differential abundances of key proteins drive functional 
differences in male and female liver.  This work also explored the utility of RNA-
seq data from nuclear, cytoplasmic and total fractions of liver tissues, specifically 
how they impact the calculation of translation efficiency.  We also identified a 
small subset of lowly transcribed sex independent genes that were occupied by 
ribosomes in a sex biased manner, indicating that sex differential translation may 
be a mechanism, albeit utilized by a small number of genes, by which sex 
differential protein output can be achieved. 
 
Sex biased hepatic gene expression has been a topic of interest since 1980s  for 
its wide implications in health and pharmacodynamcis (Jansson et al., 1985a; 
Kramer et al., 1979; Waxman and Holloway, 2009a).  Much of the effort to 
understand liver sex specificity has relied on measurements of RNA abundance 
by qPCR, microarrays or RNA-seq, with the assumption that RNA levels are 
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primarily determined by regulation taking place at transcription initiation in the 
nucleus.  Transcription regulation was initially described by Sundseth et al using 
run-on transcription assays for a few sex-specific genes in rat liver nuclei 
(Sundseth et al., 1992).  Later studies identified chromatin regulation involving 
GH regulated, sex dependent differences in chromatin accessibility (Ling et al., 
2010b) and histone marks (Sugathan and Waxman, 2013a), further implicating 
epigenetic regulation at the level of  chromatin a key factor in sex-biased gene 
expression.  However, as multiple layers of regulation take place between 
transcription and translation (Hershey et al., 2012), the extent of sex bias 
detected at the RNA level that is preserved through the translation level was 
unclear.  The ribosome profiling results presented here provide comprehensive 
quantification of protein output in liver and indicated that stringent sex specific 
genes identified on the RNA level were largely sex differentially translated as well.  
These findings provide important perspective on prior as well as future work.    
 
Genes with sex equivalent RNA levels that were translated with sex-biased 
efficiency present an interesting observation.  Translational efficiency is primarily 
influenced by synonymous mutation that influences codon usage, levels of 
tRNAs in the cell and the folding energy of the mRNA transcript that impact the 
recruitment of ribosomes at the initiation site (Hall et al., 1982; Ikemura, 1985; 
Tuller et al., 2010).  While these factors can lead to variations in translational 
efficiency as seen in this study, they were unlikely to be sex specific factors.  
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Hence, the small cohort of lowly expressed sex independent genes that 
appeared to be sex biased at the RPF level here study need to be interpreted 
with caution.  Overall, it does not appear that translational efficiency is a major 
mechanism of regulating sex biased genes.  Utility of RPF extend beyond 
calculation of translation efficiency; this project will benefit from additional 
analyses such as elucidation of ribosome occupancy of sex-biased predicted 
lincRNAs to validate their coding potentials.  In sum, the analyses presented 




Generation of matching total, cytoplasmic and nuclear RNA-seq datasets 
ICR 8-week male and female mice were anesthetized by carbon dioxide and 
livers were immediately harvested, a small piece of which was flash frozen for 
total RNA extraction.  The majority of the fresh liver tissue was rinsed in 1X PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) and 
homogenized in 3 ml of 2 M sucrose solution using an electric dounce 
homogenizer designed for isolating nuclei from liver tissues, as previously 
described (Ling and Waxman, 2013).  The liver homogenate was spun down at 
25 k RPM at 4C in a swinging bucket Sorvall centrifuge system with a SW28 
rotor for 30 min, which resulted in a white pellet at the bottom of the tube that 
comprised of liver nuclei, leaving the supernatant devoid of nuclei.  RNA was 
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extracted from the supernatant using Trizol LS, which was considered to the 
cytoplasmic fraction.  Nuclear RNA was extracted directly adding Trizol to the 
pellet.  1 μg each of total, cytoplasmic and nuclear RNA was used to prepare 
RNA-seq libraries using NEBNext RNA-seq (NEB cat. no. E7420S) kit per 
manufacturer's instructions, and subjected to 50 bp pair-end sequencing. 
 
Ribosome profiling of liver tissues 
 
Ribosome profiling was performing according to Ingolia et al with modifications 
(Ingolia et al., 2009).  Whole livers were harvested from five 8 wk ICR male and 
five 8 wk ICR female mice and immediately snap frozen in liquid nitrogen.  
Frozen livers were pulverized into a fine powder using a chilled pestle and mortar.  
0.05 g of liver powder was homogenized in 1 ml of chilled lysis buffer (20 mM 
Hepes pH7, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 μg/ml cycloheximide 
(Sigma Cat. no. C7698-1G, stock prepared by dissolving in ethanol) freshly 
added, 1% NP-40, 1% Triton X-100, 25 U/ml Turbo DNase(Thermo Fisher 
Scientific Cat. No. AM2238)) containing 100 μg/ml cycloheximide using a chilled 
glass dounce homogenizer for minimum number of strokes to achieve 
homogeneous suspension (~6 strokes).  The liver homogenate was clarified by 
spinning down at max speed (18k RCF) for 10 min at 4 °C and the lysate was 
recovered, avoiding the pellet and fat.  205 μl of lysate was digested with 2ul of 
RNaseI (Invitrogen Cat. AM2294, RNaseI 100 U/μl) for 45 min at room 
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temperature, and spun down briefly at max speed (18K RCF) to separate the fat 
layer.  100 μl of RNase-digested liver lysate was applied to Illustra MicroSpin S-
400 HR columns (GE Healthcare, Cat. No. 27-5140-01) pre-equilibrated with 3 
mls of column equilibration buffer (20 mM Hepes pH7, 150 mM NaCl, 5 mM 
MgCl2), and spin down at 600 x g for 2 min.  10 μl of 10% SDS was immediately 
added to the eluate containing the ribosome associated RNA.  After cleanup the 
eluate with Zymo RNA Clean&Concentrator -25 with modifications (Step 1: use 
22 μl binding buffer; step 2: use 495 μl absolute ethanol), RNA concentration was 
determined by Nanodrop and 5 μg of ribosome associated RNA was depleted of 
rRNA fragments using Ribo-Zero Gold rRNA removal kit (Illumina Cat. No. 
MRZG126, according to manufacturer's instructions with the following 
modifications: omit the 50 °C incubation step; purify final RNA product by Zymo 
RNA Clean and Concentrator kit -5; elute final product in 40 μl).  Note that 
modifications to manufacturer's instructions were made to ensure maximal 
recovery of small RNA molecules (e.g. purifying the output by Zymo RNA kit 
rather than by phenol chloroform; increasing the amount of ethanol to ensure 
small RNA molecules are bound to purification columns; omitting high 
temperature incubations, etc).  The rRNA depleted ribosome associated RNAs 
were denatured at 70 °C for 2 min, chilled on ice, and immediately subjected to 3' 
dephosphorylation (1μl RNase inhibitor, 5 μl T4 PNK buffer, 1μl T4 PNK kinase, 
43 μl RNA sample; incubated for 1 hour at 37 °C.  T4 polynucleotide kinase (PNK) 
reaction buffer was purchased from NEB, Cat. No. B0201S.  T4 polynucleotide 
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kinase: 10,000 units/ml from NEB, Cat. No. M0201S).  The sample was cleaned 
up using Zymo RNA Clean & Concentrator kit  -5 with modifications (Step 1: use 
200 μl binding buffer; step 2: use 250 μl absolute ethanol).   The purified RNA 
was resuspended in 43 μl of nuclease free water and subjected to 3' 
dephosphorylation reaction by adding 5 ul of T4 PNK buffer and 1ul of T4 PNK 
kinase (NEB, Cat. no. M0201S), and incubated at 37 °C for 1 hr.  The reaction 
was again cleaned up using Zymo RNA Clean and Concentration kit -5 with 
same modifications described above, and the purified RNA was eluted in 10 μl of 
nuclease free water. The 30 nt ribosome footprint fragments were isolated by 
urea 15% polyacrylamide gel electrophoresis (PAGE ) by cutting the 28-30 nt 
band, followed by elution from the pulverized gel slice in 400 μl RNA extraction 
buffer (300 mM sodium acetate, 1mM EDTA, 0.5% SDS) overnight in 4 °C 
followed by isopropanol precipitation with GlycoBlue.  The resulting pellet was 
resuspended in 7μl RNase-free water.  We used NEB Small RNA library kit (NEB 
Cat. E7330S) to prepare the ribosome footprint libraries with the following 
important modifications.  The purpose of these modifications here is to repair the 
RNase-cut ends of the ribosome footprint fragments and restore the 3'OH and 
5'P for adaptor ligation.  After the 3' adaptor ligation step, the 3' adapter ligated 
ribosome footprint hybrid was 5' phosphorylated (38 μl RNA; 5 μl T4 PNK buffer; 
5 μl 10 mM ATP, 1.5 μl PNK, 1 μl RNase inhibitor; Incubated 37 °C for 30 min) 
and cleaned up using Zymo RNA Clean and Concentrator -5 in 7.5 μl water.  The 
reaction was brought back to the original composition before the 5' 
198 
 
phosphorylation by adding back the components in the 3' adaptor ligation step, 
and rest of the NEB small RNA library preparation protocol was carried out 
according to the manufacturer's instructions.  The final libraries were amplified for 
10 PCR cycles and purified using 6% PAGE TBE gel (1X TBE: 89 mM Tris, 89 
mM boric acid, 2 mM EDTA, pH ~8.3).  Libraries were sequenced by Illumina 
single end 50-bp sequencing.  Total RNA was prepared from corresponding 
frozen liver powder from each of the same 5 male and 5 female mouse liver and 
sequenced by Illumina 50 bp paired end sequencing for comparison to the 
corresponding RPF samples.  
 
Ribosome footprint data analysis 
 
Adapter sequences were trimmed from ribosome footprint reads using 
TrimGalore 0.4.3.  The ~30 bp ribosome footprint reads  were mapped to mouse 
mm9 genome using Bowtie 2.  To mitigate confounding factors in mapping 
efficiency, 50 bp paired-end reads from the total liver RNA-seq data were 
trimmed to 30 bp and mapped to mm9 genome using Bowtie2 single end mode, 
using identical parameters used for mapping RPF reads.  Reads corresponding 
to exonic regions of 24,198 RefSeq genes were counted by FeatureCounts 
1.22.2 (Liao et al., 2013).  Normalization and differential expression between the 
13 pair-wise comparisons were performed by EdgeR (Robinson et al., 2009) 
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using default parameters.  Here, significance was defined as |fold change| > 2 
and FDR < 0.05, except where indicated otherwise. 
 
Basic data analyses strategies 
Results from EdgeR differential analyses was analyzed in R using basic data 
selection and binning techniques.  Plots were created by ggplot package in R.  
Average RPKM values across biological replicates was calculated by DESeq 
















Table 5.1.  Thirteen pair-wise comparisons performed to identify genes in sex 
specificity, localization and RPF abundances.  Significantly differentially 
expressed genes (FC>2, FDR<0.05) were classified as "Up" (higher in test group) 
or "Down" (lower in test group) 
 
# Theme Test  Control Up  Down  
1 Sex bias in 
Nuc, Cyto, total 
Nuc_M Nuc_F 151 151 
2 Cyto_M Cyto_F 148 189 
3 Total_M Total_F 143 184 
4 Localization 
(male liver) 
Nuc_M Total_M 2028 2767 
5 Cyto_M Total_M 0 17 
6 Nuc_M Cyto_M 2350 2892 
7 Localization 
(female liver) 
Nuc_F Total_F 2035 2805 
8 Cyto_F Total_F 8 1 
9 Nuc_F Cyto_F 2402 2813 
10 RPF control Ctrl_M Ctrl_F 126 119 
11 RFP M/F ratio RPF_M RPF_F 175 158 
12 RFP/total RPF_M Ctrl_M 2075 2776 
















Figure 5.1.  (A) Heatmap representation of genes in the ribosome profiling 
dataset.  8765 genes were significant in at least one of the thirteen comparisons 
(|FC|>2, FDR<0.5).  Fold changes are presented in dark orange (significant: 
FC>2), light orange (not significant: FC 1.5-2), white (not significant: FC 1.5-(-
1.5)), light blue (not significant (-1.5)-(-2)) and dark blue (significant: FC < (-2)).  
Hierarchical clustering grouped the comparisons by their respective themes.  
Notably, reciprocal patterns were prominently observed between localization 
(Nuc/Total, Nuc/Cyto) comparisons and the (RPF/total) comparisons.  (B) (Left): 
Venn Diagram representation of the overlap of significant sex-biased genes (FC 
> 2; FDR < 0.5) determined by RNA-seq from three cellular fractions: total 
(comparison 1), cytoplasmic (comparison 2) and nuclear (comparison 3).  (Right): 
Venn Diagram representation of overlap of significant sex-biased genes 




















Figure 5.2.  Nuclear/Total ratio is RPKM dependent.  Cutoff of RPKM>0 (top) or 
RPKM>1 (bottom) was applied to the ~24,000 Ref-seq genes and were divided 
into 5 bins based on their nuclear/total ratios, as indicated.  Boxplots of RPKMs 
in the total, nuclear, cyto and RPF fractions were shown (outliers excluded) for 
the genes in each bin.  Nuclear RPKMs exhibit small dynamic range, meaning 
that the RPKM of genes in nuclear measurements were relatively low across the 
five bins.  In contrast, RPKM in total, cyto and RPF measurements exhibited a 
wide dynamic range, where RPKM increased with lower nuclear/total ratios.  This 
strong RPKM dependence indicates that nuclear/total ratio cannot be used as a 


















Figure 5.3.  Total RPKM/Cyto RPKM ratios are RPKM dependent.  Genes with 
>1 RPKM were ranked by their total RPKM and divided into 20 bins.  For each 
gene, the ratio of total_RPKM to cytoplasm_RPKM was calculated as shown in 
the boxplots.  The red horizontal line indicates a ratio of 1.  A distinct trend can 
be observed, where low expressed genes (bins on the left end of spectrum) had 
ratios of close to 1.  The total/cyto RPKM ratio decreased with increasing gene 
expression, until the final bin, where genes such as Alb resided, the total/cyto 
ratio was approximately 0.8.  This observation can be interpreted in two ways: 1) 
High abundance genes tend to be accumulate more in the cytoplasm, 2) This is 
an artificial bias.  Either way, this analysis showed that total RPKM 
measurements over-estimated cytoplasmic abundance by a maximum of 25% for 






























Figure 5.4.  Translational efficiency is RPKM dependent.  Translational efficiency 
(TE) is defined as RPF reads normalized by the total abundance.  (Top)  
Histogram of TE calculated as log2(RPF/Total).  (Bottom) TE as a function of 
genes binned by increasing RPKM with a RPKM>1 cutoff. A red horizontal line 
was drawn at TE value of zero.  The upward shift in TE is observed with 















Figure 5.5. Nuclear samples provided the least resolution to identify differential 
expression.  Genes were ranked by their FDR and the first 5000 FDR values (x 
axis) were plotted according to their rank (y axis).  It can be seen that the cyto, 
total and RPF sample curves were close together while the nuclear curve was 
shifted to the left.  This indicates that nuclear samples were more limited in 
identifying differential analysis, consistent with the limited dynamic range of 
nuclear samples.  The goal of this analysis is to throw caution to data 
interpretation.  For example, if a gene was differential at the cytoplasmic level 
(cytoM/cytoF) and not at the nuclear level (nucM/nucF), we cannot automatically 




















































Figure 5.6.  Heatmap representation of sex specific genes in nuclear, 
cytoplasmic and RPF fractions.  174 sex-biased genes were identified as being 
significantly differential in both sets of wildtype male versus wild type female 
comparisons: total_male / total_female (from the localization set) and 
control_male / control_female (from the RPF control set) at significance cutoff of 
|FC|>2 and FDR<0.05.  Correlations of sex bias fold changes at three levels of 
localizations: Nuc (M/F), Cyto (M/F) and RPF (M/F) are also shown.  This 
analysis demonstrates that sex specificity is regulated at the transcription level 















Table 5.2.  Regulation of sex biased genes at the translational level.  (Top) Two 
groups of genes were identified (group A and group B).  Group A genes were sex 
biased at the RPF level (RPF_M/RPF_F; FC>2, FDR<0.01) but not at the total 
RNA level (ctrl_M/ctrl_F; FDR>0.5), and vice versa for Group B genes. (Middle) 
To determine if translation efficiency (TE) played a role in imparting sex bias to 
translation of genes that were otherwise sex-independent at the transcription 
level, TE (RPF/ctrl) in male and female liver was compared (FDR<0.05).  (Bottom) 
Complete list of the 33 genes. 
 
Significance Group A Group B 
RPF yes no 
Control no yes 
Total genes 33 3 
 






Male specific (22) 16 0 6 
Female specific 
(11) 


































Reg2 10.04 1.77E-06 3.34 7.08E-01 5.83 1.06E-03 0.94 1.00E+00 13.28 0.01 0.18 0.00
Try5 8.99 1.22E-06 3.01 5.08E-01 4.93 5.13E-03 -0.52 1.00E+00 12.35 0.02 0.33 0.02
Prss3 8.53 1.40E-03 1.24 1.00E+00 5.51 7.08E-03 0.00 1.00E+00 1.35 0.00 0.02 0.00
Cuzd1 8.33 8.99E-07 4.11 5.38E-01 3.93 2.78E-02 1.51 1.00E+00 1.86 0.00 0.10 0.00
Pla2g1b 8.21 3.43E-04 0.77 1.00E+00 5.18 5.97E-03 -1.83 9.90E-01 4.46 0.01 0.08 0.06
Serpini2 7.81 4.92E-04 3.34 7.08E-01 3.61 4.02E-02 0.94 1.00E+00 1.22 0.00 0.08 0.00
Pdia2 6.36 2.22E-03 1.66 1.00E+00 3.65 4.12E-02 -0.80 1.00E+00 0.89 0.01 0.05 0.01
Bglap3 5.95 7.17E-03 2.67 6.12E-01 0.17 1.00E+00 -2.66 5.82E-01 1.45 0.01 1.05 0.11
Spink3 5.65 1.63E-04 1.91 1.00E+00 4.81 6.28E-03 2.50 9.90E-01 4.86 0.09 0.13 0.00
Tff2 4.07 1.58E-03 1.86 1.00E+00 3.93 1.21E-02 1.92 1.81E-01 4.94 0.29 0.25 0.04
Dnase1 3.88 4.12E-09 1.87 1.00E+00 1.31 1.31E-01 -0.28 1.00E+00 0.40 0.02 0.13 0.02
Mup1 3.10 3.22E-03 0.00 1.00E+00 7.95 4.07E-06 4.89 3.31E-02 2.15 0.24 0.00 0.00
Ikzf4 3.09 2.69E-04 0.68 1.00E+00 -2.24 7.60E-05 -4.49 3.15E-09 0.11 0.01 0.45 0.25
Arhgap36 3.01 1.52E-05 1.49 1.00E+00 1.87 3.03E-02 0.53 1.00E+00 0.36 0.04 0.08 0.02
Cela1 2.95 3.10E-03 0.20 1.00E+00 2.39 4.71E-03 -0.34 5.37E-02 74.77 9.70 11.79 10.01
Mup14 2.68 1.52E-03 0.00 1.00E+00 6.24 4.12E-06 3.64 6.75E-01 0.67 0.10 0.00 0.00
Them5 2.58 3.31E-04 0.70 1.00E+00 2.00 2.06E-02 0.26 1.00E+00 0.52 0.08 0.09 0.04
Slc25a31 2.45 4.25E-03 0.47 1.00E+00 2.19 1.62E-02 0.35 1.00E+00 0.58 0.10 0.11 0.06
Mup12 2.37 1.68E-03 1.24 1.00E+00 4.75 1.58E-06 4.78 2.86E-02 1.16 0.22 0.02 0.00
Zfp872 1.70 4.07E-03 0.56 7.77E-01 -3.01 9.92E-18 -4.07 1.86E-25 0.24 0.07 1.65 1.09
Cyp2d12 1.40 8.08E-04 0.37 1.00E+00 -0.58 1.26E-01 -1.56 1.53E-04 0.54 0.20 0.65 0.49
Bok 1.24 3.63E-04 0.23 1.00E+00 -0.64 4.82E-02 -1.61 1.85E-07 2.11 0.88 2.63 2.11
Ncmap -1.14 8.24E-03 0.00 1.00E+00 0.48 8.01E-01 1.66 8.79E-05 1.72 3.76 1.05 0.91
Rcan3 -1.35 3.71E-03 -0.32 1.00E+00 -1.13 2.18E-02 -0.07 1.00E+00 0.42 1.07 0.74 0.96
Bex4 -1.53 6.59E-04 -0.39 1.00E+00 1.60 1.42E-01 2.72 1.74E-04 0.51 1.47 0.14 0.17
Ms4a4b -1.59 4.06E-05 -0.46 1.00E+00 -0.51 7.74E-01 0.62 3.25E-01 0.35 1.05 0.39 0.53
Satb1 -2.10 6.61E-03 -0.28 1.00E+00 -3.95 2.20E-12 -2.14 9.89E-07 0.02 0.08 0.26 0.31
Dpf1 -2.29 8.94E-03 -3.40 7.94E-01 2.80 5.71E-01 0.22 1.00E+00 0.02 0.13 0.00 0.09
Cga -3.62 1.09E-04 -2.26 1.00E+00 1.57 1.00E+00 1.45 2.41E-01 0.02 0.41 0.00 0.09
Zfp641 -3.68 2.71E-03 -2.00 5.44E-01 -2.66 3.29E-01 -1.40 1.02E-01 0.00 0.07 0.03 0.17
Wdr63 -4.65 9.81E-03 -1.40 5.33E-01 -5.83 1.84E-05 -3.33 9.96E-06 0.00 0.03 0.08 0.22
Fmo6 -5.09 7.32E-04 -2.28 1.00E+00 0.00 1.00E+00 0.78 1.00E+00 0.00 0.06 0.00 0.03






Figure 5.7.  Screenshot of Cela1 gene, which showed more ribosome footprints 
in the male liver than in the female liver.  Cela1 showed sex independent 
expression in the total RNA level but was male specific at the RPF level, as 





































Supplemental Figure 5.1: The ribosome profiling protocol.  (A) Schematic of the  
ribosome profiling method, taken from (Ingolia, 2014a).  Refer to Methods section 
for details.  (B) 15% Urea PAGE gel of ribosome associated RNA (the lysate 
obtained from the Illustra column purification step).  The 30 nt ribosme protected 
fragments are boxed in red.  (C) 15% Urea PAGE gel of ribosome associated 
RNA after RiboZero treatment.  The gel bands indicated in red boxes were 
extracted for library preparation.  (D) 1% Agarose gel showing the final purified 
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